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ABSTRACT 
 
Background: Patient reports of pain and function are used to inform the need for and 
timing of total knee replacement (TKR) and evaluate TKR outcomes. This dissertation 
compared measurement properties of commonly-used patient surveys in TKR and 
explored ways to develop more efficient knee-specific function measures.  
Methods: 1,179 FORCE-TJR patients (mean age=66.1, 61% female) completed 
questionnaires before and 6 months after TKR. Patient surveys included the knee-
specific Knee injury and Osteoarthritis Outcome Score (KOOS) and Western Ontario 
and McMaster Universities Osteoarthritis Index (WOMAC) and generic SF-36 Health 
Survey. Tests of KOOS and WOMAC measurement properties included evaluations of 
scaling assumptions and reliability. Item response theory methods were used to calibrate 
22 KOOS function items in one item bank; simulated computerized adaptive tests (CAT) 
then were used to evaluate shorter function scores customized for each patient. Validity 
and responsiveness of measures varying in attributes (knee-specific versus generic, 
longer versus shorter, CAT versus fixed-length) were compared. 
Results: KOOS and WOMAC scales generally met tests of scaling assumptions, 
although many pain items were equally strong measures of pain and physical function. 
Internal consistency reliability of KOOS and WOMAC scales exceeded minimum levels 
of 0.70 recommended for group-level comparisons across sociodemographic and clinical 
subgroups. Function items could be calibrated in one item bank. CAT simulations 
indicated that reliable knee-specific function scores could be estimated for most patients 
with a 55-86% reduction in respondent burden, but one-third could not achieve a reliable 
(≥ 0.95) CAT score post-TKR because the item bank did not include enough items 
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measuring high function levels. KOOS and WOMAC scales were valid and responsive. 
Short function scales and CATs were as valid and responsive as longer KOOS and 
WOMAC function scales. The KOOS Quality of Life (QOL) scale and SF-36 Physical 
Component Summary discriminated best among groups evaluating themselves as 
improved, same or worse at 6 months.   
Conclusions: Results support use of the KOOS and WOMAC in TKR. Improved knee-
specific function measures require new items that measure higher function levels. TKR 
outcomes should be evaluated with a knee-specific quality of life scale such as KOOS 
QOL, as well as knee-specific measures of pain and function and generic health 
measures. 
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Gandek B. Measurement properties of the Western Ontario and McMaster 
Universities Osteoarthritis Index: A systematic review. Arthritis Care & Research 
2014 Jul 21. [Epub ahead of print] 
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Gandek B, Ware JE. Tests of data quality, scaling assumptions and reliability of 
the KOOS and WOMAC in total knee replacement: Results from the FORCE-TJR 
cohort. 
 
WOMAC® is a registered trademark of Nicholas Bellamy.  
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CHAPTER I: INTRODUCTION 
 
The burden of osteoarthritis (OA) is an important public health concern. The 
National Arthritis Data Workgroup estimated that in 2005 nearly 27 million US adults had 
clinically-defined osteoarthritis, a 28% increase in prevalence since 19951. The 
prevalence of OA is expected to increase even further due to an aging population, with 
the CDC projecting a 40% increase in doctor-diagnosed cases of arthritis from 2005 to 
20302. Treatment of OA is focused on reducing joint pain and stiffness, preserving and 
improving joint mobility, limiting joint damage, reducing disability, and improving health-
related quality of life3. Expert consensus recommendations for conservative treatment of 
OA include a combination of pharmacological and non-pharmacological therapies3-5. 
However, when medical management of knee and hip osteoarthritis is no longer 
successful, consideration of total joint replacement (TJR) is recommended3, 6. 
Total joint replacement is one of the most common and costly Medicare surgical 
procedures. TJR also is becoming more frequent among younger adults7; nearly 45% of 
TJR patients were younger than 65 in 20088 and more than 50% are projected to be 
below age 65 by 20169. Across all age groups, rates of TJR surgery are expected to 
increase exponentially in the next few decades. Total knee replacement (TKR) is the 
most common type of TJR surgery; annual numbers of TKRs are projected to increase 
from 670,000 in 201210 to an estimated 3.5 million in 203011. 
Because TKR is performed to restore function and to reduce pain and other 
symptoms, the Osteoarthritis Research Society International (OARSI), OMERACT, and 
other clinician groups recommend that patient-reported measures of pain, function, and 
global assessment, along with radiographic measures of joint damage, be used to inform 
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the need for and timing of TKR6 and to evaluate TKR outcomes12-14. While TKR reduces 
pain and improves function substantially on average15, there are significant variations in 
patient-reported outcomes (PROs) that have been associated with both patient (e.g., 
age, gender, BMI, comorbid conditions)15-17 and provider (e.g., implant device, hospital 
and surgeon volume, post-operative care)18-20 characteristics. These variations 
underscore the importance of obtaining reliable and valid information from patients in 
evaluating TKR outcomes. 
PRO Questionnaires Used in Knee OA and Total Knee Replacement 
The most widely-used joint-specific PRO questionnaire used in knee OA and 
TKR research is the Western Ontario and McMaster Universities Osteoarthritis Index 
(WOMAC®)21-23, which was published nearly 30 years ago and is recommended by 
OARSI and other clinical groups for OA studies12. It contains 24 items that measure the 
impact of a specific joint on stiffness, pain during activities, and difficulties with function 
in activities of daily living (ADL). Shorter 7 and 8-item versions of the 17-item WOMAC 
function scale have been proposed but are not widely used24-26. The 42-item Knee injury 
and Osteoarthritis Outcome Score (KOOS)27 was developed as an extension of the 
WOMAC. The KOOS contains all 24 WOMAC items, additional pain and symptom items, 
and items about knee-related function in sport/recreation and knee-related quality of life. 
A shorter 7-item function scale (KOOS-PS) has been constructed from the KOOS 
function items28. In addition to joint-specific questionnaires, generic (general) health 
surveys, which are not specific to any disease, age, or treatment group, are also used in 
OA studies. The generic health questionnaire that is most widely-used in TKR research 
is the SF-36® Health Survey29, which is scored as an eight-scale profile as well as 
physical and mental health summary measures30, 31. 
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Collection of PRO Data in National TJR Registries 
As policy makers and payers place more emphasis on understanding the 
patient’s perspective of their health, interest in collecting PRO data from TJR patients in 
national registries has increased. The UK mandates that its Department of Health collect 
PRO data for all TJR patients before and after surgery, using the joint-specific Oxford 
Hip and Knee Scores32, 33 and the generic EuroQol EQ-5D™34; the UK may link 
payments to PRO data in the future18.  Many other registries also collect both a joint-
specific and generic measure35; for example, the New Zealand joint registry administers 
both the Oxford Hip and Knee Scores and EQ-5D, while the Swedish registry collects 
data for the EQ-5D and a joint-specific visual analogue pain scale36. While the Oxford 
Hip and Knee Scores contain 12 items each and thus are attractive due to relatively low 
respondent burden, they do not provide separate pain and function scores and thus pain 
relief cannot be assessed independently of functional improvement37. Questionnaires 
that measure pain and function separately, such as the WOMAC, are more widely-used 
in knee replacement randomized clinical trials38 and studies assessing pain after TKR39. 
In the US, a CMS Technical Expert Panel (TEP) has been established to make 
recommendations on using PROs to evaluate TJR outcomes in performance-based 
measurement systems; the TEP has recommended considering using KOOS and HOOS 
as joint-specific measures40. The US also has one of the largest registries collecting 
PRO data, the Function and Outcomes Research for Comparative Effectiveness in Total 
Joint Replacement (FORCE-TJR) cohort (Franklin, AHRQ P50 HS018910-04). Based at 
the University of Massachusetts Medical School, FORCE-TJR is enrolling more than 
30,000 diverse TJR patients of more than 130 orthopedic surgeons throughout the 
United States41, 42. FORCE-TJR administers the KOOS and SF-36 to TKR patients prior 
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to surgery, 6 months and 1 year after surgery, and annually thereafter. Because all 
WOMAC items (version LK3.0) are included in the KOOS, it is possible to score the 
WOMAC and the short WOMAC function scales using FORCE-TJR data, in addition to 
the short function scale (KOOS-PS) constructed from the KOOS. Thus, FORCE-TJR 
allows for analysis of the KOOS, KOOS-PS, WOMAC, short WOMAC function scales, 
and the SF-36. It therefore provides an ideal database for comparative research into the 
measurement properties of many of the most widely-used PRO instruments in TKR and 
for evaluating implications of the measurement properties for use of these instruments. 
Current Research Topics in PRO Measurement in Total Knee Replacement 
A number of topics related to PRO measurement in TKR warrant further 
investigation, particularly before a performance-based measurement system for TKR is 
established in the US. These topics are discussed below. 
Evaluation of KOOS and WOMAC measurement properties among TKR patients in 
the US using classical psychometric methods 
Joint-specific questionnaires such as the KOOS and WOMAC were developed 
using classical test theory, in which certain assumptions apply; for example, reliability is 
assumed to be the same at all levels of a scale, and the distance between each item 
response score generally is assumed to be equivalent. Measurement properties of the 
KOOS and WOMAC primarily have been evaluated using classical test methods; for 
example, the internal consistency reliability of KOOS and WOMAC scales generally has 
been assessed using Cronbach’s coefficient alpha. Widely-accepted guidelines for PRO 
measures recommend that an instrument’s measurement properties be re-examined 
whenever it is used in a new culture and patient population43, 44. The WOMAC was 
developed in Canada23, and initial testing of the KOOS was primarily conducted in 
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Sweden along with small tests with ACL reconstruction patients in the US45. While the 
measurement properties of the KOOS have been evaluated among patients with knee 
OA in Europe27, 46-50 and Asia51, 52, they have not been examined among knee OA and 
TKR patients in the US. There also is limited research published on the reliability and 
validity of the WOMAC among knee OA patients in the US53-56. In addition, no published 
studies have evaluated KOOS or WOMAC measurement properties for different 
sociodemographic groups, which is particularly important in a country as diverse as the 
US. Particularly because interest is growing in the US in using the KOOS as a PRO-
based performance measure for TKR40, its measurement properties should be examined 
for patients who differ in characteristics such as age, gender, education and income. 
In particular, assumptions underlying the construction and scoring of KOOS and 
WOMAC scales should be evaluated.  KOOS and WOMAC scales are scored using 
Likert’s classical method of summated ratings, in which scores for all items in a scale are 
simply added to calculate a scale score57. The simplicity of this method is based on a 
number of assumptions that should be tested prior to scoring a scale; such tests were 
used extensively in construction and evaluation of the SF-36 Health Survey, for 
example58. However, these tests have not been applied to the KOOS or WOMAC, with 
the exception of very small studies of the KOOS in Iran59 and the WOMAC in 
Singapore60. Tests of scaling assumptions may also provide a new perspective on the 
high (>0.70) correlations observed in multiple studies21 between the KOOS pain and 
function scales and between the WOMAC pain and function scales. 
Development of shorter knee-specific function measures using modern 
psychometric methods 
The KOOS and WOMAC both contain a 17-item function scale that measures 
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difficulty in performing activities of daily living due to a joint problem. Research has found 
that the reliability of this scale is consistently higher than the minimum value 
recommended for group-level comparisons21 and that there is redundancy in its item 
content61, 62. These findings indicate that this function scale could be shortened, thereby 
reducing respondent burden, and still meet reliability standards for clinical research.  
In the past few decades, modern psychometric methods such as item response 
theory (IRT) have increasingly been used to evaluate and improve PRO measures63, 64. 
IRT models are used to create item banks, which consist of a set of items measuring the 
same construct and parameters that describe the items’ measurement properties65.  An 
item bank provides information about the relative difficulty of each item in the bank and 
how well the items as a whole cover the full range of measurement. IRT models do not 
assume that item responses are equidistant and thus yield information that improves the 
scoring of items on an interval scale. In addition, item banks allow improved fixed-length 
measures to be constructed, by selecting the best subset of items from the full item bank 
based on information about the items’ measurement properties. Item banks also provide 
information needed to implement computerized adaptive tests (CATs). CATs administer 
only the most informative items to each individual respondent, thus leading to shorter, 
less redundant, and more precise measurement66.  
Despite their advantages, modern psychometric methods have not been applied 
extensively to the KOOS or WOMAC function items. Those analyses that have been 
conducted have used a specific type of model, the one parameter Rasch model, with 
inconsistent results28, 61, 62, 67-69. Two parameter IRT models are often seen as better for 
use with polytomous items that have ordered response categories (such as the KOOS 
and WOMAC items), because they allow the item discrimination parameter (the item 
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slope) to vary across items, and thus the model is thought to discriminate better between 
patients70, 71. In contrast, the item slope parameter is held constant across all items in the 
Rasch model, thereby requiring that all items have the same discrimination. IRT models 
could be particularly helpful in the development of shorter and more parsimonious 
measures of joint-specific function, by providing a new perspective on which of the 
KOOS and WOMAC function items are most informative. 
Comparison of the validity and responsiveness of PRO measures used in TKR 
No studies have compared the validity and responsiveness of the KOOS, 
WOMAC, KOOS-PS and short WOMAC function scales at the same time. Conducting 
these comparative analyses can provide additional guidance as to the relative strengths 
and weaknesses of joint-specific measures used in TKR. In addition, KOOS and 
WOMAC validity analyses have primarily evaluated correlations among scales; for 
example, the validity of the KOOS has been demonstrated by showing that its scales 
have high (e.g., KOOS Function and SF-36 Physical Functioning) or low (e.g., KOOS 
Function and SF-36 Mental Health) correlations with other scales. While informative, this 
type of analysis provides limited information about whether a scale is a stronger or 
weaker measure of a given construct than another scale. To fully evaluate validity, 
alternative forms of scales need to be compared in relation to external criteria. Such 
comparisons are often done using tests of known groups validity, which compare the 
relative efficiency of scales in detecting differences between groups known to differ at a 
point in time, or in detecting change known to have occurred over time. Tests of known 
groups validity were used extensively in the development of the SF-3672, 73, but to my 
knowledge, have not been applied to the KOOS or WOMAC.  
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Specific Aims 
This dissertation will evaluate the measurement properties of the KOOS and 
WOMAC and the short function scales derived from these questionnaires, using data 
from total knee replacement (TKR) patients enrolled in FORCE-TJR. In addition, the 
KOOS function items will be evaluated to test whether they can be calibrated using item 
response theory, and properties of the resulting item bank and simulated computerized 
adaptive tests (CATs) will be evaluated.  Psychometric analyses will be conducted using 
both classical and modern methods, which will provide complementary perspectives on 
joint-specific measurement in TKR. Specific aims of this dissertation research are to: 
Aim 1 (Chapter II). Evaluate the measurement model and reliability of the KOOS 
and WOMAC among TKR patients using classical psychometric methods. 
This paper will evaluate the KOOS in terms of its data quality, tests of scaling 
assumptions, internal consistency reliability, and floor and ceiling effects (percentage of 
patients with worst and best scores, respectively). Parallel analyses will be conducted for 
the WOMAC. Because widespread use of the KOOS and the WOMAC assumes that 
their psychometric properties apply across diverse populations, analyses also will be 
conducted for groups differing in sociodemographic characteristics such as age, gender 
and education and in clinical characteristics such as body mass index. 
Aim 2 (Chapter III). Use modern psychometric methods to evaluate measurement 
properties of KOOS function items and calibrate the items on a common metric. 
This paper will use item response theory methods to determine if KOOS function 
in ADL and function in Sport/Recreation items define a unidimensional construct and if 
these items can be calibrated in a single function item bank. In addition to providing 
information about the range of function that is measured by the KOOS and how best to 
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measure the difficulty level of individual function items, the item bank will be used to 
conduct computerized adaptive test (CAT) simulations using data from FORCE-TJR 
patients prior to and following TKR. CAT simulations will provide information as to which 
items are the most informative in TKR and how function might be measured more 
precisely with fewer items. 
Aim 3 (Chapter IV). Evaluate the validity and responsiveness of the KOOS, 
KOOS-PS, WOMAC, short WOMAC function scales, new IRT-based and CAT-
based scores developed in Aim 2, and SF-36 among TKR patients. 
This paper will use pre- and post-TKR data to evaluate the validity and 
responsiveness of the KOOS in comparison to the WOMAC, the short function scales 
derived from the KOOS and the WOMAC, and the SF-36. In addition, the validity and 
responsiveness of the new item bank that was developed using all 22 KOOS function 
items, along with computerized adaptive test (CAT) scores calculated from the item 
bank, will be evaluated. While the paper will follow approaches that have been used in 
previous KOOS analyses (e.g., examination of scale correlations), it also will evaluate 
the relative performance of all measures using tests of known groups validity. By 
conducting a variety of cross-sectional and longitudinal tests, for which there are strong 
hypotheses as to the results that would be expected for valid measures, this paper will 
advance understanding of the comparative performance of joint-specific measures. 
A long-term goal of the FORCE-TJR registry is to develop more practical patient-
reported measures for use in comparative effectiveness research and clinical practice. 
Results of this dissertation will advance understanding of the conceptualization and 
measurement of joint-specific outcomes in TKR and thus inform future development of a 
parsimonious and comprehensive measurement system.  
10 
 
CHAPTER II: TESTS OF DATA QUALITY, SCALING ASSUMPTIONS AND 
RELIABILITY OF THE KOOS AND WOMAC IN TOTAL KNEE REPLACEMENT 
 
Abstract 
 
Objective: To evaluate measurement properties of the Knee injury and Osteoarthritis 
Outcome Score (KOOS) and Western Ontario and McMaster Universities Osteoarthritis 
Index (WOMAC) in US total knee replacement (TKR) patients. 
Methods: 1,179 FORCE-TJR patients (43% below age 65) completed surveys before 
and 6 months after TKR. KOOS and WOMAC scales were evaluated for data 
completeness, tests of assumptions underlying item and scale scoring, internal 
consistency reliability, and floor and ceiling effects. Analyses were replicated for 29 
sociodemographic and clinical subgroups and paper versus electronic administration. 
Results: Item-level missing data was generally low (0.1-3.0%). Scale scores could be 
calculated for 97-100% of patients. Most tests of scaling assumptions were satisfied at 
both time points, across all subgroups, and for both methods of administration. However, 
many KOOS Symptom items had high correlations with the KOOS Pain and Activities of 
Daily Living (ADL) scales and many KOOS and WOMAC Pain items had high 
correlations with the KOOS and WOMAC Function in ADL scales. Internal consistency 
reliability exceeded 0.70 for all scales for the total sample and all subgroups with one 
subgroup exception. Floor and ceiling effects (percent with worst and best scores) 
generally were low, but ceiling effects were higher for the WOMAC Stiffness and Pain 
scales than the KOOS Symptoms and Pain scales at 6 months. 
Conclusions: Measurement properties of the KOOS and WOMAC support their use 
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among US TKR patients. However, interpretation of their Pain scales is confounded 
because many pain items were equally strong measures of pain and function. 
 
Introduction 
Patient reports of pain and function are key indicators in determining the need for 
total knee replacement (TKR) and assessing TKR outcomes3. The most frequently used 
joint-specific patient-reported measure of these domains is the Western Ontario and 
McMaster Universities Osteoarthritis Index (WOMAC), which was developed to measure 
pain, stiffness and function in relation to an index joint22. Subsequently, other joint-
specific measures have been developed that include items intended to be more relevant 
for younger and more active patients. Notable among these is the Knee injury and 
Osteoarthritis Outcome Score (KOOS), which includes all 24 WOMAC items and 18 
additional items45. 
Initial development and testing of the KOOS was conducted among patients with 
knee injuries in Sweden74 and the US45. Subsequent psychometric analyses in Europe27, 
46-50, 75-80, Asia51, 52, 59, 81, Northern Africa82 and the US83 primarily have studied ACL or 
meniscus injury patients, although some studies have evaluated patients with knee 
osteoarthritis (OA)27, 46-52. Overall, these studies found that the KOOS met internal 
consistency and test-retest reliability standards for group-level comparisons and 
demonstrated satisfactory construct validity. However, to my knowledge, no 
psychometric analysis of the KOOS has been published for knee OA patients in the US. 
In addition, previous analyses have not examined measurement properties for 
subgroups of particular interest such as those below age 65, who represent an 
increasing proportion of TKR patients9. 
12 
 
KOOS and WOMAC scales are scored using Likert’s method of summated 
ratings, in which scores for items within a scale are simply summed (with or without 
imputation for missing data) to derive a scale score57. However, the simplicity of this 
method is based on a number of assumptions which should be tested prior to scoring a 
scale; such scaling tests were used in the development of the SF-36 Health Survey, for 
example58. These tests have not been applied to the KOOS or WOMAC with the 
exception of studies of the KOOS in Iran59 and WOMAC in Singapore60, both of which 
had much smaller samples (n<70) than recommended for tests of 24-item (WOMAC) or 
42-item (KOOS) questionnaires. Tests of scaling assumptions also may provide a new 
perspective on the high (>0.70) correlations between the pain and function scales which 
have been observed in multiple studies21. 
This paper evaluated the KOOS in terms of data quality, item-level tests of 
scaling assumptions, internal consistency reliability, scale-level correlations, and floor 
and ceiling effects, using data from US knee osteoarthritis patients obtaining TKR. 
Parallel analyses were conducted for the WOMAC, since the complete WOMAC (LK 3.0) 
is included in the KOOS. Because widespread use of these measures assumes that 
their psychometric properties apply across diverse populations, analyses also were 
conducted for groups differing in sociodemographic and clinical characteristics. 
 
Methods 
Patients 
Data were from the Function and Outcomes Research for Comparative 
Effectiveness in Total Joint Replacement (FORCE-TJR) registry, which is enrolling joint 
replacement patients across the US41. Those who could not provide consent due to 
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cognitive impairment or who had emergency surgery were ineligible. All questionnaires 
were self-administered via a web-based or scannable paper-pencil survey at the 
surgeon’s office or at home prior to surgery, 6 months post-surgery and annually 
thereafter. This paper analyzed data from 1,179 randomly selected patients with knee 
osteoarthritis who elected unilateral TKR at FORCE-TJR high volume orthopedic centers 
between May 2011 and August 2012. 
Questionnaire 
The FORCE-TJR questionnaire included the KOOS, SF-36 Health Survey, and 
items about back pain severity and pain in the non-surgical knee and each hip joint. 
Additional questions asked about height and weight, chronic conditions (modified 
Charlson comorbidity index84), sociodemographics, and other patient characteristics. 
The KOOS contains 42 knee-specific items measuring pain, other symptoms, 
function in activities of daily living (ADL), function in sport/recreation, and knee-related 
quality of life (QOL). Because all 24 WOMAC items (version LK3.0) are included in the 
42-item KOOS, the WOMAC Pain (k=5), Stiffness (k=2) and Function (k=17) scales 
could be scored from the KOOS items that were administered in FORCE-TJR22. The 
KOOS Function in ADL and WOMAC Function scales are identical, while the KOOS 
Pain and Symptoms scales augment the WOMAC Pain and Stiffness scales with 4 and 5 
additional items, respectively. (KOOS and WOMAC item content is abbreviated in 
Tables 2.2 and 2.3; see www.koos.nu for more information). In FORCE-TJR, KOOS 
items were asked in reference to the surgical knee. Most KOOS items used a recall 
period of the “last week”; the first KOOS pain and all KOOS QOL items had no recall 
period. All WOMAC items used a “last week” recall period. Following the developer’s 
scoring algorithms, KOOS scales were scored so 0 was the worst possible and 100 the 
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best possible score85. To be comparable with the KOOS, WOMAC scales also were 
scored so 0 and 100 were the worst and best possible scores, respectively. 
Analysis 
The following measurement properties of the KOOS and WOMAC were 
evaluated using baseline (pre-TKR) data: (1) completeness of item and scale-level data; 
(2) tests of scaling assumptions; (3) internal consistency reliability; and (4) scale-level 
statistics including inter-scale correlations and floor and ceiling effects. Analyses were 
conducted using Stata 11.2. 
Data completeness 
The extent of missing data reflects patients’ comprehension and acceptance of a 
survey and sets a limit on reliability and validity. For each item, the percent of patients 
with missing data was examined. In addition, the percent of patients who answered all 
items within each scale and the percent for whom a scale score could be calculated 
were computed. KOOS scale score calculations used standard KOOS scoring 
algorithms in which a scale score is computed if at least 50% of items within a scale are 
answered85. The WOMAC Function scale was calculated if at most three items were 
missing and the WOMAC Stiffness and Pain scales were calculated if at most one item 
was missing, following the developer’s recommendations86. 
Tests of scaling assumptions 
These tests evaluated whether it was appropriate to derive a scale score simply 
by adding item scores, as well as the empirical basis for including a specific item in a 
specific scale87. First, to be included in a scale, an item should be substantially linearly 
related to the total score computed from all other items in a scale (test of item internal 
consistency). Second, to avoid weighting of items, items in each scale should contain 
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approximately the same proportion of information about the construct being measured 
(test of equality of item-scale correlations). Third, items within each scale should have 
roughly equivalent variances, to enable scoring without item standardization. In addition 
to these traditional Likert scaling criteria, correlations of an item with its hypothesized 
scale and all other scales were examined to determine the appropriateness of using the 
item to score one particular scale as opposed to another (test of item discriminant 
validity), following the logic of the multitrait-multimethod approach developed by 
Campbell and Fiske88, 89. Items that correlate substantially with two or more scales 
confound scales and complicate their interpretation. 
Tests of scaling assumptions were evaluated using a multitrait/multi-item matrix 
that correlates each item with all hypothesized item groupings (i.e., scale scores). The 
Pearson product-moment correlation between an item and its hypothesized scale was 
estimated as if the item was not in the scale score (corrected for overlap), to avoid 
inflating the item-scale correlation coefficient90. Item internal consistency was evaluated 
by examining the correlation of each item with its hypothesized scale; a correlation of 
0.40 or higher is considered substantial and generally accepted as satisfactory91. The 
equality of item-scale correlations was tested by examining correlations between all 
items in a scale and the hypothesized scale score. Item variances were compared within 
each scale to evaluate their equivalence92. Finally, item discriminant validity was 
supported to the extent that the correlation between an item and its hypothesized scale 
was significantly (p<0.05) higher than the correlations between that item and all other 
scales91. 
Reliability 
Internal consistency reliability was estimated using Cronbach's coefficient 
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alpha93. A minimum internal consistency reliability of 0.70 has been suggested for group-
level analyses, and a minimum of 0.90 or 0.95 for individual-level data94. In addition, the 
average inter-item correlation (item homogeneity) was calculated. The reliability of a 
scale increases with the number of items and with higher item homogeneity95. Because 
the number of items in KOOS and WOMAC scales vary, evaluating reliability but not 
item homogeneity may be misleading. 
Scale-level correlations 
Internal consistency reliability can be thought of as a correlation between a scale 
and itself87. To the extent that a correlation between two scales is less than a scale’s 
reliability, the scale has unique reliable variance94. To determine the extent to which 
each KOOS and WOMAC scale measured a distinct construct, correlations between 
scales were evaluated in relation to reliability coefficients. 
Floor and ceiling effects 
The proportion of patients scoring at the worst/lowest (floor) and best/highest 
(ceiling) levels also was examined. A high floor or ceiling effect may attenuate the 
correlation between scales. In addition, the ability of an instrument to detect change over 
time is constrained by the percent of respondents at the floor or ceiling. 
Subgroup and 6-month post-TKR analyses  
Psychometric properties were examined at baseline for subgroups defined by 
gender, age, education, income, body mass index, number of comorbid conditions (out 
of 14), back pain severity, and frequency of non-surgical knee and ipsilateral hip pain. 
Because electronic data capture is increasingly common, properties also were evaluated 
by method of data collection (paper, Internet). Internal consistency reliability was 
reported for all subgroups; other results were reported by subgroup only if they differed 
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notably from overall results. In addition, because most patients benefit from TKR, 6-
month post-TKR data was examined to confirm that psychometric properties did not 
change in a clinically improved patient population; 6-month results were reported only if 
they differed notably from pre-TKR data. 
Additional analysis of Pain and Function discriminant validity 
The KOOS and WOMAC Pain and Function scales contain items that ask about 
pain and difficulty while doing the same activity (e.g., pain walking, difficulty walking). 
This content overlap has been proposed as a reason for the high correlation between 
their Pain and Function in activities of daily living scales96. To further evaluate this 
hypothesis, the WOMAC Function items were scored as two subscales, one containing 
the eight items that have content overlap with the WOMAC Pain scale (Function-Similar) 
and the other containing the remaining nine items (Function-Dissimilar), following the 
logic proposed by Stratford97. A multitrait/multi-item correlation matrix of the WOMAC 
Pain items with the two WOMAC Function subscales was examined. It was 
hypothesized that the Pain items would have higher correlations with the Function-
Similar subscale than the Function-Dissimilar subscale, due to item content overlap. 
 
Results 
The mean age of the sample was 66.1 (standard deviation 9.7); 57% were age 
65 or older. Sixty-one percent were female, and 89% were white. The highest level of 
education was high school graduate for 24%, and 4% had not graduated from high 
school. Twelve percent reported an annual household income below $25,000. 
Data Completeness 
The amount of item-level missing data was low, generally ranging from 1-3% at 
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baseline and 6-month follow-up (Table 2.1). However, 5-6% of patients did not answer 
the Sport/Recreation items about running and jumping at 6 months. All response choices 
were endorsed at both time points. The percent of patients who answered all items 
within a scale was greater than 90% for all scales and increased as the number of items 
in the scale decreased. Scale scores could be calculated for more than 99% of patients 
for all scales except the KOOS Sport/Recreation scale, which could be calculated for 97-
98% of patients. 
Using the developer’s scoring algorithms, 1,158 patients (98.2%) had 
computable scale scores for all five KOOS scales pre-TKR; subsequent KOOS analyses 
were limited to these 1,158 patients. For the WOMAC, 1,169 patients (99.2%) had 
computable scale scores for all three scales pre-TKR; this group was evaluated in 
subsequent WOMAC analyses. 
Tests of Scaling Assumptions  
At baseline (pre-TKR), item-hypothesized scale correlations were 0.40 or greater 
for all KOOS items, meeting the test of item internal consistency (Table 2.2). However, 
item-hypothesized scale correlations for Symptom items S1 (knee swelling) and S2 
(grinding, clicking) were close to 0.40. Within each KOOS scale, item-hypothesized 
scale correlations were approximately equivalent, with the exception of a lower item-
hypothesized scale correlation for item QOL1 relative to other QOL items. Item standard 
deviations generally were similar within each KOOS scale except for item QOL1, which 
was highly skewed. In addition, standard deviations for the non-stiffness Symptom items 
were high (1.26-1.53). 
All KOOS Sport/Recreation and QOL items had item-hypothesized scale 
correlations that were significantly (p<0.05) greater than all corresponding item-other 
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scale correlations; that is, they demonstrated item discriminant validity. However, there 
were problems with item discriminant validity for the KOOS Pain, ADL and Symptom 
scales. Several KOOS Pain items (P4, P5, P6, P9) and one ADL item (A6) did not 
correlate significantly higher with their hypothesized scale than with all other scales. In 
addition, one Pain item (P6, pain on stairs) had a higher correlation with the ADL scale 
than with the Pain scale. Two KOOS Symptom items (S6, stiffness in morning; S7, 
stiffness later in day) had higher correlations with the KOOS Pain scale than with the 
Symptoms scale; several other KOOS Symptom items (S1, S2) also had high 
correlations with the Pain scale. Symptom item S6 also had a higher correlation with the 
KOOS ADL scale than with the Symptoms scale. 
WOMAC items met all tests of scaling assumptions, except for the WOMAC Pain 
item P6 (pain on stairs) which had a significantly higher correlation with the Function 
scale than the Pain scale (Table 2.3). In addition, two Pain items (P5, P9) did not have 
significantly higher correlations with the Pain scale than with the Function scale, and 
three Function items (A4, A6, A12) did not have a significantly higher correlation with the 
Function scale than with the Pain scale, demonstrating a lack of item discriminant 
validity. 
Results from tests of scaling assumptions were comparable across 
sociodemographic and clinical subgroups for both the KOOS and WOMAC, with one 
exception. Among those younger than age 55, item-hypothesized scale correlations for 
the KOOS Symptom items were notably lower (range of 0.25-0.50, with four correlations 
below 0.40); however, this group only had 139 patients. In addition, tests of scaling 
assumptions were comparable for pre-TKR and 6 month post-TKR data, also with one 
exception. At 6 months, KOOS Symptom items S2 (grinding, clicking) and S3 (knee 
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catch or hang up) had low correlations with the Symptoms scale, with item-scale 
correlations of 0.29 and 0.32, respectively. 
Additional analysis of Pain and Function discriminant validity 
The multitrait/multi-item correlation matrix of the WOMAC Pain items with the 
Function-Similar and Function-Dissimilar subscales showed that while all item-subscale 
correlations were moderate (r=0.49-0.67), four of the five Pain items (P6-P9) had 
significantly higher correlations with the Function-Similar subscale than with the 
Function-Dissimilar subscale (Table 2.4). This suggests that the high Pain and Function 
inter-scale correlation can be explained in part by the overlap in activities across the two 
scales. In addition, the Pain and Function-Similar scale correlation (r=0.80) was higher 
than the Pain and Function-Dissimilar scale correlation (r=0.71). Internal consistency 
reliability of the Function-Similar and Function-Dissimilar subscales was 0.90 and 0.92. 
Reliability 
Internal consistency reliability of all KOOS and WOMAC scales exceeded 0.70 at 
baseline and was 0.95 for the KOOS Function in ADL and WOMAC Function scales 
(Table 2.5). Reliability statistics for each KOOS and WOMAC scale were similar across 
subgroups; however, reliability was below 0.70 for the KOOS Symptoms scale among 
those younger than age 55. Item homogeneity (average inter-item correlation) was 
lowest for the KOOS Symptoms scale (0.31) and highest for the KOOS Sport/Recreation 
(0.65) and WOMAC Stiffness (0.64) scales, with homogeneity for the remaining KOOS 
and WOMAC scales ranging from 0.46-0.54. 
Scale-level correlations 
KOOS scales were moderately to highly correlated, as were the WOMAC scales 
(Table 2.6). The correlation between the KOOS Pain and Function in ADL scales was 
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r=0.78 and the internal consistency reliability of the KOOS Pain scale was α=0.88, 
indicating that most of the reliable variance in the Pain scale was shared with the ADL 
scale. Similarly, most of the reliable variance in the WOMAC Pain scale was shared with 
the WOMAC Function scale. The correlation between the KOOS Symptoms and Pain 
scales (r=0.67) also approached the reliability of the KOOS Symptoms scale (α=0.74). 
Floor and ceiling effects 
Prior to TKR, floor (percent with the worst/lowest possible score) and ceiling 
(percent with the best/highest possible score) effects were low (≤6%) to negligible for 
most scales, although there was a notable floor effect for the KOOS Sport/Recreation 
scale (Table 2.7). At 6 months, floor and ceiling effects also were low to negligible for 
many KOOS and WOMAC scales. However, ceiling effects approached 10% for the 
KOOS Function in ADL and WOMAC Function scales. In addition, the WOMAC Stiffness 
scale had a higher ceiling effect at 6 months post-TKR than the KOOS Symptoms scale, 
and the WOMAC Pain scale had a higher ceiling effect than the KOOS Pain scale. 
Among those scoring at the ceiling of the WOMAC Pain scale at 6 months, 13% reported 
some pain (monthly, weekly or daily) on KOOS Pain item P1 (knee pain frequency). 
 
Discussion 
This comprehensive evaluation of scaling assumptions underlying scoring of the 
KOOS and WOMAC scales yielded results supporting their use among US knee 
osteoarthritis patients obtaining TKR. Favorable results included low rates of missing 
data, satisfactory results from most tests of scaling assumptions, internal consistency 
reliability estimates that exceeded recommended standards for group comparisons, and 
floor and ceiling effects that generally were low and followed the pattern expected for 
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measurements before and after surgery. It also is notable that results from these 
evaluations were consistent across groups differing in age and gender, socioeconomic 
status, and clinical status. However, tests of item discriminant validity for the Pain and 
Function in activities of daily living measures and their high inter-scale correlations call 
into question the empirical basis for the conceptual distinction between the pain and 
function measures. These and other issues are discussed below, along with 
recommendations for future research. 
Notable among the issues that should be addressed is the lack of discriminant 
validity for some items in the KOOS Pain and Function in ADL scales and in the 
WOMAC Pain and Function scales. This overlap calls into question whether the pain 
items should be interpreted as measures of pain during physical function. Similar results 
demonstrating confounding of the pain and function measures have been seen with 
techniques as diverse as Rasch analysis61, item-level exploratory factor analysis96, and 
scale-level confirmatory factor analysis98. The current analysis adds to this literature 
through formal tests of item discriminant validity, which showed that many Pain items 
had high correlations with both the Function and the Pain scales, particularly the five 
Pain items included in both the WOMAC and KOOS. 
The implications of these item-level discriminant validity tests also are apparent 
at a scale level. Correlations between the Pain and Function in activities of daily living 
scales approached the reliability of the Pain scale for both the KOOS and the WOMAC, 
suggesting that there is little unique reliable variance in the Pain scales. This might be 
expected due to the identical content describing physical activities across items in the 
Pain and Function scales, although the relatively high correlations between the WOMAC 
Pain items and Function-Dissimilar subscale indicates that the issue is broader than just 
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the content of specific items. A pain scale that conceptualizes pain primarily in terms of 
its impact on physical activities will by definition be highly correlated with a physical 
function scale. A broader conceptualization of knee pain which encompasses its impact 
across a range of physical, emotional and role/social domains, as well as its severity, 
may result in greater discrimination between knee-specific measures of pain and 
physical function. Such an approach has been followed in development of the ICOAP, 
for example99, and discussed in a recent review of pain measures used in TKR39. 
However, the nature of knee OA may be such that knee-specific measures of pain and 
function will be highly correlated, regardless of pain item content100. 
The KOOS Symptoms scale had relatively heterogeneous items with greater 
variability and lower average inter-item correlations, resulting in the lowest internal 
consistency reliability of the five KOOS scales, as has been seen in other studies46, 52. 
This pattern was even greater 6 months after TKR and among patients younger than 
age 55. Accordingly, many KOOS Symptom items did not demonstrate item discriminant 
validity. Although the WOMAC Stiffness scale performed better, it had a higher ceiling 
effect after TKR (16%) compared to 4% for the KOOS Symptoms scale. The pattern of 
results seen for the KOOS Symptoms scale is often observed for symptoms that largely 
vary independently. While the substantial correlation of the Symptoms scale with the 
Function scale supports the former scale’s validity, research should address whether this 
holds true for other data and other functional outcomes. Future analyses of the KOOS 
Symptoms scale may benefit from separate scoring and interpretation of its stiffness and 
non-stiffness components in addition to its overall scale score. 
The KOOS Function in ADL and identical WOMAC Function scale consistently 
demonstrated sufficiently high reliability across subgroups (α=0.92-0.96) to support its 
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use with individual patients. However, the homogeneity (average inter-item correlation) 
of the Function in ADL scale was comparable to that of other KOOS and WOMAC 
scales; thus, the comparatively higher reliability of the Function in ADL scale was in 
large part due to its length. For group-level comparisons, the practical implication of 
using a 17-item scale to measure function is that surveys are longer than needed for 
adequate measurement. Reducing the number of function items also could allow for 
inclusion of other items that may be important in evaluating TKR outcomes (e.g., 
psychological status) in studies without increasing overall respondent burden. 
No differences were found in rates of missing data, tests of scaling assumptions, 
internal consistency reliability, or floor and ceiling effects for data collected over the 
Internet versus a traditional paper questionnaire (PQ). While some TKR patients may not 
be comfortable answering a survey electronically, PQ and Internet samples did not differ 
greatly in age (age ≥65 was 59% for PQ, 51% for Internet) or education (29% high 
school graduate or less for PQ, 26% for Internet). If data from TKR patients is to be 
routinely collected in a cost-effective manner in the future, electronic data capture will be 
required for at least part of the patient population. Results from this study, along with 
results from other KOOS101 and WOMAC102 studies and evaluation of PROMIS 
measures103, are encouraging in terms of the quality of electronic data. 
This study had a number of limitations. Data used in this analysis came from high 
volume orthopedic centers in the US only. While analyses should be replicated among 
TKR patients in other US settings, it is likely that results will be similar due to the diverse 
nature of FORCE-TJR patients. The types of analyses conducted in this paper also 
should be replicated in other countries, to increase understanding of the measurement 
properties of the KOOS internationally. In addition, the sample was 89% white and 
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therefore analyses could not be replicated by race. While the racial distribution in the 
sample parallels current national TKR utilization, additional research is needed to 
evaluate the KOOS and WOMAC across racial and ethnic groups. Data for patients 
receiving bilateral knee replacement or other types of knee surgery were not examined, 
and results may not apply to knee OA patients with mild or moderate disease. Finally, 
other measurement properties of the KOOS and WOMAC, such as their validity and 
responsiveness, were not evaluated in this analysis; these are topics of subsequent 
chapters in this dissertation. 
In summary, results of this analysis support use of the KOOS and WOMAC 
among knee osteoarthritis patients obtaining TKR in the US. However, interpretation of 
the KOOS Pain and Function in ADL scales, and the WOMAC Pain and Function scales, 
is confounded. Further research is needed to examine if these scales should be scored 
and interpreted as two separate measures or as a higher-order factor, using techniques 
such as confirmatory factor analysis. Item response theory also should be used to 
evaluate the relative difficulty of the KOOS pain and function items and the extent to 
which pain and function items that ask about the same activity may be redundant. 
Continued development and evaluation of pain measures that assess the impact of knee 
pain on domains in addition to physical function also is recommended. 
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Table 2.1: Percent missing item- and scale-level data and percent computable scales 
 KOOS Scales  WOMAC Scales 
 
Symp-
toms 
(k=7) 
Pain 
(k=9) 
ADL 
(k=17) 
Sport 
(k=5) 
QOL 
(k=4) 
 Stiff-
ness 
(k=2) 
Pain 
(k=5) 
Func-
tion 
(k=17) 
Pre-TKR (n=1,179)          
% of Missing Data per Item         
Minimum  0.7 0.6 0.5 0.9 0.5  0.7 0.6 0.5 
Maximum 2.5 2.2 3.0 2.6 1.1  2.5 1.8 3.0 
Median 2.1 0.8 0.8 1.7 0.7  1.6 0.8 0.8 
% Scales w/Complete Data 92.0 93.6 90.8 95.6 97.8  97.3 96.7 90.8 
% Computable Scales* 99.5 99.7 99.7 98.6 99.8  99.6 99.5 99.7 
6-month Post-TKR (n=886)         
% of Missing Data per Item         
Minimum  0.1 0.4 0.3 1.6 0.4  0.1 0.4 0.3 
Maximum 2.5 2.8 1.9 5.9 1.5  1.7 1.5 1.9 
Median 1.5 0.9 0.7 2.8 1.1  0.9 0.9 0.7 
% Scales w/Complete Data 93.2 91.9 91.3 91.8 96.7  98.3 96.7 91.3 
% Computable Scales* 99.9 99.8 100.0 97.3 99.7  99.9 99.5 99.3 
k=Number of items in scale. 
* Percent for whom scale scores are computable using standard KOOS and WOMAC scoring algorithms. 
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Table 2.2: KOOS item means and standard deviations and correlations between items and 
scales, Pre-TKR (n=1,158) 
     Item-Scale Correlation 
Item Abbreviated  Item Content Mean SD 
 Symp-
toms Pain ADL Sport QOL 
Symptoms         
S1 Swelling in kneea 2.33 1.29  0.40*  0.35§ 0.27 0.21 0.30 
S2 Grinding, clicking, noisea 2.59 1.26  0.41*  0.38§ 0.31 0.26  0.35§ 
S3 Knee catch/hang upa 1.78 1.26  0.48* 0.40 0.32 0.23 0.30 
S4 Straighten knee fullyb 1.38 1.46  0.44* 0.37 0.26 0.19 0.17 
S5 Bend knee fullyb 1.78 1.53  0.47* 0.39 0.27 0.27 0.23 
S6 Stiffness in morning 2.23 1.00  0.52*  0.59†  0.54‡ 0.37 0.42 
S7 Stiffness later in day 2.28 0.96  0.55*  0.58‡  0.54§ 0.38 0.39 
Pain         
P1 Frequency knee painc 3.24 0.76  0.39 0.54* 0.44 0.31 0.42 
P2 Pain twisting/pivoting 2.47 1.04  0.49 0.60* 0.53 0.47 0.46 
P3 Pain straightening fully 1.78 1.11  0.61 0.69* 0.56 0.35 0.35 
P4 Pain bending fully 2.15 1.15   0.61§ 0.63* 0.52 0.40 0.39 
P5 Pain walking on flat 1.88 0.95  0.40 0.64*  0.60§ 0.33 0.45 
P6 Pain up or down stairs 2.66 0.93  0.46 0.63*  0.64‡ 0.48 0.51 
P7 Pain at night in bed 1.69 1.06  0.43 0.62* 0.54 0.28 0.32 
P8 Pain sitting or lying 1.51 0.96  0.48 0.69* 0.58 0.30 0.34 
P9 Pain standing upright 1.95 0.96  0.45 0.67*  0.65§ 0.38 0.48 
Function in Activities of Daily Living        
A1 Descending stairs 2.42 0.97  0.41 0.55 0.63* 0.51 0.51 
A2 Ascending stairs 2.38 0.98  0.39 0.57 0.66* 0.49 0.49 
A3 Rising from sitting 2.17 0.96  0.46 0.58 0.72* 0.44 0.44 
A4 Standing 1.85 0.95  0.41 0.63 0.70* 0.37 0.45 
A5 Bending to floor 2.03 1.08  0.39 0.54 0.67* 0.41 0.41 
A6 Walking on flat surface 1.72 0.92  0.40  0.63§ 0.69* 0.37 0.46 
A7 Getting in/out of car 1.98 0.90  0.39 0.61 0.76* 0.40 0.45 
A8 Going shopping 2.14 0.97  0.39 0.61 0.72* 0.47 0.51 
A9 Putting on socks/stockings 1.58 1.02  0.38 0.55 0.73* 0.36 0.38 
A10 Rising from bed 1.76 0.98  0.47 0.60 0.76* 0.36 0.42 
A11 Taking off socks/stockings 1.53 1.00  0.39 0.56 0.75* 0.36 0.38 
A12 Lying in bed 1.61 1.00  0.44 0.62 0.69* 0.34 0.35 
A13 Getting in/out of bath 1.74 1.11  0.38 0.55 0.72* 0.42 0.41 
A14 Sitting 1.25 0.93  0.42 0.59 0.70* 0.30 0.35 
A15 Getting on/off toilet 1.65 1.00  0.41 0.56 0.76* 0.39 0.41 
A16 Heavy domestic duties 2.64 1.00  0.36 0.51 0.63* 0.55 0.46 
A17 Light domestic duties 1.65 0.91  0.40 0.60 0.73* 0.43 0.51 
Function in Sport and Recreation        
Sp1 Squatting 3.14 0.99  0.38 0.43 0.47 0.74* 0.44 
Sp2 Running 3.47 0.84  0.32 0.36 0.39 0.79* 0.45 
Sp3 Jumping 3.47 0.85  0.32 0.37 0.41 0.81* 0.44 
Sp4 Twisting/pivoting 3.08 0.99  0.36 0.47 0.51 0.70* 0.46 
Sp5 Kneeling 3.17 0.98  0.38 0.49 0.53 0.73* 0.47 
Knee-specific Quality of Life         
QOL1 Awareness knee problemd 3.62 0.55  0.35 0.44 0.41 0.39 0.54* 
QOL2 Modified life stylee 2.77 1.00  0.34 0.42 0.45 0.44 0.67* 
QOL3 Lack confidence in kneee 2.69 1.09  0.35 0.42 0.44 0.40 0.67* 
QOL4 General difficulty knee 2.85 0.86  0.49 0.59 0.60 0.52 0.73* 
* Item-hypothesized scale correlation corrected for overlap. 
† Item-other scale correlation significantly (p<0.05) higher than item-hypothesized scale correlation.  
‡ Item-other scale correlation higher than item-hypothesized scale correlation.  
§ Item-other scale correlation not significantly (p<0.05) lower than item-hypothesized scale correlation. 
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Standard error=0.029.  
Response options are 0=None, 1=Mild, 2=Moderate, 3=Severe, 4=Extreme except where noted:  
a 0=Never, 1=Rarely, 2=Sometimes, 3=Often, 4=Always.  
b 0=Always, 1=Often, 2=Sometimes, 3=Rarely, 4=Never. 
c 0=Never, 1=Monthly, 2=Weekly, 3=Daily, 4=Always.  
d 0=Never, 1=Monthly, 2=Weekly, 3=Daily, 4=Constantly.  
e 0=Not at all, 1=Mildly, 2=Moderately, 3=Severely, 4=Extremely. 
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Table 2.3: WOMAC item means and standard deviations and correlations between items 
and scales, Pre-TKR (n=1,169) 
Item 
    Item-Scale Correlation 
Abbreviated Item Content Mean SD  Stiffness Pain Function 
Stiffness       
S6 Stiffness in morning 2.22 1.00  0.64* 0.52 0.55 
S7 Stiffness later in day 2.28 0.96  0.64* 0.53 0.54 
Pain       
P5 Pain walking on flat surface 1.87 0.95  0.41 0.64* 0.60§ 
P6 Pain up or down stairs 2.65 0.93  0.46 0.57* 0.65† 
P7 Pain at night in bed 1.68 1.06  0.45 0.62* 0.54 
P8 Pain sitting or lying 1.50 0.96  0.48 0.70* 0.58 
P9 Pain standing upright 1.95 0.96  0.45 0.67* 0.65§ 
Function      
A1 Descending stairs 2.41 0.97  0.43 0.54 0.63* 
A2 Ascending stairs 2.37 0.98  0.41 0.58 0.66* 
A3 Rising from sitting 2.17 0.96  0.54 0.57 0.72* 
A4 Standing 1.85 0.95  0.44 0.66§ 0.70* 
A5 Bending to floor/pick up object 2.03 1.08  0.41 0.50 0.67* 
A6 Walking on flat surface 1.72 0.92  0.44 0.68§ 0.69* 
A7 Getting in/out of car 1.98 0.90  0.46 0.59 0.76* 
A8 Going shopping 2.14 0.97  0.42 0.62 0.71* 
A9 Putting on socks/stockings 1.58 1.01  0.42 0.52 0.73* 
A10 Rising from bed 1.76 0.98  0.58 0.58 0.76* 
A11 Taking off socks/stockings 1.53 1.00  0.43 0.54 0.74* 
A12 Lying in bed 1.61 1.00  0.47 0.64§ 0.69* 
A13 Getting in/out of bath 1.73 1.11  0.42 0.54 0.72* 
A14 Sitting 1.25 0.93  0.45 0.60 0.70* 
A15 Getting on/off toilet 1.64 1.00  0.46 0.56 0.76* 
A16 Heavy domestic duties 2.63 1.00  0.40 0.48 0.63* 
A17 Light domestic duties 1.65 0.91  0.45 0.61 0.73* 
* Item-hypothesized scale correlation corrected for overlap. 
† Item-other scale correlation significantly (p<0.05) higher than item-hypothesized scale correlation.  
§ Item-other scale correlation not significantly (p<0.05) lower than item-hypothesized scale correlation. 
Standard error=0.029.  
Response options are 0=None, 1=Mild, 2=Moderate, 3=Severe, 4=Extreme.  
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Table 2.4: Correlations of WOMAC Pain items with Function-Similar and Dissimilar 
subscales, Pre-TKR (n=1,169) 
Pain  
Item 
  WOMAC Scale 
Abbreviated Item Content 
 Pain Function Similar† 
Function 
Dissimilar‡ 
P5 Pain walking on flat surface  0.64* 0.61 0.56 
P6 Pain up and down stairs  0.57* 0.67 0.58 
P7 Pain at night in bed  0.62* 0.57 0.49 
P8 Pain sitting or lying  0.70* 0.60 0.53 
P9 Pain standing upright  0.67* 0.67 0.59 
* Item-total correlation corrected for overlap. Standard error=0.029. 
† Includes items A1, A2, A3, A4, A6, A10, A12, A14. 
‡ Includes items A5, A7, A8, A9, A11, A13, A15, A16, A17. 
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Table 2.5: Internal consistency reliability of KOOS and WOMAC scales, Pre-TKR 
 KOOS  WOMAC 
 N Symp-toms Pain ADL Sport QOL  N 
Stiff-
ness Pain 
Func
-tion 
Total Sample 1,158 0.74 0.88 0.95 0.90 0.81  1,169 0.78 0.84 0.95 
Homogeneity* 1,158 0.31 0.46 0.53 0.65 0.54  1,169 0.64 0.51 0.53 
Gender            
Male 453 0.72 0.87 0.95 0.89 0.79  457 0.78 0.83 0.95 
Female 705 0.74 0.89 0.95 0.91 0.82  712 0.78 0.84 0.95 
Age            
<55 139 0.68 0.87 0.95 0.90 0.79  138 0.77 0.82 0.95 
55-64 362 0.73 0.89 0.96 0.90 0.80  365 0.78 0.85 0.95 
65-74 422 0.71 0.87 0.95 0.90 0.82  425 0.77 0.83 0.95 
75+ 234 0.74 0.89 0.94 0.89 0.78  240 0.79 0.82 0.94 
Education†            
<= High School 325 0.74 0.89 0.96 0.93 0.82  327 0.82 0.84 0.96 
Post-high school 337 0.77 0.89 0.95 0.91 0.80  342 0.79 0.84 0.95 
College grad. 458 0.72 0.87 0.94 0.86 0.80  459 0.73 0.82 0.94 
Income            
<$25,000 121 0.80 0.91 0.96 0.96 0.81  123 0.80 0.87 0.96 
$25-45,000 216 0.73 0.89 0.96 0.89 0.83  217 0.82 0.85 0.96 
>$45,000 655 0.73 0.87 0.94 0.88 0.82  659 0.76 0.82 0.94 
BMI            
<25 152 0.76 0.89 0.94 0.90 0.77  153 0.80 0.82 0.94 
25-29.9 356 0.74 0.88 0.95 0.89 0.82  362 0.78 0.82 0.95 
30-34.9 332 0.73 0.87 0.95 0.89 0.80  332 0.76 0.84 0.95 
≥35 301 0.74 0.89 0.95 0.91 0.81  306 0.79 0.85 0.95 
Comorbid Conditions           
0 495 0.75 0.88 0.95 0.89 0.82  497 0.79 0.84 0.95 
1 410 0.74 0.88 0.95 0.90 0.81  412 0.78 0.83 0.95 
2+ 253 0.74 0.89 0.95 0.91 0.79  260 0.77 0.83 0.95 
Back Pain            
Never 560 0.73 0.88 0.94 0.89 0.80  567 0.79 0.83 0.94 
Mild 266 0.73 0.86 0.94 0.88 0.80  269 0.71 0.80 0.94 
Moderate 251 0.74 0.87 0.95 0.92 0.80  250 0.78 0.84 0.95 
Severe 78 0.74 0.85 0.92 0.84 0.86  80 0.83 0.75 0.92 
Non-Surgical Knee Pain           
None 311 0.75 0.89 0.95 0.91 0.79  315 0.83 0.85 0.95 
Monthly/Weekly 312 0.74 0.86 0.94 0.87 0.84  314 0.74 0.81 0.94 
Daily/Always 521 0.73 0.88 0.95 0.90 0.80  526 0.76 0.82 0.95 
Ipsilateral Hip Pain            
None 693 0.73 0.88 0.95 0.90 0.81  701 0.79 0.83 0.95 
Monthly/Weekly 258 0.73 0.88 0.95 0.89 0.79  261 0.77 0.84 0.95 
Daily/Always 167 0.77 0.85 0.94 0.90 0.82  167 0.76 0.81 0.94 
Survey Method            
Paper-pencil 889 0.74 0.88 0.95 0.90 0.79  899 0.77 0.83 0.95 
Internet 269 0.75 0.89 0.96 0.90 0.86  270 0.82 0.86 0.95 
* Average inter-item correlation.  
† Education categories: <= High School=High school graduate or less; Post-high school=Some post-high 
school education but not 4-year college graduate; College graduate=4-year college graduate or higher. 
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Table 2.6: Correlations between scales and internal consistency reliability, Pre-TKR* 
KOOS (n=1,158)  WOMAC (n=1,169) 
 
Symp-
toms Pain ADL Sport QOL   
Stiff-
ness Pain 
Func-
tion 
Symptoms (0.74)      Stiffness (0.78)   
Pain 0.67 (0.88)     Pain 0.58 (0.84)  
ADL 0.54 0.78 (0.95)    Function 0.60 0.77 (0.95) 
Sport 0.42 0.51 0.55 (0.90)       
QOL 0.47 0.57 0.58 0.54 (0.81)      
* Cronbach’s coefficient alpha on diagonal. 
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Table 2.7: KOOS and WOMAC scale-level descriptive statistics 
 KOOS Scales  WOMAC Scales 
 N Symp-toms Pain ADL Sport QOL 
 
N Stiff-
ness Pain 
Func-
tion 
Pre-TKR           
Mean 1,158 48.6 46.3 52.8 18.3 25.4  1,169 43.6 51.8 52.9 
SD  19.8 17.9 18.3 19.6 17.9   22.3 18.9 18.2 
% Floor  0.7 1.3 0.7 28.9 14.4   6.1 1.3 0.7 
% Ceiling 0.3 0.5 0.3 0.9 0.1   2.3 0.9 0.3 
6-month Post-TKR          
Mean 859 73.9 80.0 81.6 48.0 63.3  878 71.1 83.9 81.7 
SD  17.1 17.5 16.7 27.5 22.9   20.8 16.2 16.8 
% Floor  0.0 0.0 0.0 4.8 0.8   1.0 0.1 0.0 
% Ceiling 3.6 14.2 9.5 4.2 8.0   16.1 21.9 9.3 
% Floor: percent with worst possible score, % Ceiling: percent with best possible score. 
All scales are scored so 0=worst score, 100=best score.  
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CHAPTER III: DEVELOPMENT AND EVALUATION OF A KOOS FUNCTION 
ITEM BANK IN TOTAL KNEE REPLACEMENT PATIENTS 
 
Abstract 
 
Objective: To use item response theory (IRT) methods to calibrate the 22 function in 
Activities of Daily Living (ADL) and Sport/Recreation items from the Knee injury and 
Osteoarthritis Outcome Score (KOOS) questionnaire and conduct computerized 
adaptive testing (CAT) simulations with total knee replacement (TKR) patients. 
Methods: 1,179 patients completed surveys before and 6 months after TKR. To 
represent different functional states, one survey per patient (pre- or post-TKR) was 
randomly selected for IRT analyses. IRT assumptions of unidimensionality, local 
independence, item monotonicity and differential item functioning were tested; items 
were calibrated using the graded response model. Real data CAT simulations were 
conducted on pre- and post-TKR data. 
Results: IRT assumptions were supported. The item bank was most reliable -2.5 SD 
below to 1.7 SD above the combined pre/post-TKR sample mean. Sport items measured 
higher levels of function than ADL items but were less informative. In CAT simulations, a 
reliable score could be achieved for most patients in 3-8 items pre-TKR, but more items 
were needed post-TKR. One-third could not achieve a reliable (≥ 0.95) CAT score post-
TKR because the item bank had few items at a high function level. Eight items 
accounted for most CAT administrations; most Sport items were rarely selected by CAT. 
Conclusions: Knee-specific function items were unidimensional. CAT scores could be 
reliably estimated in less than 22 items, but additional items that measure higher levels 
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of function are needed for TKR. Use of IRT methods to test new items and evaluate new 
short function scales is recommended. 
 
Introduction 
Treatment of knee osteoarthritis (OA) is focused on reducing joint pain and 
stiffness, preserving and improving joint mobility, limiting joint damage, reducing 
disability, and improving health-related quality of life3. Therefore, patient reports of pain 
and function are central to the management of knee OA, including the decision to 
undergo total joint replacement when medical treatment is no longer successful6 . The 
most frequently used joint-specific measure of these patient-reported outcomes (PRO) is 
the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), which 
contains 17 items measuring difficulty in function, along with 5 pain and 2 stiffness 
items22, 23. A body of research has found that the reliability of the WOMAC function scale 
is consistently higher than the minimum level required for group-level comparisons21 and 
that there is redundancy in its item content61, 62. These findings indicate that the WOMAC 
function scale could be shortened, thereby reducing respondent burden and still meet 
group-level reliability standards needed for clinical research. 
Several short function scales have been developed from the full-length WOMAC 
function scale. Methods used to select items for these 7 and 8-item scales have included 
patient ratings of item importance before and after total knee (TKR) and hip (THR) 
replacement24; patient and clinician ratings of item importance along with descriptive 
analyses of data from knee and hip OA patients25; and clinician recommendations and 
descriptive analyses of data from TKR and THR patients26. Only four items (ascending 
stairs, rising from sitting, walking on a flat surface, getting in/out of car) were selected for 
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all three short function scales. None of these scales has been widely adopted. 
While the WOMAC function scale is lengthy, at the same time it does not include 
items about activities that are more likely to be done by younger and more active OA 
patients. The 42-item Knee injury and Osteoarthritis Outcome Score (KOOS) 
questionnaire was developed in part to address this limitation of the WOMAC45. The 
KOOS includes the 17-item WOMAC Function in Activities of Daily Living (ADL) scale 
(version LK3.0), along with a 5-item joint-specific Function in Sport and Recreation scale 
that measures difficulty with more demanding physical activities45, 104. To reduce 
respondent burden, the KOOS-PS, a shorter form containing four ADL and three Sport 
items, was developed using Rasch analysis of KOOS data from 2,145 knee OA patients 
in five countries28. In a subsequent Rasch analysis, Franchignoni et al. corroborated that 
the KOOS ADL and Sport items could be combined into a single scale, but they were not 
able to replicate the KOOS-PS item selection process67. They concluded that additional 
work was needed to develop a robust KOOS short function scale. 
The past two decades have seen increased use of Rasch and item response 
theory (IRT) models in PRO survey development. Rasch and IRT models can be used to 
calibrate item banks, which consist of a set of items measuring the same construct and 
parameters that describe the items’ measurement properties65. Improved short forms 
can be constructed by selecting a subset of items from the bank based on the items’ 
measurement properties. In addition to their use in developing short forms, item banks 
are also the foundation for computerized adaptive tests (CATs). Unlike fixed-length 
surveys such as the WOMAC and KOOS, CATs administer only the most informative 
items to each individual, resulting in more efficient and precise measurement66. 
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Rasch models have been used in a number of studies to calibrate the WOMAC 
and KOOS function items28, 61, 62, 67-69. While these studies all have confirmed that the 
function items are unidimensional -- that is, that they measure a single underlying 
domain -- the studies differed in terms of the number of items that were excluded 
because they did not fit the Rasch model, as well as the values of the item calibrations. 
These inconsistencies in results have been attributed to the use of different Rasch 
software packages, differences in the samples examined, and differences in the criteria 
used to evaluate Rasch model fit67. Another possible explanation for these differences is 
that the Rasch model is not optimal for the WOMAC and KOOS function items. A 
separate class of IRT models are widely-used in the PRO field (such as in the NIH-
sponsored PROMIS initiative105) but have not been used to analyze the WOMAC or 
KOOS function items, to the best of my knowledge. Unlike the Rasch model, in which 
item discrimination (or the model slope, α) is held constant across all items, these two 
parameter IRT models are often seen as better for use with polytomous items that have 
ordered response categories (such as the WOMAC and KOOS items), because they 
allow item discrimination to vary across items70, 71. Two parameter IRT models are 
particularly useful in CATs, which require a combination of items with steeper slopes 
(which are more discriminating over a narrower range) and items with less steep slopes 
(which are more useful in categorizing respondents over a wider range). 
Because the KOOS function items have not been evaluated with IRT models, 
there is a gap in our understanding of their measurement properties. This paper will use 
IRT methods to determine if the KOOS function in ADL and Sport items define a 
unidimensional construct, and if these items can be calibrated in a function item bank. It 
then will use information from the item bank to conduct CAT simulations using data from 
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knee OA patients prior to and after TKR, to better understand the performance of the 
KOOS function items in measuring outcomes for patients receiving surgical treatment. In 
addition, results of the CAT simulations will provide guidance as to which items might be 
most informative in a short fixed-length KOOS function scale.  
 
Methods 
Patients 
Data for this analysis came from the Function and Outcomes Research for 
Comparative Effectiveness in Total Joint Replacement (FORCE-TJR) registry, which 
includes joint replacement patients from across the US41. Patients who could not provide 
consent due to cognitive impairment or who had emergency surgery were ineligible. All 
questionnaires were self-administered via a web-based or scannable paper-pencil 
survey at the surgeon’s office or at home prior to surgery, 6 months post-surgery and 
annually thereafter. This analysis included data from 1,179 TKR patients randomly 
selected from FORCE-TJR enrollees at high volume surgical centers between May 2011 
and August 2012. Of these, data was available for 886 patients at the 6-month follow-up. 
Questionnaire 
TKR patients in FORCE-TJR completed the KOOS at baseline and 6 months. 
The KOOS contains 42 knee-specific items measuring pain, other symptoms, function in 
activities of daily living (ADL), function in sport/recreation (Sport), and knee-related 
quality of life (see Table 2.2 and www.koos.nu for more information). KOOS items were 
asked in reference to the surgical knee, and all ADL and Sport items had a recall period 
of the last week. ADL and Sport items used the same response scale (none--extreme). 
The KOOS was administered midway through the 140-item FORCE-TJR survey, after 
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questions about health habits, surgical status, back pain and sociodemographics, the 
SF-36 Health Survey31, and a modified Charlson comorbidity index84. The majority of 
respondents (76.9%) completed the paper-pencil version of the survey, with the 
remainder (23.1%) completing the survey via the Internet. 
Analysis 
IRT methods were used to calibrate the KOOS function in ADL and Sport items 
on a common metric, and the resulting item calibrations were applied to pre-TKR and 
post-TKR patient data to conduct real data CAT simulations. Prior to calibrating the 
items, assumptions of unidimensionality, local independence, and monotonicity of item 
response categories were tested, and differential item functioning (DIF) also was 
examined71, 106, 107. Unless otherwise indicated, analyses were performed in Stata 11.2. 
Unidimensionality. IRT models assume that all items within an item bank are 
unidimensional; that is, that they measure a single underlying construct. To evaluate 
unidimensionality, both exploratory and confirmatory factor analyses of all 22 ADL and 
Sport items were conducted. Exploratory factor analysis (EFA), using a principal 
components model, was performed to evaluate the structure of the data without 
assuming any pre-specified assignment of items to factors. Because the KOOS items 
are ordinal, the factor analysis was based on the matrix of polychoric correlations among 
all 22 items71. The number of factors that were retained was determined by a number of 
criteria, including Kaiser's eigenvalue-greater-than-one rule and whether a minimum of 
5% of the total variance was explained by the factor. If loadings on the first factor were 
substantial (≥0.70) and greater than loadings on the second factor, that supported 
calibrating all 22 KOOS items in a single item bank. 
As a second test of unidimensionality, and following the approach often used in 
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item bank development71, 106, item-level categorical confirmatory factor analysis (CFA) 
was performed using Mplus software108 and weighted least square methods for factor 
analysis of categorical data109, 110. Overall model fit was evaluated with the Comparative 
Fit Index (CFI) and the root mean square error of approximation (RMSEA) for categorical 
data, with commonly-used (CFI≥0.95, RMSEA≤.08) criteria used to judge model fit. 
Three CFA models were evaluated: (1) 1 factor (all 22 items); (2) 2 correlated factors (17 
ADL items, 5 Sport items); and (3) a bifactor model (1 common factor of all 22 items, 
plus ADL and Sport group factors). If the 1-factor model fit sufficiently and all items had 
high (≥0.70) factor loadings, this supported evaluating the ADL and Sport items in one 
bank; it was anticipated that the 1-factor solution would fit the data, based on previous 
research28, 67. In the 2-factor solution, items were assigned to factors based on how they 
were presented to respondents, either as items measuring “physical function” (17 ADL 
items) or “physical function when being active on a higher level” (5 Sport items). A high 
correlation between the two factors supported analyzing all 22 items in a single bank. 
Finally, the bifactor model is another method used to determine if items are “sufficiently” 
unidimensional71, 111. In a bifactor model, each item loads on a common factor (all items) 
and on a group factor (a subset of items). If item loadings on the common factor were 
substantial and substantively larger than corresponding item loadings on the group 
factor, then the items were seen as sufficiently homogeneous.  
If all 22 items were viewed as unidimensional, then any items with loadings <0.70 
in the 1-factor CFA were eliminated from further analysis, as in previous studies71, 107. 
Local independence. IRT models assume that there are not any significant 
associations among pairs of items once a respondent’s overall level on a domain is 
controlled for; that is, that items are locally independent71. Local independence was 
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evaluated in the final CFA model by examining residual correlations of all item pairs. A 
residual correlation of ≥0.20 was used to identify items with possible local dependence, 
as in previous analyses71, 106. IRT parameter estimates may be inflated if items that have 
local dependence are included in an item bank71, and therefore a strategy to handle 
these items needed to be determined. One approach is to delete items showing local 
dependence from the bank. However, this approach was not followed because a primary 
purpose of this analysis was to better understand the measurement properties of all 22 
ADL and Sport items. Therefore, another approach, which has been used in calibrating 
SF-36 physical functioning items which are locally dependent107, was followed, in which 
locally dependent items were modelled separately during item calibration (see below). 
Item monotonicity. IRT models assume that, for each item, each response choice has 
a maximum probability of being selected over a unique interval of a scale106. The 
monotonicity of response choices was evaluated on an item-by-item basis, using 
nonparametric kernel-smoothing techniques and the TestGraf software112, 113. If a 
response option curve did not have a clear maximum, that response option was 
combined with an adjacent response option, for purposes of IRT modeling of the item. 
Differential Item Functioning (DIF). IRT models assume that the probability of 
responding to an item in a certain way is the same for all people who are at an 
equivalent level of the underlying domain. If the likelihood of answering an item in a 
particular way is related to another factor (e.g., gender), DIF is present. DIF was 
examined for groups defined by age (<55, 55-64, 65-74, 75+), gender, and education 
(less than high school, high school graduate, some post-high school education, college 
graduate), using ordinal logistic regression models in which the item response was the 
dependent variable and the total sum score (of all items) and the group indicator were 
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the independent variables114, 115. A significant effect of the group variable indicated 
uniform DIF, while a significant interaction effect (between the group variable and the 
sum score) indicated non-uniform DIF116, 117. The magnitude of DIF was evaluated with 
the coefficient of determination R² as developed by Nagelkerke118 (∆R²); a ∆R²>0.03 
(combined uniform and non-uniform DIF) indicated notable DIF as in previous 
analyses107. 
Item calibration. Items were calibrated with the graded response model (GRM)119, 120, a 
unidimensional, polytomous IRT model, using the software program IRTPRO121, 122. The 
first GRM model excluded items that demonstrated local dependence. Item parameters 
were fixed for all items included in the first IRT model, and then a second GRM model 
was run to estimate item parameters for the remaining items. Item fit was assessed 
using S-X2 fit statistics, which quantify the difference between observed and expected 
item response frequencies at various score levels123, 124. Items were calibrated to have a 
mean of 0 and standard deviation (σ) of 1 in the TJR population. To be consistent with 
KOOS scale scoring, in which a higher scale score indicates better function, items were 
recoded so a higher item score indicated better function. 
After items were calibrated, slopes (measuring item discrimination) and threshold 
parameters (measuring item difficulty) were examined. The number of threshold 
parameters equals the number of response choices minus one. For GRM, a threshold 
parameter indicates the location along the latent trait continuum (or theta, θ) where the 
probability is 50% or more that a respondent selects a particular response choice or a 
higher response choice. Examination of threshold parameters indicates the extent to 
which item responses span the full measurement range and also indicates whether an 
item is harder or easier. Item slopes measure an item’s discrimination, that is, how 
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quickly the probability of endorsing a particular response choice increases at any given 
level of the latent trait65. Items with higher slopes provide more information about the 
likelihood of endorsing one response choice versus another along the latent continuum. 
After item calibration, the item information function (IIF) was calculated and 
graphed for each item125. The IIF indicates the degree of precision that an item provides 
at each level of the latent trait; a higher level of information indicates lower measurement 
error65. The sum of the IIFs is the test information function [I(θ)], which measures the 
information provided by all items in a bank at each level of the latent trait. The test 
information function allows for estimation of the standard error (SE) and reliability of an 
item bank across all levels of theta, where SE=1/√     and reliability=σ2/(σ2+SE2). For 
example, if σ=1, a standard error of 0.32 is comparable to a reliability of 0.90; a standard 
error of 0.23 is comparable to a reliability of 0.95. Reliability was assessed across all 
levels of the latent trait, to determine the range of theta scores across which reliability 
was ≥0.95 (often recommended as a minimum level of reliability when measures are 
used with individual patients) and ≥0.90 (a less conservative reliability level that also has 
been used)94. 
Finally, for each FORCE-TJR patient, total item bank scores (i.e., theta scores) 
were estimated, based on the responses to all KOOS function items that the respondent 
answered and the item parameters (i.e., slope, difficulty) of those items. Theta scores 
were calculated for all patients prior to TKR and 6 months post-TKR 
CAT Simulations. Real data CAT simulations were conducted using the pre-TKR and 6 
month post-TKR data to approximate how well the item bank would perform in a CAT, 
using data from FORCE-TJR patients and CAT simulation software FIRESTAR126, 127. A 
simulated CAT selects the most informative items for each respondent, using actual data 
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and pre-set stopping rules, to derive a CAT score for that respondent66, 128. Two CATs 
were run on the pre-TKR data, with different stopping rules: (1) CAT stopped when the 
standard error of the score (SE) was ≤0.32 (equal to a reliability of 0.90) or a maximum 
of 10 items were administered (to limit respondent burden); and (2) CAT stopped at 
SE≤0.23 (reliability=0.95) or a maximum of 10 items. Both CATs required that a 
minimum of 2 items be administered. The first item (start item) in the CAT was 
determined by FIRESTAR, based on the mean of the prior distribution127. Two similar 
CATs (SE≤0.32, SE≤0.23; maximum of 10 items) also were run on the post-TKR data. 
Results of the CAT simulations were examined to determine how often each item was 
selected by the CAT, as well as the number of items administered to each respondent 
and the percentage of CAT scores that met the criteria of SE≤0.32 and SE≤0.23. 
 
Results 
The mean age of the sample was 66.1 (SD=9.7); 57% were age 65 or older, 
while 12% were younger than age 55. Sixty-one percent were female. The majority 
(89.8%) were white, while 7.6% were black and 2.6% were another race. The highest 
level of education was high school graduate or less for 28%, while 39% were college 
graduates or had post-college education. 
Descriptive statistics and creation of analytic dataset. Prior to TKR, most patients 
reported substantial impairment on the Sport items. All five Sport items were negatively 
skewed (range -1.00 to -2.16), and nearly 90% of patients reported “severe” or “extreme” 
difficulty running and jumping (Table 3.1). The high level of disability before TKR can be 
seen in the knee pain frequency item (P1), with more than 92% reporting knee pain 
“daily” or “always”. In contrast, most ADL items had mean values ranging from 2.5 to 3.5 
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(on a 1=never to 5=extreme scale) and little skewness. However, 6 months after TKR, 
many of the ADL items showed substantial positive skewness, with ≤5% of patients 
reporting “severe” or “extreme” difficulty in most ADL activities (Table 3.2). The Sport 
items had a more symmetrical distribution and little skewness 6 months after TKR. 
While this favorable shift in the distribution of responses to the function items is 
to be expected after successful TKR, it has implications for calibrating item banks, in 
terms of having sufficient data for all items at all response levels. Many item by response 
choice cells had fewer than 25 patients prior to TKR, and many item by response choice 
cells had fewer than 10 patients in the 6 month post-TKR data. For that reason, an 
analytic dataset was created by randomly selecting either pre-TKR or 6-month post-TKR 
data for each patient; the resulting dataset contained pre-TKR items for 2/3 of the 
sample (n=786) and 6-month post-TKR items for the remaining 1/3 (n=393). The 
combined dataset had substantial numbers of patients in each item by response choice 
cell, and skewness was reduced in comparison to pre-TKR and post-TKR data (Table 
3.3). This dataset was used to evaluate and calibrate the ADL and Sport items. 
Exploratory factor analysis. In the combined dataset, eigenvalues for the first two 
unrotated factors were 13.88 and 1.91, and the percentage of total variance explained 
was 63.1% and 8.7%, supporting extraction of two factors (Table 3.4). Loadings on the 
first unrotated factor ranged from 0.74 to 0.88 for the ADL items, and ADL item loadings 
were considerably higher on the first factor than on the second factor. For the Sport 
items, loadings on the first unrotated factor ranged from 0.69 to 0.78, and loadings on 
the second unrotated factor ranged from 0.40 to 0.62. Loadings were always higher on 
the first factor than on the second factor for all Sport items, but loadings were particularly 
high on the second factor for Sport items Sp2 (running) and Sp3 (jumping). Therefore, 
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while the preponderance of evidence supported analyzing all 22 items in a single bank, 
particular attention was paid to Sport items Sp2 and Sp3 in subsequent analyses. 
Confirmatory factor analysis. Confirmatory factor analysis (CFA) of the ADL and Sport 
items demonstrated that all 22 items had high (0.77-0.94) loadings in the 1-factor model 
(Table 3.5), indicating that the 22 function items measured a unidimensional construct. 
These 22 items explained 72.6% of the variance in the data. The CFI for the 1-factor 
model approached 0.95, which indicated good model fit; the RMSEA (0.158) was high in 
relation to accepted standards, although RMSEA is often high in CFAs of PRO data129. 
There were 22 item pairs of residual correlations that were 0.20 or higher (see below, 
Local Independence). Fit of the 1-factor model was not notably improved by allowing 
ADL items with similar content (ascending stairs/descending stairs) to correlate. Model fit 
also was not notably improved in the 2-factor model (CFI=0.954, RMSEA=0.142); the 
ADL and Sport factors had a correlation of 0.764. Model fit was improved in the bifactor 
model (CFI=0.979, RMSEA=0.101). While the RMSEA of 0.10 was a bit higher than the 
criteria of 0.08, it was lower than in the 1- and 2-factor models and RMSEA is often 
slightly higher than conventional criteria in CFAs of ordinal PRO items129. In the bifactor 
model, factor loadings on the common factor were high (0.66-0.92) and 20 of the 22 
items (all but A09 and A11) had a higher loading on the common factor than on a group 
(ADL or Sport) factor. Four items (A09, A11, Sp2, Sp3) had high loadings on a group 
factor. However, these four items also had very high (0.92-0.94) factor loadings in the 1-
factor model, indicating that they also were strong measures of a unidimensional 
construct. Overall, the results indicated that the 22 ADL and Sport items were sufficiently 
unidimensional to be considered homogeneous for purposes of item bank calibration.  
Local independence. In the 1-factor model, there were 22 pairs of items (out of 231 
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total pairs) that had residual correlations of 0.20 or greater. All 22 item pairs included 
one or more of the items A09 (putting on socks), A11 (taking off socks), Sp2 (running), 
or Sp3 (jumping), which were the same items that had high loadings on the group factors 
in the bifactor CFA model (see above). The activities in items A09 and A11 are so 
comparable that most respondents may have provided similar answers to them. 
Similarly, while running (Sp2) and jumping (Sp3) are more distinct, it may be that both of 
these items were seen as high impact activities by TKR patients and thus responses to 
both items tended to be similar. When items A11 and Sp3 (i.e., the latter item in each 
item pair) were removed from the 1-factor CFA, only one residual correlation was ≥0.20 
(A14 (sitting) with Sp2 (running) r=0.226; model CFI=0.958, RMSEA=0.130). Because 
there was only one high residual correlation out of 190 item pairs in the 20-item CFA 
(less than what might be expected by chance), and because there was no content 
reason for items about “sitting” and “running” to be locally dependent, items A14 and 
Sp2 were both included in the first IRT calibration model. However, to address issues of 
local dependence, items ADL11 and Sp3 were not in the first IRT model (see below). 
Item monotonicity. Evaluation of trace curves for item response categories supported 
the monotonicity of most ADL and Sport items; each response choice had a maximum 
probability of being selected over a unique interval of its scale. An example is provided in 
Figure 3.1 for ADL04 (difficulty standing); there is a unique range across the ADL scale 
(on the x-axis, ranging from 17-84) for which each of the 5 response choices was most 
likely to be selected. However, monotonicity was not seen for some items. For ADL12 
(lying in bed), there was not a unique range for which response choice 4 (“severe”) was 
most likely to be chosen, with the curve for response choice 4 totally subsumed under 
the curve for response choice 3 (“moderate”). Similarly, there was not a unique range for 
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which response choice 2 (“mild”) was most likely to be selected for both Sport items 2 
(running) and 3 (jumping) (Figure 3.1 continued, on the x-axis ranging from 5-25). 
For purposes of IRT modeling, response choices were collapsed if a response 
curve did not have a clear maximum and a unique range for which it was most likely to 
be selected. Response choices collapsed were: “moderate” and “severe” for item ADL12 
(lying in bed), and “mild” and “moderate” for Sport items 2 (running) and 3 (jumping). 
Differential item functioning. Differential item functioning (DIF) was evaluated for 
groups differing in age, gender, and education. DIF was not found for any item in any 
test; the ∆R² (test of combined uniform and non-uniform DIF) was below 0.03 for all 
items in all tests (Table 3.6). Although no DIF was found using pre-specified and 
conventional criteria, women were significantly more likely than men to report difficulty 
kneeling at a given level of function (odds ratio OR=1.88 (95% CI 1.46, 2.43)) and were 
less likely than men to report difficulty twisting/pivoting on their surgical knee (OR=0.67 
(0.52, 0.86)). College graduates also were more likely than other education groups to 
report difficulty descending stairs (OR=1.53 (1.15, 2.02)). From a content point of view, it 
is unclear why women would report less difficulty twisting/pivoting on their knee but more 
difficulty kneeling, or why higher education would be related to more difficulty climbing 
stairs. Furthermore, given the large number of DIF tests, these results are only slightly 
more than would be expected by chance. 
Item bank calibration. The initial IRT model included 19 ADL and Sport items; it did not 
include items ADL11 (taking off socks), Sp3 (jumping), and ADL02 (ascending stairs). 
ADL11 and Sp3 were excluded due to issues of local dependence (as discussed above), 
while ADL02 was excluded due to content overlap with item ADL01 (descending stairs). 
All 19 items in the initial model showed satisfactory fit. Therefore, item parameters for 
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these 19 items were fixed, and then item parameters for the remaining 3 items (ADL02, 
ADL11, Sp3) were estimated in a second IRT model that included all 22 items. Item fit 
(S-X2) statistics are presented in Table 3.7; almost all items fit the model well. 
Across all 22 ADL and Sport items, discrimination parameters (slopes) ranged 
from 1.72 to 3.66 (mean=2.70), with higher slopes for the ADL (slope=2.23-3.66) items 
than the Sport (slope=1.72-2.17) items (Table 3.7). Difficulty parameters for the ADL 
items ranged from -2.69 (threshold between “extreme” and “severe” difficulty sitting, item 
ADL14) to 1.55 (threshold between “none” and “mild” difficulty with heavy domestic 
duties, item ADL16); only 23 (34.3%) of the 67 ADL item thresholds were positive and 
only 5 of these thresholds were greater than 1.0. For the Sport items, difficulty 
parameters ranged from -0.68 (threshold between “extreme” and “severe” difficulty 
twisting/pivoting, item Sp4) to 2.64 (threshold between “none” and “mild” difficulty 
kneeling, item Sp5); 13 (72.2%) of the 18 Sport item thresholds were positive and 9 of 
these were greater than 1.0. Thus the ADL items primarily measured at a lower level of 
function and the Sport items primarily measured at a higher level. 
The ADL items provided more information than the Sport items, with a mean 
maximum information value of 2.44 (range 1.42-3.66), compared to maximum 
information values ranging from 0.87 to 1.45 for the Sport items. (See column labeled 
Imax at Θ in Table 3.7; for example, the maximum information for item ADL02 was 2.34 at 
a theta (Θ) score of 0.4). However, the Sport items had their greatest information value 
at a higher range of the latent trait continuum than most ADL items. Sport items 
achieved their maximum item information at a theta score ranging from 0.6-0.9, and 
were the only items (aside from ADL16, heavy domestic duties) to provide information at 
a theta score higher than 2.0. In contrast, the maximum item information for most ADL 
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items was provided at a negative theta score, and information for most ADL items 
dropped sharply above a theta score of 1.0. This pattern is illustrated for two items in 
Figure 3.2. Item ADL17 (light domestic duties) provided information starting at a theta 
score of about -2.7 but its information value dropped off sharply after a theta score of 
1.0. In contrast, item Sp3 (jumping) did not provide information over most of the negative 
theta score range but did provide information throughout the positive score range. Item 
information curves for all 22 items are provided in Figure 3.5. 
Evaluation of the test information function showed that the total item bank was 
most reliable (reliability≥ 0.95, or SE≤0.23) over the range of theta scores from -2.5 to 
1.7 (Figure 3.3). Item bank reliability dropped sharply at a theta score greater than 1.7 
and was below 0.90 at a theta score greater than 2.2. Thus, the total item bank was 
more reliable at lower levels of function. For this reason, the KOOS function items better 
matched the function levels of the sample prior to TKR, when 70.7% of the sample had a 
negative theta score (Figure 3.4). Six months after TKR, 85.3% of the sample had a 
positive theta score; 46.4% had a theta score ≥1.0 and 15.7% had a theta score ≥1.7. 
The mean theta score (calculated from the 22-item bank) was -0.40 (SD=0.74) 
prior to TKR and 0.90 (SD=0.85) 6 months after TKR, where 0 is the combined (pre-
TJR/post-TJR) sample mean and 1 is the standard deviation. Prior to TKR, theta score 
reliability was ≥0.90 for 99.2% of the patients and ≥0.95 for 98.6%.  Six months after 
TKR, theta score reliability was ≥0.90 for 94.4% of the patients and ≥0.95 for 84.4%. 
CAT Simulations. When the CAT was instructed to stop once the SE for a score was 
≤0.32 (equivalent to reliability≥0.90) or at a maximum of 10 items, patients answered an 
average of 3.4 items pre-TKR, with 97% achieving a SE ≤0.32 in 3 to 5 items (Table 
3.8). More items were required post-TKR to achieve a SE ≤0.32, with a mean number of 
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5.0 items answered. However, 8.5% of patient scores did not reach a SE ≤0.32 post-
TKR (reliability≥0.90), even after 10 items were administered.   
When the higher reliability standard of achieving a SE≤0.23 (reliability≥0.95) or a 
maximum of 10 items was applied, patients answered a mean of 6.9 items pre-TKR, with 
most patients answering 6 to 8 items. However, the SE was higher than 0.23 for 4.2% of 
patients pre-TKR, even after they had answered 10 items, indicating that CAT scores for 
these patients did not achieve a reliability of 0.95. Post-TKR, patients answered a mean 
of 8.3 items, and 34% of patient scores did not have a SE≤0.23 (reliability of 0.95) even 
after answering 10 items. Patients whose scores had a reliability <0.95 post-TKR 
generally had relatively high function (median post-TKR CAT score=1.67, interquartile 
range=1.43, 2.03).  In contrast, patients whose scores had a reliability of ≥0.95 post-TKR 
generally had lower function (median CAT score=0.63, interquartile range=0.15, 0.95). 
In the pre-TKR data, three items (going shopping, light domestic duties, walking 
on flat surface) accounted for 74.7% of item administrations in the CAT using the 
SE≤0.32 stopping rule, with two other items (rising from bed, standing) accounting for 
another 17.7%. The same five items accounted for 69.7% of item administrations pre-
TKR when the SE≤0.23 stopping rule was applied. There was more variation in item 
usage post-TKR, with five items (going shopping, getting in/out of a car, light domestic 
duties, rising from sitting, heavy domestic duties) accounting for 62.6% of item 
administrations using the SE≤0.32 stopping rule. Sport items accounted for less than 1% 
of administrations pre-TKR and 13% of the administrations post-TKR using either 
stopping rule. Five items (putting on socks, taking off socks, lying in bed, getting in/out of 
bath, sitting) each accounted for less than 1% of item administrations in all four CAT 
simulations. 
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In simulations where the CAT stopped once the SE was ≤0.32 (reliability≥0.90) or 
at a maximum of 10 items, the mean CAT score was -0.39 (SD=0.72) pre-TKR and 0.89 
(SD=0.83) 6 months post-TKR. In CAT simulations where the CAT stopped once the SE 
was ≤0.23 (reliability≥0.95) or at a maximum of 10 items, the mean CAT score was -0.41 
(SD=0.73) pre-TKR and 0.92 (SD=0.84) 6 months after TKR. Thus, on average, CAT 
scores were similar to theta scores for the full 22-item bank (mean theta score (SD) pre-
TKR=-0.40 (SD=0.74); mean theta score (SD) 6 months after TKR=0.90 (SD=0.85)). 
 
Discussion 
 This analysis demonstrated that the 22 KOOS function in ADL and Sport items 
defined a unidimensional construct and could be calibrated on a common metric using 
an IRT model. As would be expected from their content, the ADL items primarily 
measured at a lower level of function and the Sport items primarily measured at a higher 
level; the full item bank was more reliable at lower levels of function. The KOOS item 
bank could be used to successfully conduct CAT simulations, thereby achieving precise 
and much more efficient measurement of knee-specific function for most patients. 
Results of the simulations also indicated that a relatively few items accounted for the 
majority of CAT administrations. However, the simulations also showed the limitations of 
conducting a computerized adaptive test using the KOOS function items. These findings 
and related methodological issues are discussed below. 
In the CAT simulations, a reliable function score could be achieved in 10 items or 
less for almost all patients prior to TKR and for a substantial proportion of patients 6 
months after TKR. Prior to TKR, a reliable score (reliability ≥0.95 or ≥0.90) could be 
estimated for 96-99% of patients using CAT, with a 55-86% reduction in respondent 
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burden compared to answering all 22 KOOS function items. However, the number of 
items needed to achieve a reliable score increased after TKR, and one third of patients 
could not achieve a function score with a reliability of 0.95 six months post-TKR, even 
after administration of 10 KOOS items. These patients tended to score at a higher level 
of function, where there were relatively few informative items to administer. As illustrated 
in Figure 3.4, 6 months after TKR nearly 25% of patients had a theta score of 1.5 or 
higher. Only six items -- ADL16 (heavy domestic duties) and all five Sport items -- had at 
least one item threshold above 1.5. Thus there was a ceiling effect post-TKR -- a high 
percentage of patients achieving the best possible score -- due to the mismatch between 
where a notable proportion of patients were located and where the KOOS items were 
located. This mismatch between people and items post-TKR would be even greater for 
the WOMAC, because the WOMAC does not include any Sport items. 
While the KOOS Sport/Recreation scale was developed to add activities that 
were more difficult than the ADL items, the performance of the Sport items in the TKR 
data was mixed. The Sport items did measure a higher level of function than almost all 
of the ADL items. However, the Sport items had relatively low item information, did not 
discriminate well (i.e., had low slopes) and were not administered frequently in CAT 
simulations. Thus while the Sport items extended the measurement range, they did not 
fully meet the need for more difficult items to administer to TKR patients. Additional 
items that extend the measurement range to measure a higher level of function are 
needed in TKR. This can be done by developing new knee-specific items with more 
difficult item content130 or by modifying the response choices of existing items to 
measure higher levels of function131; both of these approaches have been used to 
extend the measurement range of generic (general, not applying to any specific disease) 
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items. These results may also have implications for studies of patients with milder knee 
OA who are not substantially impaired, as well as for studies of treatments that are 
anticipated to move knee OA patients into the positive end of the function spectrum. 
Conclusions from this study about the Sport/Recreation items should not be 
generalized to patients with other knee disorders, however. KOOS Sport/Recreation 
items were selected to add specific activities that were affected by knee problems but 
not included in the WOMAC, as well as to extend the WOMAC’s range of measurement. 
The KOOS initially was developed and tested on young and middle-aged patients with 
anterior cruciate ligament injuries, meniscus injuries and early knee osteoarthritis45 and 
was only later applied to patients undergoing total knee replacement27, 104. Empirical 
evidence from this study showed that the Sport items raised the ceiling among TKR 
patients, but not as effectively as needed. However, these items may perform better in a 
younger, more active population of patients with early knee OA or other knee disorders. 
Evaluation of all 22 KOOS function items among other groups of knee patients, using 
IRT methods similar to those used in this study, is recommended. 
Only two of the seven KOOS-PS items (rising from sitting, rising from bed) were 
selected frequently in the CAT simulations, raising the question as to whether the 
optimal set of items was selected for this KOOS short form. The process of selecting 
items for the KOOS-PS was in large part driven by Rasch DIF analyses, which resulted 
in nine of the 22 ADL and Sport/Recreation items being eliminated due to age and/or 
gender DIF and another six items being eliminated due to country DIF28. Underscoring 
the importance of replication in tests of DIF, none of the items that demonstrated age or 
gender DIF in the KOOS-PS development study28 had notable age or gender DIF in this 
analysis. Franchignoni et al. also did not find age or gender DIF for 18 of the 22 KOOS 
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function items, including all seven KOOS-PS items (DIF results for the other four 
function items were not reported)67. Researchers have cautioned against large-scale 
elimination of items from an item bank based on finding statistically significant DIF alone, 
without considering whether the DIF has substantive or clinical meaning67, 70. In addition, 
the variation in slopes between the ADL (2.23-3.66) and Sport (1.72-2.17) items 
suggests that the Rasch model (which sets all slopes to be equivalent) may not be 
appropriate for the KOOS function items. Therefore, IRT methods are recommended 
when constructing any new short function scales from the KOOS. CAT simulations also 
indicated that other items which are not in the KOOS-PS (e.g., ADL08 going shopping, 
ADL17 light domestic duties) may be good candidate items for a short form because 
they were selected frequently for the CAT. 
The IRT analyses benefitted from use of a combined sample of pre-TKR and 
post-TKR data. As a result, the analyses included data from patients with widely varying 
function levels, ranging from patients with severe functional limitations (pre-TKR) to 
those with high functioning (post-TKR). If the analyses had been conducted with only 
pre-TKR data or only post-TKR data, the sample size would have been sparse in many 
item by response choice cells, which is not optimal for establishing stable IRT parameter 
estimates120. Item frequency distributions are often not described in Rasch and IRT 
analyses, and thus the potential impact of any lack of sample diversity is unaddressed. 
At a minimum, reporting of summary item descriptive statistics (e.g., skewness) is 
recommended. 
This analysis has a number of limitations. First, patients were from high volume 
orthopedic centers in the US only. Similar analyses using IRT methods should be 
replicated in other patient groups, particularly with patients from other countries. Second, 
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the calibrations presented in this article are centered (mean=0, SD=1) on a particular 
sample (2/3 pre-TKR, 1/3 post-TKR) and thus the absolute values of the threshold 
parameters reported here are not generalizable to other populations. Ultimately, 
establishment of a standard metric for calibrations of the KOOS function items would 
need to be based on a representative and well-defined patient population, as has been 
done in other diseases106. Third, data was collected by both paper-pencil and PC 
methods. Analyses were not conducted separately by method of administration because 
the PC sample (n=272) did not meet minimum sample size recommendations for IRT 
analyses71. However, a meta-analysis of PRO studies that compared paper-pencil and 
PC methods of data collection found that scale scores generally were equivalent across 
these methods of administration132. In addition, a recent study of PROMIS physical 
function items using IRT methods found no significant differences in item parameters 
(slopes and thresholds) between paper-pencil and PC data133. Thus it is unlikely that 
results of this analysis were notably impacted by the multiple methods used to collect 
data. Fourth, additional IRT modeling should be conducted before a knee-specific 
function CAT is used with TKR patients in real-time. In particular, other types of IRT 
models such as the generalized partial credit model (GPCM) might be applied to the 
data; although results for GRM and GPCM models are likely to be similar overall65, they 
may vary for individual patients. Finally, the response scale for all items was keyed in the 
same direction (“None” to “Extreme” in the survey form), which makes it difficult to 
identify any possible straight-lining (respondents providing the same answer to all items). 
While it is common for function scales to present all response choices in the same order, 
the potential impact on item calibrations of even a small number of respondents who 
engage in straight-lining has not been studied, to the best of my knowledge. If new knee-
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specific function items are developed to address the lack of measurement at the higher 
end of the function spectrum, it is recommended that not all responses be keyed in the 
same direction. 
In summary, this analysis has used IRT modeling, including evaluation of the 
underlying IRT assumptions of unidimensionality and local independence, to develop 
and evaluate a knee-specific function item bank based on KOOS function in ADL and 
Sport items. KOOS items could successfully be calibrated, and the resulting item bank 
was sufficiently reliable for individual administrations over a wide range of theta scores, 
although primarily at lower levels of function. In addition, CAT simulations suggested that 
while a function score can be estimated precisely and efficiently in many fewer than 22 
items for those with severe OA, the item bank was less successful for patients at higher 
levels of knee-specific function. Furthermore, the CAT simulations raised questions as to 
whether the best items had been selected for the KOOS-PS. Additional research to 
extend the measurement range of the KOOS function items and to develop new KOOS 
short function scales is recommended.  
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Table 3.1: KOOS Pain and Function item descriptive statistics, pre-TKR (n=1,179) 
    Percentage by Response Choice 
Item Abbreviated Content Mean SD 
Skew-
ness 1 2 3 4 5 
Miss
-ing 
Pain          
P1 Frequency knee pain* 4.24 0.75 -1.74 2.1 0.8 3.8 56.5 35.9 0.8 
P2 Pain twisting/pivoting 3.48 1.03 -0.45 4.2 12.3 28.9 37.2 15.1 2.2 
P3 Pain straighten fully 2.78 1.11 0.10 14.4 24.3 35.3 18.1 6.7 1.2 
P4 Pain bending fully 3.15 1.15 -0.14 8.8 19.5 31.0 26.8 12.7 1.2 
P5 Pain walking on flat 2.88 0.95 0.02 7.7 24.3 44.4 18.6 4.4 0.6 
P6 Pain up or down stairs 3.66 0.93 -0.40 1.8 7.8 31.4 40.0 18.2 0.8 
P7 Pain at night in bed 2.68 1.06 0.17 14.5 28.6 35.2 16.3 4.7 0.8 
P8 Pain sitting or lying 2.50 0.96 0.28 15.1 34.7 37.1 9.8 2.7 0.7 
P9 Pain standing upright 2.95 0.97 -0.01 6.7 22.7 42.4 21.1 5.3 1.8 
Function in Activities of Daily Living         
A1 Descending stairs 3.41 0.97 -0.12 2.2 14.2 37.3 31.4 14.2 0.8 
A2 Ascending stairs 3.37 0.98 -0.12 2.5 15.4 37.1 31.5 13.1 0.5 
A3 Rising from sitting 3.17 0.96 -0.09 4.2 18.1 41.6 27.7 7.8 0.6 
A4 Standing 2.85 0.95 -0.04 8.5 24.9 42.6 19.9 3.5 0.7 
A5 Bending to floor 3.03 1.08 0.04 7.8 23.7 35.1 22.5 9.7 1.3 
A6 Walking on flat surface 2.72 0.92 0.12 8.7 31.0 41.8 14.9 2.8 0.8 
A7 Getting in/out of car 2.98 0.91 0.01 4.7 23.3 44.9 21.9 4.2 0.9 
A8 Going shopping 3.14 0.97 -0.06 4.6 19.3 41.1 26.3 8.0 0.8 
A9 Putting on socks 2.58 1.02 0.21 15.9 29.6 38.0 12.1 3.6 0.7 
A10 Rising from bed 2.76 0.99 0.13 10.1 28.6 40.0 16.2 4.2 0.8 
A11 Taking off socks 2.52 1.00 0.26 16.5 32.1 35.5 11.5 3.1 1.3 
A12 Lying in bed 2.60 1.00 0.25 13.9 32.0 36.6 12.8 3.7 0.9 
A13 Getting in/out of bath 2.73 1.12 0.26 14.2 27.4 33.8 14.0 7.6 3.1 
A14 Sitting 2.24 0.93 0.45 22.5 39.4 29.4 6.4 1.5 0.8 
A15 Getting on/off toilet 2.64 1.00 0.26 12.0 34.4 34.0 15.4 3.6 0.7 
A16 Heavy domestic duties 3.64 1.00 -0.50 2.9 9.1 28.7 37.8 20.3 1.3 
A17 Light domestic duties 2.65 0.91 0.20 9.6 33.1 42.2 11.8 2.8 0.6 
Function in Sport and Recreation         
Sp1 Squatting 4.13 0.99 -1.11 2.1 4.7 15.7 30.9 45.0 1.6 
Sp2 Running 4.48 0.83 -2.11 2.2 0.8 6.1 27.3 61.0 2.6 
Sp3 Jumping 4.48 0.85 -2.16 2.4 1.2 5.1 27.8 61.0 2.5 
Sp4 Twisting/pivoting 4.07 0.99 -1.00 2.4 4.2 18.1 33.2 40.5 1.7 
Sp5 Kneeling 4.17 0.97 -1.11 1.9 4.4 15.7 30.5 46.6 0.9 
Response options are 1=None, 2=Mild, 3=Moderate, 4=Severe, 5=Extreme except where noted:  
* 1=Never, 2=Monthly, 3=Weekly, 4=Daily, 5=Always. 
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Table 3.2: KOOS Pain and Function item descriptive statistics, 6 months post-TKR (n=886) 
     Percentage by Response Choice 
Item Abbreviated Content Mean SD 
Skew-
ness 1 2 3 4 5 
Miss
-ing 
Pain          
P1 Frequency knee pain* 2.52 1.36 0.14 35.7 12.1 16.5 28.0 4.5 3.2 
P2 Pain twisting/pivoting 1.83 0.96 1.05 45.1 30.0 14.9 5.2 1.2 3.6 
P3 Pain straighten fully 1.53 0.82 1.66 63.2 22.7 9.6 2.2 0.8 1.5 
P4 Pain bending fully 2.05 1.08 0.87 38.2 31.2 18.3 7.8 3.0 1.5 
P5 Pain walking on flat 1.36 0.66 1.90 71.4 18.6 6.6 1.0 0.1 2.2 
P6 Pain up or down stairs 2.04 0.94 0.66 32.0 38.4 20.5 6.5 0.9 1.7 
P7 Pain at night in bed 1.71 0.84 1.03 49.5 31.4 14.4 2.6 0.4 1.7 
P8 Pain sitting or lying 1.55 0.74 1.28 57.3 30.2 9.4 1.3 0.2 1.5 
P9 Pain standing upright 1.55 0.78 1.31 59.4 26.3 11.1 1.8 0.2 1.2 
Function in Activities of Daily Living         
A1 Descending stairs 2.05 0.97 0.67 33.9 35.3 21.7 6.6 1.2 1.2 
A2 Ascending stairs 1.92 0.91 0.76 37.7 36.3 18.6 4.8 0.7 1.9 
A3 Rising from sitting 1.91 0.89 0.82 37.3 38.9 17.9 3.8 0.9 1.2 
A4 Standing 1.49 0.77 1.54 64.6 22.6 9.5 1.9 0.2 1.1 
A5 Bending to floor 1.76 0.94 1.22 49.2 30.9 11.8 5.3 1.2 1.7 
A6 Walking on flat surface 1.35 0.65 1.92 73.1 17.8 6.8 0.8 0.1 1.3 
A7 Getting in/out of car 1.87 0.83 0.72 36.5 41.2 17.5 2.7 0.4 1.7 
A8 Going shopping 1.70 0.90 1.18 52.6 27.1 14.0 3.6 0.8 1.9 
A9 Putting on socks 1.80 0.92 1.09 46.0 32.5 14.9 4.0 1.2 1.3 
A10 Rising from bed 1.62 0.83 1.32 56.0 27.9 11.5 2.6 0.6 1.5 
A11 Taking off socks 1.70 0.87 1.27 50.8 31.5 12.1 3.0 1.0 1.6 
A12 Lying in bed 1.67 0.84 1.17 52.1 31.0 12.2 3.0 0.4 1.2 
A13 Getting in/out of bath 1.67 0.95 1.46 56.6 24.9 10.1 4.9 1.5 2.1 
A14 Sitting 1.42 0.69 1.76 67.3 22.7 7.3 0.8 0.3 1.6 
A15 Getting on/off toilet 1.62 0.80 1.10 54.2 29.2 13.1 1.9 0.2 1.3 
A16 Heavy domestic duties 2.36 1.15 0.56 26.1 31.2 23.5 11.3 5.2 2.7 
A17 Light domestic duties 1.49 0.76 1.58 64.5 22.6 10.0 1.2 0.4 1.2 
Function in Sport and Recreation         
Sp1 Squatting 2.93 1.26 0.16 13.4 26.3 25.5 17.7 14.4 2.6 
Sp2 Running 3.38 1.31 -0.31 9.6 15.6 22.2 21.9 24.3 6.4 
Sp3 Jumping 3.37 1.32 -0.34 11.1 13.0 23.6 21.5 24.2 6.6 
Sp4 Twisting/pivoting 2.47 1.24 0.46 26.8 26.8 23.2 13.7 7.3 2.4 
Sp5 Kneeling 3.25 1.24 -0.09 8.3 20.2 27.7 19.9 20.4 3.6 
Response options are 1=None, 2=Mild, 3=Moderate, 4=Severe, 5=Extreme except where noted:  
* 1=Never, 2=Monthly, 3=Weekly, 4=Daily, 5=Always. 
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Table 3.3: KOOS Pain and Function item descriptive statistics, combined pre- and post-
TKR sample (n=1,179) 
     Percentage by Response Choice 
Item Abbreviated Content Mean SD 
Skew-
ness 1 2 3 4 5 
Miss
-ing 
Pain          
P1 Frequency knee pain* 3.67 1.28 -1.06 13.4 4.4 8.1 47.1 25.0 2.0 
P2 Pain twisting/pivoting 2.95 1.29 -0.11 18.2 17.1 23.9 26.3 11.4 3.1 
P3 Pain straighten fully 2.38 1.17 0.42 29.5 24.1 27.8 12.5 4.7 1.4 
P4 Pain bending fully 2.80 1.25 0.10 19.0 22.7 26.2 21.0 9.8 1.3 
P5 Pain walking on flat 2.39 1.12 0.24 28.3 22.1 32.6 13.1 2.8 1.2 
P6 Pain up or down stairs 3.16 1.20 -0.26 11.6 16.8 27.7 30.1 12.7 1.0 
P7 Pain at night in bed 2.37 1.09 0.39 25.6 29.3 29.3 11.4 3.2 1.3 
P8 Pain sitting or lying 2.19 0.99 0.51 28.4 33.5 28.2 6.7 2.0 1.3 
P9 Pain standing upright 2.52 1.13 0.18 23.5 22.6 33.0 15.2 3.9 1.8 
Function in Activities of Daily Living         
A1 Descending stairs 2.99 1.18 -0.06 12.6 20.1 31.9 23.6 10.6 1.2 
A2 Ascending stairs 2.93 1.19 -0.04 14.4 20.1 31.5 22.9 9.8 1.4 
A3 Rising from sitting 2.77 1.11 0.06 14.8 24.8 33.6 20.3 5.8 0.8 
A4 Standing 2.43 1.10 0.21 25.5 24.3 32.7 13.7 2.7 1.0 
A5 Bending to floor 2.64 1.21 0.25 20.5 26.5 26.0 17.8 7.4 1.8 
A6 Walking on flat surface 2.29 1.06 0.34 29.2 26.2 31.3 10.2 2.0 1.1 
A7 Getting in/out of car 2.66 1.01 0.14 13.6 28.9 37.5 15.2 3.6 1.3 
A8 Going shopping 2.69 1.18 0.06 20.8 20.5 31.9 19.9 5.8 1.1 
A9 Putting on socks 2.35 1.05 0.39 24.4 30.7 31.0 9.8 2.9 1.1 
A10 Rising from bed 2.41 1.09 0.31 24.9 27.1 31.0 12.4 3.2 1.4 
A11 Taking off socks 2.27 1.04 0.49 26.8 32.1 28.2 8.5 2.6 1.7 
A12 Lying in bed 2.30 1.04 0.45 26.0 31.6 29.9 8.6 2.8 1.1 
A13 Getting in/out of bath 2.40 1.19 0.46 28.1 25.4 26.0 12.0 5.7 2.8 
A14 Sitting 1.97 0.94 0.74 36.6 35.1 21.3 4.6 1.2 1.2 
A15 Getting on/off toilet 2.32 1.07 0.41 26.6 30.3 28.1 11.2 2.6 1.2 
A16 Heavy domestic duties 3.26 1.20 -0.34 10.4 14.9 26.7 30.7 15.3 2.0 
A17 Light domestic duties 2.29 1.04 0.36 27.5 28.9 31.6 9.1 2.1 0.8 
Function in Sport and Recreation         
Sp1 Squatting 3.74 1.23 -0.69 6.1 11.9 18.2 27.0 34.9 1.9 
Sp2 Running 4.12 1.14 -1.27 4.7 5.9 11.3 25.3 48.6 4.2 
Sp3 Jumping 4.13 1.14 -1.33 5.1 4.7 11.6 25.3 49.1 4.2 
Sp4 Twisting/pivoting 3.58 1.30 -0.60 9.8 12.0 17.9 28.2 29.9 2.1 
Sp5 Kneeling 3.88 1.15 -0.76 3.6 10.3 19.0 27.0 38.3 1.9 
Response options are 1=None, 2=Mild, 3=Moderate, 4=Severe, 5=Extreme except where noted:  
* 1=Never, 2=Monthly, 3=Weekly, 4=Daily, 5=Always. 
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Table 3.4: Exploratory factor analysis - Unrotated factor loadings for KOOS ADL and Sport 
items, combined TKR sample (n=1,167)  
Item Abbreviated Content Mean SD 
 Factor Loading 
Uniqueness  Factor 1 Factor 2 
Activities of Daily Living       
A1 Descending stairs 2.99 1.18  0.809 0.092 0.337 
A2 Ascending stairs 2.93 1.19  0.831 0.052 0.307 
A3 Rising from sitting 2.77 1.11  0.864 -0.065 0.249 
A4 Standing 2.43 1.10  0.819 -0.114 0.316 
A5 Bending to floor 2.64 1.21  0.791 -0.131 0.357 
A6 Walking on flat 2.29 1.06  0.817 -0.125 0.317 
A7 Getting in/out of car 2.66 1.01  0.834 -0.177 0.273 
A8 Going shopping 2.69 1.18  0.854 -0.044 0.269 
A9 Putting on socks 2.35 1.05  0.758 -0.312 0.328 
A10 Rising from bed 2.41 1.09  0.826 -0.265 0.248 
A11 Taking off socks 2.27 1.04  0.777 -0.321 0.293 
A12 Lying in bed 2.30 1.04  0.762 -0.245 0.359 
A13 Getting in/out of bath 2.40 1.19  0.792 -0.140 0.354 
A14 Sitting 1.97 0.94  0.740 -0.347 0.332 
A15 Getting on/off toilet 2.32 1.07  0.818 -0.209 0.287 
A16 Heavy domestic 3.26 1.20  0.806 0.159 0.325 
A17 Light domestic duties 2.29 1.04  0.875 -0.074 0.230 
Sport/Recreation       
Sp1 Squatting 3.74 1.23  0.767 0.426 0.230 
Sp2 Running 4.12 1.14  0.693 0.621 0.135 
Sp3 Jumping 4.13 1.14  0.691 0.622 0.137 
Sp4 Twisting/pivoting 3.58 1.30  0.775 0.396 0.243 
Sp5 Kneeling 3.88 1.15  0.747 0.397 0.284 
        
Eigenvalue    13.88 1.91  
% total variance explained    63.1 8.7  
 
  
62 
 
Table 3.5: Confirmatory factor analysis - Factor loadings for KOOS ADL and Sport items in 
three models, combined TKR sample (n=1,167) 
 Abbreviated 
Content 
  
1 factor 
2 factor  Bifactor 
Item Mean SD ADL Sport  Common ADL Sport 
Activities of Daily Living          
A1 Descending stairs 2.99 1.18 0.863 0.875   0.905 -0.126  
A2 Ascending stairs 2.93 1.19 0.879 0.889   0.921 -0.105  
A3 Rising from sitting 2.77 1.11 0.853 0.863   0.852 0.180  
A4 Standing 2.43 1.10 0.853 0.861   0.864 0.112  
A5 Bending to floor 2.64 1.21 0.795 0.807   0.777 0.262  
A6 Walking on flat 2.29 1.06 0.863 0.870   0.872 0.121  
A7 Getting in/out of car 2.66 1.01 0.855 0.864   0.828 0.289  
A8 Going shopping 2.69 1.18 0.880 0.890   0.893 0.112  
A9 Putting on socks 2.35 1.05 0.920 0.924   0.658 0.698  
A10 Rising from bed 2.41 1.09 0.853 0.861   0.809 0.342  
A11 Taking off socks 2.27 1.04 0.937 0.940   0.679 0.708  
A12 Lying in bed 2.30 1.04 0.788 0.800   0.740 0.356  
A13 Getting in/out of bath 2.40 1.19 0.805 0.815   0.782 0.269  
A14 Sitting 1.97 0.94 0.798 0.808   0.737 0.390  
A15 Getting on/off toilet 2.32 1.07 0.849 0.857   0.809 0.324  
A16 Heavy domestic 3.26 1.20 0.818 0.835   0.856 0.018  
A17 Light domestic duties 2.29 1.04 0.866 0.879   0.872 0.163  
Sport/Recreation          
Sp1 Squatting 3.74 1.23 0.798  0.887  0.727  0.490 
Sp2 Running 4.12 1.14 0.926  0.956  0.709  0.659 
Sp3 Jumping 4.13 1.14 0.926  0.957  0.712  0.661 
Sp4 Twisting/pivoting 3.58 1.30 0.815  0.927  0.781  0.414 
Sp5 Kneeling 3.88 1.15 0.770  0.858  0.703  0.485 
           
Model Fit Statistics         
CFI    0.943 0.954   0.979  
RMSEA   0.158 0.142   0.101  
# of item pairs w/residual correlations >0.20 22 7   0  
Correlation between factors   - 0.764   -  
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Table 3.6: Tests of differential item functioning, combined TKR sample (n=1,179) 
Item Abbreviated Content 
Age Gender Education 
∆R² p ∆R² p ∆R² p 
Activities of Daily Living      
A1 Descending stairs 0.003 0.7047 0.000 0.7607 0.027 0.0000 
A2 Ascending stairs 0.009 0.1181 0.005 0.0444 0.006 0.1833 
A3 Rising from sitting 0.007 0.2457 0.001 0.5968 0.004 0.3799 
A4 Standing 0.005 0.5043 0.002 0.3016 0.004 0.3987 
A5 Bending to floor 0.009 0.1029 0.004 0.0878 0.004 0.3137 
A6 Walking on flat surface 0.008 0.1787 0.012 0.0010 0.003 0.4955 
A7 Getting in/out of car 0.005 0.4379 0.001 0.4988 0.002 0.7919 
A8 Going shopping 0.004 0.5191 0.003 0.1651 0.005 0.2360 
A9 Putting on socks/stockings 0.012 0.0303 0.011 0.0015 0.006 0.1454 
A10 Rising from bed 0.004 0.5265 0.002 0.3399 0.002 0.7517 
A11 Taking off socks/stockings 0.006 0.2778 0.007 0.0145 0.002 0.6219 
A12 Lying in bed 0.002 0.9109 0.010 0.0027 0.004 0.3937 
A13 Getting in/out of bath 0.007 0.2471 0.012 0.0010 0.002 0.7866 
A14 Sitting 0.012 0.0315 0.000 0.7943 0.005 0.2623 
A15 Getting on/off toilet 0.010 0.0647 0.003 0.1974 0.002 0.7728 
A16 Heavy domestic duties 0.008 0.1810 0.006 0.0249 0.001 0.8260 
A17 Light domestic duties 0.012 0.0327 0.002 0.2804 0.001 0.9144 
Sport/Recreation       
Sp1 Squatting 0.014 0.0160 0.006 0.0249 0.006 0.1667 
Sp2 Running 0.004 0.5718 0.002 0.2775 0.006 0.1482 
Sp3 Jumping 0.008 0.1676 0.004 0.0807 0.002 0.6818 
Sp4 Twisting/pivoting 0.004 0.6166 0.015 0.0002 0.002 0.6448 
Sp5 Kneeling 0.016 0.0057 0.020 0.0000 0.006 0.1382 
Groups are: age (<55, 55-64, 65-74, 75+); gender (male, female); education (less than high school, high 
school graduate, some post-high school education, college graduate). 
∆R²= Nagelkerke’s coefficient of determination. 
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Table 3.7: Item statistics for the function (ADL and Sport) item bank, combined TKR 
sample 
  Skew-
ness CFA 
Slope 
(SE) 
Step1 
(SE) 
Step2 
(SE) 
Step3 
(SE) 
Step4 
(SE) S-X
2 
Imax 
at Θ 
% CAT 
Util. Item Abbreviated Content 
A1 Descending stairs -0.06 0.863 2.67 -1.43 -0.51 0.47 1.40 0.236 2.00 0.25 
    0.10 0.05 0.03 0.03 0.05  0.5‡ 5.26 
A2 Ascending stairs -0.04 0.879 2.89 -1.46 -0.56 0.39 1.26 0.679 2.34 0.61 
    0.14 0.06 0.04 0.05 0.07  0.4 6.10 
A3 Rising from sitting 0.06 0.853 3.12 -1.71 -0.75 0.24 1.23 0.724 2.63 1.38 
    0.15 0.07 0.04 0.04 0.07  -0.8 10.91 
A4 Standing 0.21 0.853 3.24 -2.09 -1.08 -0.08 0.72 0.474 2.89 7.77 
    0.16 0.09 0.04 0.04 0.05  0.0 6.97 
A5 Bending to floor 0.25 0.795 2.56 -1.67 -0.81 0.00 0.98 0.747 1.91 0.00 
    0.12 0.07 0.04 0.04 0.07  -0.8 0.25 
A6 Walking on flat surface 0.34 0.863 3.27 -2.22 -1.26 -0.24 0.57 0.205 2.92 17.66 
    0.16 0.10 0.05 0.04 0.05  -0.2 3.87 
A7 Getting in/out of car 0.14 0.855 3.29 -1.95 -0.99 0.14 1.27 0.083 2.88 2.53 
    0.16 0.08 0.04 0.04 0.07  -1.0 12.51 
A8 Going shopping 0.06 0.880 3.66 -1.64 -0.74 0.15 0.89 0.520 3.66 28.78 
    0.18 0.06 0.04 0.04 0.06  0.2 19.70 
A9 Putting on socks 0.39 0.920 2.23 -2.38 -1.40 -0.21 0.86 0.476 1.42 0.22 
    0.11 0.11 0.06 0.04 0.06  -1.5 0.13 
A10 Rising from bed 0.31 0.853 3.23 -2.01 -1.12 -0.14 0.74 0.975 2.84 9.96 
    0.16 0.08 0.04 0.04 0.06  -0.1 1.15 
A11 Taking off socks 0.49 0.937 2.54 -2.31 -1.42 -0.32 0.72 0.189 1.83 0.22 
    0.10 0.09 0.05 0.03 0.04  -1.5 0.02 
A12 Lying in bed* 0.45 0.788 2.54 -2.26 -0.28 0.76  0.988 1.74 0.22 
    0.13 0.10 0.04 0.06   -0.1 0.07 
A13 Getting in/out of bath 0.46 0.805 2.74 -1.80 -1.09 -0.22 0.64 0.282 2.19 0.00 
    0.14 0.07 0.05 0.04 0.06  -1.2 0.00 
A14 Sitting 0.74 0.798 2.62 -2.69 -1.77 -0.72 0.36 0.001 1.93 0.37 
    0.13 0.14 0.07 0.04 0.05  -1.8 0.00 
A15 Getting on/off toilet 0.41 0.849 3.17 -2.12 -1.19 -0.26 0.67 0.808 2.74 0.61 
    0.16 0.09 0.05 0.04 0.05  -1.2 0.09 
A16 Heavy domestic duties -0.34 0.818 2.67 -1.20 -0.16 0.76 1.55 0.554 2.07 0.52 
    0.13 0.05 0.04 0.06 0.08  0.9 7.38 
A17 Light domestic duties 0.36 0.866 3.60 -2.16 -1.28 -0.25 0.63 0.193 3.44 28.28 
    0.18 0.09 0.05 0.04 0.05  -1.3 12.15 
Sp1 Squatting -0.69 0.798 1.83 -0.55 0.40 1.24 2.20 0.311 1.03 0.15 
    0.10 0.05 0.05 0.08 0.12  0.8 3.33 
Sp2 Running† -1.27 0.926 1.72 -0.04 1.01 2.43  0.053 0.87 0.05 
    0.10 0.05 0.08 0.14   0.7 1.10 
Sp3 Jumping† -1.33 0.926 1.81 -0.02 1.02 2.34  0.003 0.97 0.10 
    0.09 0.04 0.05 0.10   0.7 2.45 
Sp4 Twisting/pivoting -0.60 0.815 2.17 -0.68 0.24 0.97 1.70 0.541 1.45 0.25 
    0.11 0.04 0.05 0.07 0.09  0.9 4.48 
Sp5 Kneeling -0.76 0.770 1.74 -0.44 0.54 1.52 2.64 0.036 0.92 0.07 
    0.10 0.05 0.06 0.09 0.15  0.6 2.09 
* Severe/moderate response choices collapsed. † Moderate/mild response choices collapsed.  
‡ Maximum item information was at theta values of -0.5 as well as theta value of 0.5. 
CFA: Factor loading in one-factor confirmatory factor analysis. 
Step1-Step4: Item difficulty thresholds. Unless response choices were collapsed, step1/threshold 1 is extreme/severe;  
step 2/threshold 2 is severe/moderate; step 3/threshold 3 is moderate/mild; step 4/threshold 4 is mild/none. 
S-X2: p-value for S-X2 fit statistic. 
Imax at Θ: Maximum item information (upper number) at a particular value of theta Θ (lower number). 
% CAT Util.: % of item administrations in pre-TKR (upper number) and post-TKR (lower number) CAT administrations 
using stopping rule of SE≤0.32 or maximum of 10 items.  
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Table 3.8: Number of items administered and item characteristics in simulated CATs 
  SE ≤ 0.32*  SE ≤ 0.23† 
  Pre-TKR Post-TKR  Pre-TKR Post-TKR 
Number of Items Administered      
1 0.0 0.0  0.0 0.0 
2 0.0 0.0  0.0 0.0 
3 71.3 28.6  0.0 0.0 
4 20.2 32.7  0.0 0.0 
5 5.4 10.9  4.3 0.0 
6 1.3 5.1  41.9 16.8 
7 0.6 5.8  30.2 18.5 
8 0.3 3.6  12.3 16.5 
9 0.1 2.4  4.8 8.7 
10 0.9 10.9  6.5 39.5 
       
Average number of items per patient 3.45 5.02  6.91 8.30 
       
% patients with SE ≤ 0.32 99.1 91.5    
% patients with SE ≤ 0.23    95.8 65.7 
      
% of Times Item Administered      
Activities of Daily Living      
A1 Descending stairs 0.25 5.26  0.34 5.67 
A2 Ascending stairs 0.61 6.10  1.69 6.76 
A3 Rising from sitting 1.38 10.91  4.53 9.00 
A4 Standing 7.77 6.97  13.65 8.29 
A5 Bending to floor 0.00 0.25  0.10 2.51 
A6 Walking on flat surface 17.66 3.87  13.15 5.08 
A7 Getting in/out of car 2.53 12.51  9.47 10.02 
A8 Going shopping 28.78 19.70  14.39 11.91 
A9 Putting on socks/stockings 0.22 0.13  0.11 0.14 
A10 Rising from bed 9.96 1.15  14.28 9.14 
A11 Taking off socks/stockings 0.22 0.02  0.21 0.04 
A12 Lying in bed 0.22 0.07  0.18 0.05 
A13 Getting in/out of bath 0.00 0.00  0.50 0.19 
A14 Sitting 0.37 0.00  0.28 0.03 
A15 Getting on/off toilet 0.61 0.09  11.82 4.01 
A16 Heavy domestic duties 0.52 7.38  0.52 6.27 
A17 Light domestic duties 28.28 12.15  14.25 7.80 
Sport/Recreation      
Sp1 Squatting 0.15 3.33  0.14 3.26 
Sp2 Running 0.05 1.10  0.02 0.68 
Sp3 Jumping 0.10 2.45  0.10 2.58 
Sp4 Twisting/pivoting 0.25 4.48  0.18 4.51 
Sp5 Kneeling 0.07 2.09   0.07 2.05 
Stopping rules: * SE≤0.32 (reliability≥0.90) or maximum number of items=10; † SE≤0.23 (reliability≥0.95)  
or maximum number of items=10. Minimum number of items=2 in all CATs. 
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Figure 3.1: Monotonicity of item response curves, combined sample (n=1,179) 
Probability of selecting each item response for Items AD04 (Standing) and ADL12 (Lying in bed),  
in relation to ADL scale score (on horizontal axis) 
 
 
Response options are 1=None, 2=Mild, 3=Moderate, 4=Severe, 5=Extreme.
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Figure 3.1:  Monotonicity of item response curves (continued) 
Probability of selecting each item response for Sport items Sp2 (Running) and Sp3 (Jumping),  
in relation to Sport/Recreation scale score (on horizontal axis)  
 
 
 
Response options are 1=None, 2=Mild, 3=Moderate, 4=Severe, 5=Extreme  
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Figure 3.2: Sample ADL and Sport item information functions 
 
Item ADL17 - Light domestic duties  
 
 
Item Sport 3 - Jumping   
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Figure 3.3: ADL and Sport 22-item bank - Total test information and standard error 
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Figure 3.5: All ADL and Sport item information functions 
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CHAPTER IV: VALIDITY AND RESPONSIVENESS OF THE KOOS IN 
COMPARISON WITH OTHER PATIENT-REPORTED OUTCOME MEASURES  
IN TOTAL KNEE REPLACEMENT 
 
Abstract 
 
Objective: To evaluate validity and responsiveness of the Knee injury and Osteoarthritis 
Outcome Score (KOOS) and other patient-reported outcome measures before and after 
total knee replacement (TKR). 
Methods: Pre-TKR and 6-month post-TKR data from 1,143 patients was used to 
compare measures varying in attributes (knee-specific versus generic, longer versus 
shorter, computerized adaptive test (CAT) versus fixed-length) including KOOS, 
WOMAC, 7- and 8-item KOOS and WOMAC function scales, 3 to 10-item CAT function 
scores, and the SF-36. Validity was evaluated using ANOVA to compare pre-TKR 
scores for groups known to differ in knee pain, assistive device use and comorbid 
conditions, and to compare change scores (post- minus pre-TKR) for groups rating 
6-month outcomes as better, same or worse. Responsiveness also was evaluated with 
effect sizes and standardized response means. 
Results: Before TKR, KOOS scales discriminated between known groups as 
hypothesized. At 6 months post-TKR, the KOOS Quality of Life (QOL) scale 
discriminated significantly (p<0.05) better than all other knee-specific scales among 
better/same/worse outcome groups. All fixed-length function scales had similar validity in 
discriminating between post-TKR outcome groups. KOOS Pain and Symptom scales 
discriminated better than WOMAC Pain and Stiffness scales. The SF-36 Physical 
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Component Summary (PCS) discriminated as well as KOOS QOL among post-TKR 
outcome groups, although PCS had a smaller effect size. 
Conclusions: KOOS was valid and responsive in TKR, and KOOS QOL was more 
responsive than other KOOS and WOMAC scales. Knee-specific short function scales 
and CATs were as valid and responsive as longer KOOS and WOMAC function scales.  
 
Introduction 
Important attributes of a patient-reported outcome (PRO) questionnaire include 
its conceptual and measurement model, reliability, validity and responsiveness43. 
Previous analyses in this dissertation have evaluated the conceptual and measurement 
models underlying the Knee injury and Osteoarthritis Outcome Score (KOOS) and its 
reliability. These analyses supported the developer’s conceptual and measurement 
models and found that KOOS scales met scoring assumptions and were reliable across 
multiple sociodemographic and clinical groups (see Chapter II). This paper will evaluate 
the validity and responsiveness of the KOOS in relation to other PRO measures used in 
studies of knee osteoarthritis (OA) and total knee replacement (TKR).  
Tests of validity and responsiveness provide information that is useful in 
interpreting the meaning of the quantitative scores (i.e., scales) that are derived from a 
questionnaire. Validity indicates the extent to which a scale measures what it is intended 
to measure. Responsiveness indicates the ability of a scale to detect change over time. 
Some have argued that from a psychometric perspective, the responsiveness of a PRO 
scale is best evaluated in relation to another variable, such as the change in clinician 
ratings or the patient’s own rating of change134, 135. This type of anchor-based method of 
validation allows the meaning of a scale to be interpreted in relation to other 
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measures136, 137. In this sense, responsiveness can be seen as longitudinal validity. 
Convergent and discriminant validity of the KOOS have been demonstrated 
through examination of correlations between KOOS and SF-36 Health Survey scales in 
studies of knee OA27, 46, 47, 49, 51, 52 and of ACL and meniscus injuries77-79, 81-83. While 
showing that scales from different questionnaires (e.g., KOOS Function and SF-36 
Physical Functioning) have a high correlation provides some information about their 
validity, to fully evaluate validity, alternative forms of scales need to be compared in 
relation to external criteria. This is often done using tests of known groups validity, which 
compare the statistical efficiency of scales in detecting differences between groups 
known to differ at a point in time, or in detecting differences in change known to have 
occurred over time138. Tests of known groups validity provide additional information that 
is useful in interpreting the meaning of an individual scale or comparing the relative 
validity of multiple scales. These tests were used extensively in development of the 
SF-3672, 73, but to my knowledge, have not been used with the KOOS. 
In addition to the KOOS, a number of other questionnaires have been used to 
evaluate patient-reported outcomes in knee OA and TKR. Foremost among the joint-
specific questionnaires is the Western Ontario and McMaster Universities Osteoarthritis 
Index (WOMAC), which is included in its entirety in the KOOS. Both the KOOS and the 
WOMAC include a 17-item scale that measures the degree to which function in activities 
of daily living (ADL) is difficult due to a specific joint. A number of studies have found that 
this scale contains redundant items and could be shortened61, 62. Several 7 or 8-item 
joint-specific function scales have been derived from the 17-item WOMAC Function 
scale24-26, but the relative performance of these shorter scales has not been compared. 
Similarly, a 7-item KOOS function scale, which combines items from the KOOS Function 
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in ADL and Function in Sport/Recreation scales, has been derived28, but its performance 
in relation to other short function scales also has not been evaluated. Thus, while there 
is consensus that knee-specific function can be measured with fewer than 17 items, 
there is no consensus as to what the best method is for doing so.  
In addition to joint-specific questionnaires, generic (general) health surveys that 
are not specific to any disease or treatment also are often used in knee OA and TKR 
studies, most notably the SF-36 Health Survey29, 30. Many TKR studies administer both a 
knee-specific questionnaire (e.g., WOMAC, KOOS) and a generic questionnaire (e.g., 
SF-36), to include scales that are more specific to the impact of knee problems along 
with scales that are more sensitive to the impact of comorbidity and allow outcomes to 
be compared across conditions. However, as a result up to 27 or 32 items may be used 
to measure function, if both the WOMAC or KOOS and the SF-36 are administered, 
which greatly increases respondent burden. While knee-specific measures such as 
KOOS and WOMAC have been shown to be more responsive to TKR than the generic 
SF-3656, 139, other research has found that knee-specific and generic function measures 
were equally sensitive to the severity of knee problems140. The extent to which knee-
specific measures of function provide different information than generic measures of 
function is an area of ongoing research. 
While a multiplicity of knee-specific and generic PRO instruments are used in 
TKR, comprehensive information on their comparative validity and responsiveness is 
lacking. Therefore, this paper will evaluate the validity and responsiveness of the KOOS 
in comparison to the WOMAC, the short function scales derived from the KOOS and the 
WOMAC, and the SF-36, using pre-TKR and post-TKR data from a national joint 
replacement registry. In addition, the validity and responsiveness of a new knee-specific 
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function item bank that was developed from all 22 KOOS function items and 
computerized adaptive test (CAT) scores calculated from the item bank (see Chapter III) 
will be evaluated. While the paper will follow approaches used in previous KOOS studies 
(e.g., examination of scale correlations and post-TKR effect sizes), it also will evaluate 
the relative performance of all measures using tests of known groups validity. To 
increase the generalizability of results, multiple tests of known groups validity will be 
conducted; multiple tests of known groups validity also were conducted when the validity 
of the physical and mental component scores from the SF-36 was initially evaluated, for 
similar reasons73. By conducting a variety of cross-sectional and longitudinal tests, for 
which there are strong hypotheses as to the results that would be expected for valid 
measures, this paper will advance understanding of the comparative performance of the 
KOOS and other PRO measures, thereby informing their use in future studies of knee 
OA and TKR. 
 
Methods 
Patients 
Data came from the Function and Outcomes Research for Comparative 
Effectiveness in Total Joint Replacement (FORCE-TJR) registry, which includes joint 
replacement patients from across the US41. Patients who could not provide consent due 
to cognitive impairment or who had emergency surgery were ineligible. All 
questionnaires were self-administered via a web-based or scannable paper-pencil 
survey at the surgeon’s office or at home prior to surgery, 6 months post-surgery, and 
annually thereafter. This analysis included data from 1,179 TKR patients randomly 
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selected from FORCE-TJR enrollees at high volume surgical centers between May 2011 
and August 2012. Of these, data was available for 886 patients at the 6-month follow-up. 
Questionnaire 
The FORCE-TJR questionnaire included the KOOS and SF-36 Health Survey. 
Patients first answered a number of questions about their TKR surgery, assistive device 
use and sociodemographic characteristics, followed by the SF-36, a modified Charlson 
comorbidity index84, a back pain severity item, the KOOS, and additional items on pain in 
joints other than the surgical knee. 
KOOS and KOOS-PS. The KOOS contains 42 knee-specific items that measure pain 
(number of items k=9), other symptoms (k=7), function in activities of daily living (ADL) 
(k=17), function in sport and recreation (Sport) (k=5), and knee-related quality of life 
(QOL) (k=4)45, 50. (Abbreviated item content for all KOOS items is provided in Table 2.2). 
All KOOS items have 5-point response scales and were answered in reference to the 
surgical knee. Most KOOS items have a recall period of the last week; one Pain 
frequency and all QOL items do not have a specific recall period.  
A score for each KOOS scale was calculated by summing its component items 
and then transforming the sum so that 0 was the worst possible and 100 was the best 
possible score, following the developer’s scoring algorithms85.  A scale score was 
calculated as long as at least 50% of the items in the scale were answered; the mean 
score of all non-missing items within the scale was imputed for any missing item-level 
data.  Assumptions underlying KOOS scale scoring were confirmed in the FORCE-TJR 
data (see Chapter II). In addition, the KOOS-PS was constructed from four KOOS ADL 
and three KOOS Sport items28. Unlike the KOOS, the KOOS-PS is scored so 0 is the 
best possible and 100 is the worst possible score; the KOOS-PS is the only scale 
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evaluated in this paper in which a higher score indicates poorer functioning.  
WOMAC and short WOMAC Function scales. Because all 24 WOMAC items (version 
LK3.0) are included in the 42-item KOOS50, the WOMAC Pain (k=5), Stiffness (k=2) and 
Function (k=17) scales could be scored from the KOOS items that were administered in 
FORCE-TJR22. To be consistent with KOOS scoring, all WOMAC scales were scored so 
0 was the worst possible and 100 was the best possible score. Following the developer’s 
scoring algorithms, the WOMAC Function scale was calculated if at most three items 
were missing, and the WOMAC Stiffness and Pain scales were calculated if at most one 
item was missing86.  
As noted previously, the content of the 17 items in the WOMAC Function (LK3.0) 
scale is identical to that of the 17 items in the KOOS Function in ADL scale; the scales 
differ only in the number of items that need to be answered to calculate a scale score (9 
for KOOS, 14 for WOMAC). Because there was so little missing data in the FORCE-TJR 
dataset and because the validity and responsiveness analyses were limited to patients 
who had scores for all KOOS and WOMAC scales, the psychometric performance of 
these two scales was identical in this paper. Therefore, to simplify the narrative, these 
two scales will be described as the “KOOS/WOMAC Function in ADL” scale in some 
parts of the text, which indicates that the same results were found for the KOOS 
Function in ADL scale and the WOMAC Function scale.  
In addition, short WOMAC function scales were constructed from subsets of the 
17 WOMAC function items, including a 7-item scale developed by Liebs24, an 8-item 
scale developed by Tubach25 and a 7-item scale developed by Whitehouse26. For all of 
these short function scales, 0 was the worst possible and 100 was the best possible 
score. 
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IRT function bank and CAT scores. Previously in this dissertation (see Chapter III), a 
function item bank was developed that contained all 22 KOOS ADL and Sport items, 
following procedures used in previous IRT calibration studies106 and more recently in 
PROMIS71. In summary, a graded response model was used to calibrate the items, after 
evaluation of underlying IRT assumptions of item bank unidimensionality, local 
independence, and item monotonicity. The resulting IRT calibration parameters (item 
slopes and item difficulty thresholds) then were used to calculate a total item bank score 
(i.e., theta score) at both the pre-TKR and 6-month post-TKR time points for all patients, 
based on their responses to all 22 ADL and Sport items.  
The item bank also was used to conduct real-data simulations of computerized 
adaptive tests (CAT)106, 141. A simulated CAT selects the most informative items for each 
patient, using data that has already been collected from the patient and pre-set stopping 
rules, to derive a CAT score66, 128. CATs minimize respondent burden while optimizing 
test precision, resulting in more efficient measurement66.  In previous analyses (see 
Chapter III), two CAT scores were calculated from patient responses to the ADL and 
Sport items at each time point (pre-TKR and 6 months post-TKR) using two stopping 
rules: (1) CAT stopped when the standard error (SE) of an individual patient score was 
≤0.23 (equal to a reliability ≥0.95) or a maximum of 10 items were administered; or (2) 
CAT stopped when SE≤0.32 (reliability≥0.90) or at a maximum of 10 items. As shown in 
Chapter III, all simulated CAT scores were estimated with 3 to 10 items. The mean 
number of items used in CAT simulations was: (a) pre-TKR, reliability≥0.95=6.9 items; 
(b) post-TKR, reliability≥0.95=8.3 items; (c) pre-TKR, reliability≥0.90=3.4 items; and (d) 
post-TKR, reliability≥0.90=5.0 items. All theta and CAT measures were scored to have a 
mean of 0 and standard deviation of 1 in a combined pre-TKR and post-TKR sample.  
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SF-36 Health Survey. Unlike the KOOS and WOMAC which are joint-specific, the 
SF-36 Health Survey is a generic measure of health status, containing 36 items that are 
not specific to any diagnosis or treatment30, 31. Generic measures are expected to reflect 
both the impact of a primary condition (e.g., knee osteoarthritis in TKR) along with all 
other comorbid conditions that a patient may have.  The SF-36 (Version 2, standard 4-
week recall) was scored as eight scales, including scales primarily measuring physical 
health (Physical Functioning (PF), Role Limitations due to Physical Health (RP) and 
Bodily Pain (BP)), scales primarily measuring emotional health (Mental Health (MH) and 
Role Limitations due to Emotional Problems (RE)), and scales that have been shown to 
be strong to moderate measures of both physical and emotional health (General Health 
(GH), Vitality (VT) and Social Functioning (SF))72. In comparison with the KOOS and the 
WOMAC, the SF-36 Physical Functioning scale asks about limitations in physical 
activities due to health in general (versus the KOOS and WOMAC which ask about joint-
specific difficulty in function) and the SF-36 Bodily Pain scale asks about pain throughout 
the body (versus joint-specific pain in the KOOS and WOMAC). All SF-36 scales were 
scored so 0 was the worst possible and 100 was the best possible score, following the 
developer’s scoring algorithms142, 143. Summary Physical (PCS) and Mental (MCS) 
Component Scores, which are often used in TKR studies, were calculated from all eight 
scales using the developer’s scoring algorithms73; PCS and MCS were scored so 50 was 
the mean and 10 was the standard deviation in the US general population143. Reliability 
and validity of the SF-36 in TKR patients has been established in numerous studies29, 144. 
Analysis 
Construct validity, or the extent to which a scale is related to measures in a 
manner consistent with theory, was evaluated with correlations among measures prior to 
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TKR and with tests of known-groups validity using cross-sectional (pre-TKR) and 
longitudinal data. Responsiveness of the scales to TKR also was assessed with the 
effect size and standardized response mean. 
Concurrent validity was evaluated by examining product-moment correlations among 
measures of the conceptually related (e.g., KOOS pain, SF-36 pain) and conceptually 
different (e.g., KOOS pain, SF-36 mental health) domains at baseline (pre-TKR). Two-
tailed tests were used to determine significant (p<0.05) differences between correlations. 
A number of hypotheses about the magnitude of the correlations were established based 
on scale content and results from previous studies: 
 The correlation between the KOOS Pain and Function in ADL scales was 
hypothesized to be high (r>0.70), as was the correlation between the WOMAC 
Pain and Function scales145. 
 
 The correlation between the KOOS Pain and SF-36 Bodily Pain scales was 
hypothesized to be moderate (0.40-0.70), as was the correlation between the 
KOOS/WOMAC Function in ADL and SF-36 Physical Functioning scales27, 46. 
 
 All KOOS and WOMAC scales were hypothesized to have low (<0.40) 
correlations with the SF-36 Mental Health (MH) scale because joint-specific 
impairment was hypothesized to be only weakly related to mental health27. 
 
 The short WOMAC function scales (Liebs, Tubach, Whitehouse) and 17-item 
WOMAC Function scale all were hypothesized to have similar correlations with 
other scales, because the short scales contain WOMAC Function items only. 
 
 Because the KOOS-PS contains both ADL and Sport items, the correlation of the 
KOOS-PS with other scales were hypothesized to be between the correlation of 
the KOOS Function in ADL scale and the correlation of the KOOS Sport scale. 
 
 IRT theta and CAT scores were hypothesized to have stronger correlations with 
the KOOS Function in ADL scale than with other knee-specific scales, because 
the IRT theta and CAT scores primarily contain ADL items. The IRT theta and 
CAT scores were hypothesized to have moderate correlations with the KOOS 
Sport scale. 
 
 The remaining knee-specific scales (KOOS Symptoms, KOOS QOL, WOMAC 
Stiffness) were hypothesized to have higher correlations with other knee-specific 
scales than with generic SF-36 scales because the latter are not joint-specific. 
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Cross-sectional known groups validity. All measures were compared in terms of how 
well they discriminated according to conceptually-related external variables at a point in 
time, using baseline (pre-TKR) data. Known groups were defined that were expected to 
show differing patterns of relationships with knee-specific and generic measures: 
 Surgical knee pain. The KOOS includes one item about the frequency of pain in 
the surgical knee. It was hypothesized that patients reporting more frequent knee 
pain would have worse scores on all knee-specific scales, particularly knee-
specific pain scales. (To avoid criterion-measure confounding, this item was not 
included in calculating the KOOS pain scale for this known group comparison 
only). It also was hypothesized that knee pain would be weakly related to generic 
SF-36 scales, except for the SF-36 Bodily Pain scale for which a strong 
relationship was hypothesized.  
 
 Assistive walking device. Patients who used a walking device (cane, crutch or 
wheelchair) prior to TKR were hypothesized to have poorer scores on all knee-
specific scales and on SF-36 scales measuring physical health but not mental 
health47, 146.  
 
 Comorbidity. Comorbid condition groups (0, 1, 2+ conditions) were defined using 
a 14-item self-reported condition checklist based on the Charlson index147; 
conditions were: COPD, connective tissue disease, diabetes, cancer, liver 
disease, peripheral vascular disease, kidney disease, ulcer disease, AIDS, 
paralysis, heart attack/congestive heart failure/CABG, procedure to unblock neck 
blood vessels, stroke, and other (non-osteoarthritis). It was hypothesized that 
there would be a weaker relationship between the number of comorbid conditions 
and all knee-specific scales, in comparison with generic SF-36 scales. 
 
 
In all known group validity tests, the total item bank (theta) score calculated from 
all 22 function items was hypothesized to perform better than the KOOS and WOMAC 
function scales and the CAT scores, because theta is scored using IRT parameters for 
all 22 function items and thus has greater precision128. CAT scores (calculated with 3 to 
10 items) were hypothesized to perform better than the 7 and 8 item fixed-length 
function scales (short WOMAC function scales, KOOS-PS), because CATs use the most 
informative items for each patient to derive a more precise score using an IRT metric. 
The relative performance of the scales in discriminating among groups was 
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compared using one-way analysis of variance (ANOVA) and relative validity (RV) 
statistics72, 138. For each known group validity test, an ANOVA was conducted for each 
scale, with levels of the known group as the dependent variable and the scale as the 
independent variable, holding sample size constant across ANOVAs. The ANOVA 
F-statistic indicates how strongly a scale discriminates between groups, thus providing 
information about the scale’s validity. To facilitate comparisons across scales, RV 
statistics were calculated. RV statistics express in proportional terms the empirical 
validity of a scale relative to the most valid scale. Within each known group test, the 
scale with the highest F-statistic has an RV of 1.0 and all other scales have an RV less 
than 1.0, based on the ratio of the F-statistic for that scale to the F-statistic for the best 
performing scale. 95% confidence intervals for RV statistics were estimated using 
empirical bootstrap148, 149; this allowed statistically significant differences between RV 
statistics to be identified within each known group validity test.  
Longitudinal known groups validity. Validity also was assessed longitudinally, using 
hypotheses about the performance of change scores (6 month post-TKR minus pre-TKR 
scores) in relation to external markers of change. For this purpose, overall changes 
(better/same/worse) were rated by patients six months after TKR. To distinguish different 
domains of outcomes, patients were asked to compare their status at six months post-
TKR to their status before surgery in four areas: capability to do everyday physical 
activities (e.g., walking, climbing stairs, sports), ability to accomplish their daily work role 
(including work at home and in the workplace), feeling bothered by emotional problems, 
and general health; the verbatim content of these self-evaluated transition (SET) items is 
provided in Figure 4.1. For each SET item, patients were classified into four levels (much 
better, somewhat better, same, worse), as in previous analyses73.  The four SET items 
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then were used in four separate known groups validity analyses, in which the known 
groups were the patient’s rating of their change in physical activities, daily work role, 
emotional problems, or general health at six months. 
As in the cross-sectional known groups tests of validity (see above), ANOVA 
models were used to test longitudinal known groups validity, with the 4-level SET item as 
the independent variable and the change score for each scale (6 months minus pre-
TKR) as the dependent variable. Relative validity (RV) statistics were used to compare 
the responsiveness of all scales in distinguishing among much better/better/same/worse 
groups for each SET item. It was hypothesized that: 
 Scales that measured similar constructs as a SET item (e.g., KOOS Function in 
ADL scale in test of the physical activities SET; KOOS QOL scale in test of the 
daily work role SET) would have higher RVs than other scales in that SET test. 
 
 Knee-specific measures would be more responsive than generic SF-36 
measures, because the SET items asked patients to compare their status at 6 
months to their status “before your joint surgery”, plus two SET items (physical 
activities, daily work role) included specific attribution to change “because of your 
joint surgery”. 
 
 SF-36 measures previously shown to be most valid for physical outcomes (PF, 
RP and BP scales, PCS) would be more responsive than other SF-36 measures. 
 
 
Effect sizes and standardized response means. The degree of patient-reported 
change in pain and function after surgery is important in evaluating the success of 
TKR21. In the TKR literature, responsiveness of scales to TKR is often assessed by 
examining the effect size (ES; observed change score divided by the standard deviation 
of the baseline score)150 and the standardized response mean (SRM; observed change 
score divided by the standard deviation of the change score)151.  Pre-TKR and 6-month 
post-TKR data were used to calculate these statistics for all measures. 
All analyses were performed using Stata Version 11.2 (StataCorp, Irving, TX). 
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Results 
Data was available for n=1,179 patients at baseline (pre-TKR). The mean age of 
the sample was 66.1 (SD=9.7); 57% were age 65 or older and 12% were younger than 
age 55. Sixty-one percent were female. The majority (89.8%) were white, while 7.6% 
were black and 2.6% reported another race. The highest level of education was high 
school graduate or less for 28%, while 39% were college graduates or had post-
graduate education. Of the n=1,179 patients, 6 month post-TKR data was available for 
n=886. Six-month data was not available for the remaining 293 patients at the time the 
dissertation data was made available from the FORCE-TJR database, primarily because 
the patients were not yet scheduled to complete their 6-month post-TKR survey. In the 
n=886 sample, 59% were age 65 or older, 10% were younger than age 55, and 62% 
were female. Mean pre-TKR KOOS Pain scores for the n=1,179 and n=886 samples 
were 46.4 and 47.4 (p=0.20 for difference between samples), and the mean KOOS ADL 
scores for the n=1,179 and n=886 samples were 52.9 and 54.0 (p=0.18), respectively.  
Missing data and scale reliability. The amount of missing item- and scale-level data at 
baseline (pre-TKR) was low. Before TKR, the mean percentage of missing data per 
KOOS item was 1.27% (range 0.51-3.05% missing per item), while the mean percent of 
missing data per SF-36 item was 0.88% (range 0.25-2.12% missing per item). Scale 
scores could be calculated for more than 99% of patients for all measures except the 
SF-36 PCS and MCS, the KOOS Sport/Recreation scale, and KOOS-PS, which could be 
scored for 98.9%, 98.6% and 94.8% of patients, respectively. Of the 1,179 patients at 
baseline, 26 were missing one or more of the KOOS or WOMAC scales and another 10 
were missing one or more of the SF-36 measures. To maintain a constant sample for all 
baseline analyses, the sample was restricted to the n=1,143 patients who had scores for 
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all KOOS, WOMAC, short WOMAC function, IRT theta, CAT, and SF-36 measures. An 
additional 41 patients were missing the KOOS-PS at baseline, so all cross-sectional 
analyses of the KOOS-PS were based on data from n=1,102 patients.  Mean KOOS 
Function in ADL and Sport scores did not differ significantly for patients with and without 
KOOS-PS at baseline (mean KOOS ADL score=52.9 versus 50.7 (p=0.46), mean KOOS 
Sport score=18.3 versus 20.6 (p=0.45), for groups with and without KOOS-PS scores). 
Six month post-TKR data was available for 886 of the 1,179 patients. Change 
scores could be calculated for more than 98% of these patients for all measures except 
the SF-36 PCS/MCS, KOOS Sport/Recreation scale and KOOS-PS, for whom change 
scores could be calculated for 97.5%, 96.2% and 94.8% of patients, respectively. Of the 
886 patients for whom data was available at 6 months, 49 were missing change scores 
for one or more of the KOOS or WOMAC scales and another 17 were missing change 
scores for one or more of the SF-36 measures. To maintain a constant sample for all 
responsiveness analyses, the sample was restricted to the n=820 patients who had 
change scores for all KOOS, WOMAC, short WOMAC function, IRT theta, CAT, and SF-
36 measures. An additional 31 patients were missing a change score for the KOOS-PS, 
so all longitudinal analyses of the KOOS-PS were based on data from n=789 patients.  
Reliability statistics are provided for baseline (pre-TKR) data in Table 4.1, along 
with descriptive statistics. Reliability was calculated using Cronbach’s coefficient alpha 
for all scales except the IRT and CAT scores. For IRT and CAT scores, the reliability of 
each individual patient score was computed based on the standard error of the patient 
score; the mean reliability across all patients is reported in Table 4.1. Reliability of all 
scales exceeded the minimum level of 0.70 recommended for group-level analyses94; 
reliability statistics were similar at baseline and 6 months (data not reported). 
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Concurrent validity. Correlations at baseline (pre-TKR) of all knee-specific scales with 
each other and with the SF-36 measures are in Table 4.2. As hypothesized, correlations 
of the KOOS Function in ADL and KOOS Pain scales (r=0.78) and the WOMAC 
Function and WOMAC Pain scales (r=0.77) were high. The KOOS Pain and WOMAC 
Pain scales had moderate correlations with the SF-36 Bodily Pain (BP) scale (r=0.66 
and 0.63, respectively); these correlations were significantly (p<0.05) higher than 
correlations of the KOOS Pain and WOMAC Pain scales with the SF-36 Physical 
Functioning (PF) scale (r=0.49 and 0.50). However, the KOOS Function in ADL and 
WOMAC Function scales had a significantly (p<0.05) lower correlation with the SF-36 
PF scale (r=0.57) than with the SF-36 BP scale (r=0.64). In addition, correlations of the 
KOOS Sport scale were nearly identical with the SF-36 PF (r=0.44) and BP (r=0.42) 
scales. Correlations of all KOOS and WOMAC scales were much lower with the SF-36 
Mental Health scale (r=0.18-0.34) as hypothesized, demonstrating discriminant validity. 
As would be expected, the 7- and 8-item short WOMAC Function scales (Liebs, 
Tubach, Whitehouse) and 17-item WOMAC Function scale all had similar correlations 
with other scales. All three short WOMAC Function scales also had significantly (p<0.05) 
lower correlations with the SF-36 PF scale (r=0.53-0.56) then with the SF-36 BP scale 
(r=0.62-0.64). The KOOS-PS had high correlations with the KOOS ADL (r=-0.89) and 
KOOS Sport (r=-0.71) scales, and the correlation of the KOOS-PS with another scale 
was consistently between the correlations of the KOOS Function in ADL scale and 
KOOS Sport scale with that scale. The IRT theta function score and CAT function scores 
had high correlations with the KOOS ADL scale (r=0.88-0.98) but only moderate 
correlations with the KOOS Sport scale (r=0.48-0.63), reflecting that the IRT item bank 
and thus the CAT scores mostly contained ADL items.  
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Among the remaining knee-specific scales, the WOMAC Stiffness scale had a 
higher correlation with the other WOMAC scales (Pain, Function) than with the generic 
SF-36 scales. The KOOS Symptoms scale generally had a higher correlation with the 
other KOOS scales than with the SF-36 scales, although it had a moderate correlation 
with the SF-36 BP scale (r=0.46). The KOOS QOL scale had moderate (r=0.47-0.59) 
correlations with the other KOOS scales but also with the SF-36 PF (r=0.50), BP 
(r=0.53) and Role Physical (RP, r=0.48) scales and the SF-36 PCS (r=0.50). 
Cross-sectional known groups validity. Means and standard deviations for all scales 
along with F-statistics and relative validity (RV) statistics are presented for known groups 
defined by knee pain frequency, use of an assistive device, and number of comorbid 
conditions in Tables 4.3-4.5.  ANOVA F-statistics and RV statistics for all known groups 
are summarized in Table 4.6.  As expected, scores on all measures became 
monotonically worse as known group status declined (e.g., the mean KOOS Symptoms 
score was 66.9 for the group with knee pain “less than daily” compared to 39.6 for the 
group with knee pain “always”). Results for each known group comparison are 
summarized below. 
As hypothesized, the knee-specific pain scales were most valid at discriminating 
between groups defined by the frequency of surgical knee pain. While the KOOS Pain 
scale (RV=1.00) had a higher relative validity than the WOMAC Pain scale (RV=0.91), 
RVs for these two scales were not significantly different (see overlapping confidence 
intervals (CIs) for their RVs in Table 4.3). Most of the knee-specific function scales had 
moderate RVs (RV=0.52-0.61); however, the RV for the KOOS Sport scale was lower 
(RV=0.27) than the RV for all other function measures. RVs for other KOOS and 
WOMAC scales (KOOS Symptoms, KOOS QOL, WOMAC Stiffness) were moderate 
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(RV=0.43-0.52). Generic SF-36 scales and summary measures (excluding Bodily Pain, 
RV=0.76) only weakly (RV=0.05-0.30) discriminated between knee pain groups, as 
hypothesized. 
The generic SF-36 Physical Functioning (PF) scale was best at discriminating 
between groups who did and did not use an assistive device (cane, crutch or wheelchair) 
(RV=1.00), followed by the SF-36 PCS (RV=0.97) and Role Physical (RV=0.80) scale; 
the upper bound of the 95% CIs for the latter measures included the value of 1.00 
indicating that it cannot be concluded that they discriminated less well than PF. All knee-
specific function measures discriminated moderately between assistive device groups 
(RV=0.53-0.67), with the exception of the KOOS Sport scale (RV=0.28); however, the 
upper bound of the 95% CI for these function measures did not include 1.00, indicating 
that none of the knee-specific scales were as valid as the SF-36 PF scale in 
discriminating between assistive device groups. RVs for other KOOS and WOMAC 
scales (Symptoms, Stiffness, Pain, QOL) were low to moderate (RV=0.11-0.41). 
The SF-36 General Health (GH) scale (RV=1.00) was the most valid measure in 
discriminating between groups with different numbers of comorbid conditions (0, 1, 2+), 
as might be expected since it is an overall evaluation of health. RVs of all other generic 
and all knee-specific measures were low in relation to the GH scale. Of note, all knee-
specific and generic function scales had similar (RV=0.16-0.24) RVs. In addition, the 
KOOS Symptoms and QOL scales did not discriminate significantly (p>0.05) between 
comorbid condition groups, while the KOOS Pain, KOOS Sport, WOMAC Stiffness and 
WOMAC Pain scales discriminated significantly (p<0.05) but not strongly so. In contrast, 
all SF-36 measures demonstrated stronger discrimination across groups differing in 
numbers of comorbid conditions (p<0.01). 
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Longitudinal known groups validity. Mean change scores and standard deviations for 
all scales along with F-statistics and RV statistics are presented in Tables 4.7-4.10 for 
groups defined by self-evaluated transition (SET) items about changes in capability to do 
everyday physical activities, to accomplish daily work roles (at home or at work), in 
emotional problems, and in general health. ANOVA F statistics and RV statistics for all 
SET item groups are summarized in Table 4.11. 
Mean change scores for all measures generally were monotonically less 
favorable as self-evaluated transitions went from better to worse. However, the 
magnitude of the mean change scores differed for knee-specific and generic measures, 
particularly for the worst group, in all SET tests. Among those who rated themselves as 
worse 6 months after surgery, mean change scores on all knee-specific measures 
showed improvement. In contrast, mean change scores for the SF-36 generally 
remained stable or declined among those who rated themselves as worse 6 months 
after surgery. For example, the mean change score on the KOOS Function in ADL scale 
was 12.4 (0.7 SD unit improvement) for the group who rated themselves as “less” 
capable in doing everyday physical activities. In contrast, the mean change score on the 
SF-36 Physical Functioning scale for patients who rated their capability to do everyday 
physical activities as “less” was 3.4 points or 0.15 SD, far below the minimum value that 
is viewed as an important change152-154. In addition, only the generic SF-36 scales 
showed average declines for the “worse” groups. Mean change scores in the “worse” 
groups were negative for many SF-36 scales; most notably, those who rated their overall 
health as “worse” 6 months after surgery had a decline of -12.8 points (more than -0.9 
SD) on the SF-36 General Health (GH) scale. The one exception to this pattern was for 
the SF-36 Bodily Pain (BP) scale, where patients in the “worse” groups had a notable 
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improvement of 0.3-0.6 SD units across the four SET items.  
It was hypothesized that change scores for scales that were most closely 
conceptually related to a SET item would be most responsive in that SET test. All KOOS 
and WOMAC scales were responsive in all known groups tests of SET items. However, 
the KOOS QOL scale was the most responsive (RV=1.00) of all measures (both knee-
specific and generic) for three of the four SET items (physical activities, daily work role, 
emotional problems) and also had the highest RV statistic of all knee-specific measures 
for the fourth SET item (general health). For the physical activities SET item, the upper 
bound of the knee-specific IRT theta and CAT function scores approached 1.00, 
indicating that these measures were nearly as strong as the KOOS QOL scale in 
responding to the overall change in ability to do physical activities. However, RVs for the 
fixed-length knee-specific function scales were only moderate (RV=0.43-0.57), and 
these scales were significantly worse than the KOOS QOL scale in responding to the 
SET item about overall change in physical capabilities. Similarly, for the SET item about 
changes in daily work role, the upper bound of the 95% CI for all other KOOS scales and 
all WOMAC scales was below 1.00, indicating that the KOOS QOL scale was 
significantly more responsive than all other knee-specific scales in relation to the 
patient’s rating of change in their ability to do everyday work.  
The performance of the SF-36 Physical Component Summary (PCS) was not 
significantly different from that of the KOOS QOL scale for all four SET items; the upper 
bound of the 95% CI for PCS included 1.00 in three SET comparisons and PCS was the 
most valid measure in the fourth (general health). While the KOOS QOL scale was the 
most valid measure for the SET item about emotional problems, many SF-36 measures 
(Physical Functioning, Role Physical, Bodily Pain, Vitality, PCS) had RVs that were not 
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significantly different from 1.00. However, RVs for the SF-36 Mental Health scale and 
the overall Mental Component Summary (MCS) were low (RV=0.29-0.35), indicating that 
patient answers to the SET item about changes in emotional problems since joint 
surgery were more related to changes in their physical health than their general mental 
health. The SF-36 PCS had the highest RV for the SET general health item (RV=1.00), 
but RVs for the SF-36 Bodily Pain scale, KOOS QOL scale and IRT theta score also did 
not differ significantly from 1.00.  
Relative validity statistics did not differ notably for any of the fixed-length knee-
specific function measures (KOOS/WOMAC Function in ADL, KOOS Sport, KOOS-PS, 
short WOMAC scales) in almost all of the longitudinal validity tests, indicating that no 
knee-specific function measure was better than the others. However, IRT theta 
(RV=0.67-0.74) and CAT (RV=0.53-0.77) scores consistently had the highest RVs of all 
function measures across all four SET tests. Furthermore, the KOOS-PS consistently 
had the lowest RVs (RV=0.33-0.39). In addition, RVs for the KOOS Pain scale were 
consistently higher than RVs for the WOMAC Pain scale, and RVs for the KOOS 
Symptoms scale were consistently higher than RVs for WOMAC Stiffness scale.  
Effect sizes and standardized response means. Six months after TKR, the KOOS 
QOL scale had the highest effect size (ES=1.99), followed by the KOOS Pain scale 
(1.80) in tests of responsiveness (Table 4.12). The ES for the KOOS Pain scale was 
slightly higher than that for the WOMAC Pain scale (1.63). Effect sizes for IRT theta and 
CAT function scores (1.72-1.79) were somewhat higher than the ES for all KOOS and 
WOMAC function scales including the KOOS-PS and short WOMAC function scales 
(1.36-1.69). Effect sizes were lower for the SF-36, with the highest ES for the Bodily 
Pain (1.31) and Physical Functioning (1.04) scales and the PCS (1.08).  
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Standardized response means (SRM) were similar for the KOOS/WOMAC 
Function in ADL, short WOMAC function, IRT theta and CAT function scales 
(SRM=1.41-1.59), but lower for the KOOS-PS (1.25) and Sport (1.07) scales. SRM for 
the KOOS (1.51) and WOMAC (1.47) Pain and KOOS QOL scales (1.46) were similar to 
those for the function scales. Standardized response means were lower for the SF-36, 
with the highest SRM for the Bodily Pain (1.06) and Physical Functioning (0.96) scales 
and the PCS (1.00).  
 
Discussion 
This study demonstrated the validity and responsiveness of the KOOS and other 
knee-specific measures among total knee replacement patients using various methods 
and criteria. Most hypotheses in tests of concurrent validity and cross-sectional and 
longitudinal known groups validity were supported, with a few exceptions discussed 
below. However, knee-specific KOOS and WOMAC measures (with the exception of the 
KOOS QOL scale) were not more valid than generic SF-36 measures of pain, physical 
functioning and overall physical health (Physical Component Summary, PCS) in 
discriminating between groups who rated their outcomes as better, the same or worse at 
6 months. The implications of these findings and other results from this study for the 
measurement of patient-reported outcomes in TKR are discussed below. 
Measurement of knee-specific function. A major issue addressed in this paper 
concerned the relative validity of the different knee-specific function measures that have 
been proposed to measure function in ADL. How well can knee-specific function be 
estimated with fewer than the 17 ADL items in the KOOS/WOMAC Function in ADL 
scale? Almost all of the fixed-length function measures (excluding the KOOS 
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Sport/Recreation scale) had high correlations with each other, had similar performance 
in cross-sectional and longitudinal tests of relative validity (RV), and had similar 
responsiveness statistics. Thus, it could not be concluded that any of the fixed-length 
short function scales was less valid than the 17-item function scale used in the KOOS 
and WOMAC.  
CAT scores performed significantly better than the short WOMAC function scales 
(Liebs, Tubach, Whitehouse) and the KOOS-PS in most longitudinal tests of known 
groups validity.  CAT scores consistently had higher RVs than the short function scales 
(Liebs, Tubach, Whitehouse, KOOS-PS) in all longitudinal validity tests, even though all 
of these measures were of similar length; CAT scores were estimated in a mean of 3 to 
8 items and maximum of 10 items (see Chapter III) and the KOOS-PS and short 
WOMAC function scales each had 7 or 8 items. These trends suggest that a short knee-
specific function measure that targets items to each patient’s function level, as a CAT 
does, may be more useful than a similar length scale that administers the same items to 
all patients. 
In addition, the KOOS-PS was notably weaker than the other short function 
measures in tests of longitudinal known groups validity and responsiveness. These 
findings, in addition to the relatively high rate of missing KOOS-PS data because its 
scoring algorithm requires that all 7 KOOS-PS items be answered, suggest that the 
KOOS-PS is not a preferred measure for use in TKR.  
Performance of KOOS Function in Sport/Recreation scale in TKR. The KOOS 
Sport/Recreation scale did not discriminate well among known groups in cross-sectional 
tests of validity, which may have been due to the low functional level of patients prior to 
TKR and the resulting lack of variation in Sport scores. Six months after TKR, the Sport 
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scale performed as well as the other function measures in longitudinal known groups 
validity analyses, and the Sport scale had an equivalent effect size as the KOOS 
Function in ADL scale. However, the Sport scale had a much higher standard deviation 
after TKR than before TKR, and therefore its standardized response mean was low in 
comparison with its effect size. The higher post-TKR variation in Sport scores may 
reflect differences in trajectories of functional recovery. However, some variation also 
may reflect patient preferences for engaging in Sport activities. In an early KOOS study, 
Roos noted that the activities included in the Sport scale (squatting, running, jumping, 
twisting, kneeling) were very important to only about 50% of TKR patients27. Thus, as 
opposed to ADL activities such as walking that all patients would find relevant, some 
patients may not attempt many Sport activities after TKR, and their overall functional 
improvement may not be reflected in the Sport items. Additional items that ask about 
more difficult activities but which are more applicable to the broader TKR population may 
need to be developed and tested, to measure higher levels of function after TKR. 
Discriminant validity of KOOS Pain and Function in ADL scales. Previous studies 
have found that the WOMAC Pain and Function scales have high correlations and thus 
have questioned the extent to which these scales measure distinct constructs61, 96, 98. 
The high correlations have been attributed in part to content overlap, since items about 
the same activities (e.g., pain walking, difficulty walking) are included in both scales 97. 
Because the KOOS Function in ADL scale is the same as the WOMAC Function scale, 
and because the 9-item KOOS Pain scale includes all 5 WOMAC Pain items, it is not 
surprising that issues that were raised previously for the WOMAC surfaced again in this 
study for the KOOS. The KOOS Pain and KOOS Function in ADL scales had a high 
correlation, and the KOOS Function in ADL scale had a significantly higher correlation 
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with the SF-36 Bodily Pain scale than with the SF-36 Physical Functioning scale, 
indicating a lack of discriminant validity of the ADL scale. However, in tests of relative 
validity, the KOOS Pain scale had significantly higher relative validity than the ADL scale 
in the test involving the frequency of surgical knee pain, and the ADL scale had higher 
relative validity than the Pain scale in the test involving use of an assistive device. Thus, 
while the KOOS Pain and Function in ADL scales are highly related, the scales also 
performed differently in relation to other criteria, lending some support to their 
distinctiveness. These results also underscore the importance of looking at validity in 
relation to external criteria, not just in terms of scale correlations.  
Comparison of KOOS and WOMAC Pain scales. The 9-item KOOS Pain and 5-item 
WOMAC Pain scales had a high correlation (r=0.94) and their relative validity was not 
significantly different across cross-sectional tests. However, RV statistics were higher for 
the KOOS Pain scale (RV=0.51-0.62) than the WOMAC Pain scale (RV=0.36-0.49) in 
longitudinal validity tests, and the KOOS Pain scale had a higher effect size and 
standardized response mean than the WOMAC scale. Thus, it may be worthwhile to 
administer the KOOS Pain scale instead of the WOMAC Pain scale, in spite of the 
slightly higher respondent burden of the KOOS measure. 
Comparison of KOOS Symptoms and WOMAC Stiffness scales. The KOOS 
Symptoms scale adds 5 items about joint symptoms to the WOMAC Stiffness scale. The 
KOOS scale contains relatively heterogeneous item content, and the KOOS and 
WOMAC scales only had a moderately high correlation (r=0.72). In longitudinal validity 
comparisons of better, same and worse outcome groups, the KOOS scale had higher 
RVs (RV=0.38-0.46) than the WOMAC scale (RV=0.22-0.29), although many of the RVs 
were low. This finding suggests that it may be worthwhile to administer the KOOS 
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Symptoms scale instead of the WOMAC Stiffness scale, but this depends on the extent 
to which joint symptoms are of interest in a particular study. 
KOOS Quality of Life scale. The KOOS QOL scale was not hypothesized to perform 
better than the other KOOS scales in most tests of validity and responsiveness, with the 
exception of the longitudinal known groups validity test involving the daily work role SET 
item. However, KOOS QOL was the knee-specific scale with the highest relative validity 
in all four longitudinal validity tests of SET items, and was the scale with the highest RV 
of all knee-specific and generic measures in three of the four SET tests. This scale also 
had the highest effect size 6 months after TKR. Unlike other KOOS and WOMAC scales 
which focus on the physical impact of a knee problem, the 4-item KOOS QOL scale asks 
about its cognitive (awareness of knee problem), emotional (troubled by knee problem), 
functional (modification of life style due to knee problem) and overall (general difficulty 
with knee) impact. Healing from TKR takes place in the mind as well as the knee, as 
patients adapt both physically and psychologically to a new way of life post-surgery. The 
KOOS QOL scale does not provide clinicians with a direct measure of whether TKR 
surgery reduced knee pain and improved function; rather, it provides a more holistic 
evaluation of the broader life impact of knee problems.  
Comparison of knee-specific and SF-36 measures.  As in previous studies27, 155, this 
study found that knee-specific measures of function and pain had higher effect sizes and 
standardized response means than generic measures 6 months after TKR; in particular, 
the KOOS QOL scale had an effect size that was nearly twice that of the most 
responsive SF-36 measure. However, in tests of longitudinal validity with groups who 
rated themselves as better, the same or worse 6 months after TKR, generic (SF-36) and 
knee-specific (KOOS, WOMAC) function and pain scales were equally valid in 
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discriminating between groups. Furthermore, the best SF-36 measure (PCS) was as 
valid as the most valid knee-specific scale (KOOS QOL) in these longitudinal validity 
tests. While there may be conceptual or other reasons to include a knee-specific function 
scale in studies of knee OA and TKR, these results suggest that for measuring function 
at least, the SF-36 may be sufficient, or that a much shorter knee-specific function 
measure could be administered along with the SF-36. 
It is notable that even patients who rated their status as “worse” 6 months after 
TKR improved on average on all knee-specific scales. In contrast, mean scores for the 
“worse” groups generally declined or remained stable on the generic SF-36 measures. 
This difference between generic and knee-specific results for the “worse” group may 
reflect the impact of comorbid (non-knee) conditions on health (leading to lower generic 
change scores) even if there was an actual knee-specific improvement, or it may reflect 
other factors. From a measurement perspective, however, these results suggest that 
knee-specific measures are not sufficient by themselves to fully understand patient 
outcomes after TKR and should be supplemented with generic measures such as the 
SF-36. Administering fewer knee-specific function items appears to be a more effective 
way to reduce respondent burden than excluding generic measures. 
Study limitations. This study had a number of limitations. First, TKR patients were from 
high volume orthopedic centers in the US only. Analyses should be replicated with 
patients from other countries and from lower volume US orthopedic centers. Second, the 
criteria used to establish the known groups were based on patient self-report; additional 
analyses using clinician reports to define knee OA severity groups or to rate patient 
change after TKR should be conducted. Third, only 6-month post-TKR data was 
available, and results should be re-examined using data collected 1 or more years after 
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surgery to see if longitudinal validity and responsiveness findings are consistent. Fourth, 
some significant differences in relative validity statistics may not have been detected. 
The power to detect significant differences in relative validity between two measures is 
related to a number of factors, including sample size, the correlation between the 
measures, and the magnitude of the F-statistic for the more valid measure148. While the 
sample for this study was relatively large, the power for some validity tests was below 
0.80 and some significant differences between measures may not have been identified. 
Failure to do so, however, would not change the major conclusions of this paper. Finally, 
this study was limited to TKR patients. Tests of known groups validity that compare the 
KOOS and other questionnaires should be conducted for patients with milder knee OA 
and other knee disorders. Results of this study may not apply to these other patient 
populations. 
Conclusion.  In summary, this study demonstrated that the KOOS is valid and 
responsive in TKR patients in the US. Due to its high responsiveness and ability to 
discriminate among groups differing in self-evaluated ratings of change post-TKR, use of 
the KOOS QOL scale in all studies of TKR is encouraged, even if the entire KOOS is not 
used in the study. Furthermore, the KOOS Symptoms and Pain scales appear to have 
advantages over their WOMAC counterparts in terms of their validity. Knee-specific 
function in ADL can be measured with fewer than 17 items, either using computerized 
adaptive tests or fixed-length short forms, without a reduction in validity or 
responsiveness. KOOS Sport scores had wide variation after TKR, and other methods 
for measuring higher levels of function that are more applicable to the entire TKR patient 
population should be pursued. Finally, to comprehensively understand the health of 
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patients after TKR, generic measures such as the SF-36 are needed in addition to knee-
specific measures.  
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Table 4.1: Summary of measures compared and score interpretation 
Questionnaire/Scale k Mean* SD* Reliab.† Lowest Score Highest Score 
KOOS       
Symptoms 7 48.6 19.8 0.74 Extreme stiffness and 
other knee symptoms 
No stiffness or other  
knee symptoms 
Pain 9 46.4 18.0 0.88 Constant knee pain, 
extreme pain in activities 
No knee pain, no knee 
pain doing activities 
Function in Activities 
of Daily Living (ADL) 
17 52.8 18.3 0.95 Extreme difficulty doing 
ADL due to knee 
No difficulty doing ADL  
due to knee 
Function in Sport/ 
Recreation 
5 18.4 19.6 0.89 Extreme difficulty in sport 
activities due to knee 
No difficulty in sport 
activities due to knee 
Knee-Specific Quality 
of Life (QOL) 
4 25.4 18.0 0.81 Extreme problems with 
quality of life due to knee  
No problems or changes 
in lifestyle due to knee 
KOOS-PS (scored 
negatively) 
7 49.0 14.6 0.86 No difficulty with sport or 
ADL activities due to knee 
Extreme difficulty with 
sport/ADL due to knee 
WOMAC       
Stiffness 2 43.5 22.3 0.78 Extreme knee stiffness on 
wakening and during day 
No knee stiffness on 
wakening or during day 
Pain 5 51.7 18.9 0.84 Extreme knee pain while 
doing activities 
No knee pain while  
doing activities 
Function (same items 
as KOOS ADL scale) 
17 52.8 18.3 0.95 Extreme difficulty doing 
ADL due to knee 
No difficulty doing ADL  
due to knee 
Short WOMAC Function      
Liebs 7 48.0 18.7 0.89 See WOMAC Function See WOMAC Function 
Tubach 8 49.9 18.6 0.90 See WOMAC Function See WOMAC Function 
Whitehouse 7 54.2 18.5 0.89 See WOMAC Function See WOMAC Function 
IRT-based KOOS ADL/Sport      
IRT Theta score 22 -0.41 0.74 0.98 Extreme difficulty with 
ADL/sport due to knee 
No difficulty with ADL or 
sport due to knee 
CAT RTT≥0.95‡ 3-10 -0.41 0.72 0.95 See IRT Theta score See IRT Theta score 
CAT RTT≥0.90‡ 3-10 -0.40 0.71 0.92 See IRT Theta score See IRT Theta score 
SF-36 Health Survey       
Physical Functioning 
(PF) 
10 38.6 22.1 0.87 Limited in all activities 
including bathing/dressing 
Not limited in vigorous  
activities due to health 
Role Physical (RP) 4 43.5 27.3 0.93 Extreme problems with 
role due to physical health 
No problems with role due 
to physical health 
Bodily Pain (BP) 2 36.0 18.4 0.77 Very severe and 
extremely limiting pain 
No pain or limitations  
due to pain 
General Health (GH) 5 70.0 18.8 0.77 Evaluates health as poor Rates health as excellent 
Vitality (VT) 4 51.8 20.8 0.82 Tired and worn out 
all of the time 
Full of energy 
all of the time 
Social Functioning 
(SF) 
2 67.0 27.6 0.83 Health interferes with 
social activities extremely 
No interference of health 
with social activities 
Role Emotional (RE) 3 73.8 28.6 0.92 Extreme problems with 
role due to emotions 
No problems with role due 
to emotional problems 
Mental Health (MH) 5 73.4 18.9 0.85 Feels nervous and 
depressed all of the time 
Feels calm, peaceful and 
happy all of the time 
Physical Component 
Summary (PCS) 
35 33.2 8.4 0.92 Limited in self-care, work, 
daily activities; severe 
pain/fatigue; health poor 
No limits in physical, work, 
daily activities; no pain; high 
energy; health excellent 
Mental Component 
Summary (MCS) 
35 51.7 11.9 0.92 Frequent mental distress, 
limited in activities due to 
emotional problems 
Frequent positive affect, 
not limited in activities due 
to emotional problems 
k=number of items.  
Mean/SD/reliability data are for pre-TKR patients with scores for all scales (n=1,143), except for KOOS-PS (n=1,102).  
* All measures scored so 0=worst possible/100=best possible score, except KOOS-PS (0=best/100=worst poss ble), IRT 
and CAT ADL/Sport (FORCE-TJR pre/post mean=0, SD=1), SF-36 PCS/MCS (US general population mean=50, SD=10). 
† Cronbach’s alpha for all scales, except IRT theta/CAT scores where reliability=mean reliability across all patient scores.  
‡ CAT RTT≥0.95=CAT stopped when SE≤0.23 or at 10 items; CAT RTT≥0.90=CAT stopped at SE≤0.32 or at 10 items.   
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Table 4.2: Correlations of knee-specific and SF-36 measures, pre-TKR (n=1,143) 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
KOOS                
1) Symptoms (.74)               
2) Pain 0.67 (.88)              
3) ADL 0.55 0.78 ( 95)             
4) Sport 0.43 0.51 0.55 (.89)            
5) QOL 0.47 0.57 0.59 0.54 (.81)           
6) KOOS-PS -0 54 -0.71 -0 89 -0.71 -0.57 (.86)          
WOMAC                
7) Stiffness 0.72 0.65 0.61 0.42 0.45 -0.58 (.78)         
8) Pain 0.57 0.94 0.77 0.45 0 54 -0.67 0 58 (.84)        
9) ADL 0.55 0.78 1.00 0.55 0 59 -0.89 0 61 0.77 (.95)       
Short WOMAC Function          
10) Liebs 0.53 0.76 0.94 0.55 0 60 -0.85 0 58 0.76 0 94 (.89)      
11) Tubach 0.53 0.76 0.97 0.56 0 60 -0.86 0 58 0.76 0 97 0.96 (.90)     
12) Whitehouse 0.54 0.76 0.97 0.51 0 56 -0.87 0 61 0.76 0 97 0.93 0 97 (.89)    
IRT-based KOOS ADL/Sport         
13) IRT Theta  0.56 0.78 0.98 0.63 0 61 -0.91 0 61 0.77 0 98 0.94 0 96 0.95 (.98)   
14) CAT≥0.95* 0.52 0.76 0.95 0.51 0 58 -0.83 0 59 0.76 0 95 0.91 0 93 0.93 0 96 (.95)  
15) CAT≥0.90* 0.48 0.71 0.88 0.48 0 57 -0.76 0 52 0.72 0 88 0.83 0 86 0.83 0 90 0.95 (.92) 
SF-36                
PF 0.38 0.49 0.57 0.44 0 50 -0.51 0 37 0.50 0 57 0.55 0 56 0.53 0 58 0.56 0.56 
RP 0.36 0.49 0.53 0.42 0.48 -0.48 0 36 0.47 0 53 0.51 0 53 0.50 0 54 0.51 0.50 
BP 0.46 0.66 0.64 0.42 0 53 -0.57 0 50 0.63 0 64 0.62 0 64 0.62 0 64 0.63 0.61 
GH 0.19 0.29 0.31 0.18 0 26 -0.27 0.17 0.31 0 31 0.27 0 29 0.30 0 31 0.30 0.30 
VT 0.30 0.41 0.46 0.31 0.40 -0.40 0 30 0.40 0.46 0.40 0.43 0.43 0.46 0.45 0.45 
SF 0.37 0.49 0.53 0.32 0.45 -0.47 0 34 0.48 0 53 0.48 0 51 0.50 0 53 0.52 0.53 
RE 0.28 0.38 0.43 0.20 0 31 -0.36 0 24 0.38 0.43 0.38 0.40 0.41 0.42 0.42 0.40 
MH 0.24 0.33 0.34 0.18 0 30 -0.29 0 21 0.34 0 34 0.29 0 31 0.32 0 33 0.32 0.32 
PCS 0.37 0.52 0.56 0.46 0 50 -0.51 0.40 0.51 0 56 0.55 0 56 0.52 0 58 0.55 0.54 
MCS 0.26 0.36 0.38 0.18 0 31 -0.33 0 22 0.36 0 38 0.33 0 35 0.37 0 37 0.38 0.37 
All measures scored so lower score=poorer health, except for KOOS-PS where lower score=better health.  
KOOS-PS N=1,102. SE for all correlations=0.029 except for KOOS-PS correlations where SE=0.030. 
Internal consistency reliability for knee-specific measures on diagonal. 
* CAT≥0.95=CAT stopped when SE≤0.23 or at 10 items; CAT≥0.90=CAT stopped at SE≤0.32 or at 10 items. 
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Table 4.3: Relative validity tests for surgical knee pain groups, pre-TKR (n=1,137) 
 Mean (Standard Deviation) 
F statistic RV (95% CI)  Pain Less Than Daily (n=76) 
Pain Daily 
(n=649) 
Pain Always 
(n=412) 
KOOS      
Symptoms 66.9  
(20.0) 
52.1  
(17.9) 
39.6  
(18.4) 
100.62 0.43 
(0.34-0.56) 
Pain* 75.6  
(17.6) 
54.0  
(15.6) 
38.2  
(15.9) 
232.33 1.00 
- 
ADL 71.0 
(18.2) 
56.8  
(15.9) 
43.1  
(16.8) 
137.98 0.59 
(0.48-0.70) 
Sport 32.3 
(26.7) 
21.3  
(19.6) 
11.0  
(14.9) 
61.72 0.27 
(0.18-0.37) 
QOL 42.2 
(22.9) 
28.9  
(16.9) 
16.6  
(13.9) 
115.34 0.50 
(0.38-0.65) 
KOOS-PS (-)  37.3 
(12.0) 
45.6  
(12.1) 
56.5  
(15.1) 
114.78 0.49 
(0.40-0.64) 
WOMAC      
Stiffness 66.1  
(21.5) 
47.7  
(20.1) 
32.6  
(20.3) 
121.47 0.52 
(0.40-0.67) 
Pain 76.3  
(18.4) 
55.9  
(15.7) 
40.3  
(16.5) 
211.57 0.91 
(0.84-1.00) 
ADL 71.0  
(18.2) 
56.8  
(15.9) 
43.1  
(16.8) 
137.98 0.59 
(0.48-0.70) 
Short WOMAC Function     
Liebs 67.9  
(19.7) 
51.7  
(16.4) 
38.5  
(16.8) 134.01 
0.58 
(0.46-0.68) 
Tubach 69.2  
(19.0) 
53.9  
(16.1) 
40.0  
(17.0) 142.01 
0.61 
(0.49-0.73) 
Whitehouse 72.6  
(17.9) 
58.2  
(16.1) 
44.4  
(17.1) 137.02 
0.59 
(0.48-0.70) 
IRT-based KOOS ADL/Sport     
Theta score 0.34  
(0.76) 
-0.24  
(0.62) 
-0.80  
(0.70) 
142.12 0.61 
(0.50-0.72) 
CAT RTT≥0.95 0.33  
(0.75) 
-0.26  
(0.61) 
-0.80  
(0.68) 
139.11 0.60 
(0.48-0.71) 
CAT RTT≥0.90 0.29  
(0.75) 
-0.26  
(0.61) 
-0.75  
(0.68) 
120.47 0.52 
(0.41-0.64) 
SF-36      
PF 52.4  
(21.4) 
40.7  
(21.6) 
32.4  
(21.1) 
36.13 0.16 
(0.09-0.23) 
RP 62.4  
(25.4) 
46.9  
(26.1) 
34.3  
(26.4) 
50.71 0.22 
(0.14-0.30) 
BP 58.8  
(20.1) 
39.7  
(16.6) 
25.8  
(14.3) 
176.81 0.76 
(0.59-0.93) 
GH 77.0  
(17.6) 
71.1  
(18.1) 
67.0  
(19.6) 
11.76 0.05 
(0.02-0.09) 
VT 67.5  
(18.9) 
53.8  
(19.3) 
45.5  
(21.3) 
46.63 0.20 
(0.13-0.29) 
SF 80.1  
(23.4) 
70.5  
(26.0) 
58.7  
(28.7) 
34.49 0.15 
(0.09-0.22) 
RE 81.2  
(23.9) 
77.1  
(26.5) 
67.4  
(31.3) 
17.81 0.08 
(0.04-0.13) 
MH 81.1  
(16.0) 
75.0  
(17.9) 
69.4  
(20.1) 
18.05 0.08 
(0.03-0.13) 
PCS 40.7  
(7.2) 
34.2  
(8.0) 
30.1  
(8.0) 
70.12 0.30 
(0.21-0.40) 
MCS 55.4  
(9.8) 
52.9  
(11.3) 
49.1  
(12.8) 
17.44 0.08 
(0.04-0.13) 
All measures scored so a lower score=poorer health, except for KOOS-PS where lower score=better health. 
KOOS-PS N=1,097. Bold=most valid scale or scale RV not significantly different from 1.00. All F-statistics p<0.0001. 
* Frequency of knee pain item not included in KOOS Pain scale.  
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Table 4.4: Relative validity tests by assistive walking device use, pre-TKR (n=1,142) 
 Mean (Standard Deviation)  
F statistic RV (95% CI)  No Device (n=790) 
Use Device 
(n=352) 
 
KOOS      
Symptoms 50.4  
(18.8) 
44.7  
(21.3) 
 20.59 0.11 
(0.04-0.22) 
Pain 49.3  
(17.1) 
39.8  
(18.1) 
 73.04 0.38 
(0.24-0.59) 
ADL 56.5  
(16.9) 
44.4  
(18.5) 
 118.17 0.62 
(0.44-0.90) 
Sport 21.1  
(19.6) 
12.2  
(18.1) 
 52.93 0.28 
(0.15-0.46) 
QOL 27.6  
(17.8) 
20.5  
(17.5) 
 39.79 0.21 
(0.11-0.34) 
KOOS-PS (-) 46.2  
(12.8) 
55.3  
(16.2) 
 100.14 0.53 
(0.35-0.80) 
WOMAC      
Stiffness 45.6  
(21.8) 
38.7  
(22.8) 
 23.70 0.12 
(0.05-0.24) 
Pain 54.9  
(17.9) 
44.5  
(19.3) 
 77.68 0.41 
(0.25-0.61) 
ADL 56.5  
(16.9) 
44.4  
(18.5) 
 118.17 0.62 
(0.44-0.90) 
Short WOMAC Function     
Liebs 51.6  
(17.5) 
40.1  
(18.8) 
 100.89 0.53 
(0.35-0.76) 
Tubach 53.7  
(17.3) 
41.4  
(18.7) 
 117.05 0.62 
(0.43-0.88) 
Whitehouse 57.8  
(17.1) 
46.0  
(18.9) 
 109.39 0.57 
(0.40-0.86) 
IRT-based KOOS ADL/Sport     
Theta score -0.25  
(0.67) 
-0.76  
(0.76) 
 127.45 0.67 
(0.49-0.97) 
CAT RTT≥0.95 -0.27  
(0.66) 
-0.75  
(0.74) 
 120.46 0.63 
(0.45-0.90) 
CAT RTT≥0.90 -0.25  
(0.65) 
-0.72  
(0.73) 
 116.35 0.61 
(0.42-0.86) 
SF-36      
PF 44.1  
(20.9) 
26.0  
(19.3) 
 190.27 1.00 
- 
RP 49.7  
(26.0) 
29.4  
(24.8) 
 153.08 0.80 
(0.58-1.09) 
BP 39.3  
(17.7) 
28.4  
(17.4) 
 92.05 0.48 
(0.32-0.72) 
GH 73.8  
(16.7) 
61.4  
(20.5) 
 116.63 0.61 
(0.41-0.94) 
VT 54.9  
(19.8) 
44.7  
(21.2) 
 62.00 0.33 
(0.18-0.52) 
SF 72.8  
(25.3) 
53.7  
(28.0) 
 130.74 0.69 
(0.46-1.02) 
RE 78.4  
(26.1) 
63.6  
(31.1) 
 69.57 0.37 
(0.21-0.59) 
MH 75.7  
(18.2) 
68.4  
(19.5) 
 36.94 0.19 
(0.09-0.37) 
PCS 35.3  
(7.8) 
28.5  
(7.9) 
 184.63 0.97 
(0.78-1.20) 
MCS 53.3  
(11.4) 
48.1  
(12.4) 
 47.38 0.25 
(0.12-0.44) 
All measures scored so a lower score=poorer health, except for KOOS-PS where lower score=better health. 
KOOS-PS N=1,101. Bold=most valid scale or scale RV not significantly different from 1.00. All F-statistics p<0.0001.   
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Table 4.5: Relative validity tests by number of chronic conditions, pre-TKR (n=1,143) 
 Number of Comorbid Conditions 
F statistic RV (95% CI)  0 (n=488) 
1 
(n=405) 
2+ 
(n=250) 
KOOS      
Symptoms 48.9  
(20.1) 
48.8  
(19.7) 
47.8  
(19.4) 
  0.29§ 0.01 
(0.00-0.02) 
Pain 47.8  
(17.7) 
46.6  
(17.7) 
43.4  
(18.5) 
  5.04† 0.11 
(0.02-0.26) 
ADL 54.7  
(17.9) 
53.3  
(18.5) 
48.3  
(17.9) 
10.57 0.22 
(0.08-0.45) 
Sport 19.5  
(19.3) 
18.8  
(19.6) 
15.5  
(20.0) 
  3.64‡ 0.08 
(0.00-0.22) 
QOL 26.1  
(18.3) 
25.9  
(18.1) 
23.5  
(17.0) 
  1.90§ 0.04 
(0.00-0.12) 
KOOS-PS (-) 47.5  
(13.5) 
48.6  
(14.7) 
52.6  
(15.8) 
10.22 0.21 
(0.08-0.48) 
WOMAC      
Stiffness 44.8  
(22.9) 
44.2  
(22.0) 
39.9  
(21.2) 
  4.33‡ 0.09 
(0.01-0.24) 
Pain 53.2  
(18.7) 
51.9  
(18.8) 
48.5  
(19.2) 
  5.16† 0.11 
(0.02-0.25) 
ADL 54.7  
(17.9) 
53.3  
(18.5) 
48.3  
(17.9) 
10.57 0.22 
(0.08-0.45) 
Short WOMAC Function     
Liebs 49.7  
(18.6) 
48.3  
(18.7) 
44.2  
(18.4) 
  7.46* 0.16 
(0.04-0.35) 
Tubach 51.7  
(18.4) 
50.3  
(18.8) 
45.6  
(17.9) 
  9.28* 0.19 
(0.07-0.41) 
Whitehouse 56.1  
(18.3) 
54.6  
(18.6) 
49.7  
(18.0) 
10.29 0.21 
(0.07-0.42) 
IRT-based KOOS ADL/Sport     
Theta score -0.32  
(0.72) 
-0.39  
(0.75) 
-0.60  
(0.72) 
11.54 0.24 
(0.10-0.48) 
CAT RTT≥0.95 -0.34  
(0.71) 
-0.41  
(0.74) 
-0.57  
(0.71) 
  8.99* 0.19 
(0.06-0.38) 
CAT RTT≥0.90 -0.32  
(0.69) 
-0.40  
(0.74) 
-0.54  
(0.70) 
  7.89* 0.16 
(0.05-0.36) 
SF-36      
PF 40.4  
(21.2) 
39.9  
(23.2) 
32.8  
(21.1) 
11.16 0.23 
(0.08-0.42) 
RP 46.5  
(26.7) 
43.6  
(27.9) 
37.4  
(26.6) 
  9.38* 0.20 
(0.06-0.37) 
BP 37.9  
(18.5) 
36.5  
(18.7) 
31.2  
(16.9) 
11.56 0.24 
(0.09-0.45) 
GH 75.5  
(16.4) 
68.4  
(18.9) 
62.1  
(19.8) 
47.91 1.00 
- 
VT 54.3  
(20.1) 
52.2  
(20.9) 
46.2  
(20.9) 
12.98 0.27 
(0.12-0.48) 
SF 69.6  
(26.7) 
68.2  
(27.4) 
60.0  
(28.7) 
10.83 0.23 
(0.07-0.43) 
RE 75.8  
(27.9) 
75.1  
(27.8) 
68.0  
(30.3) 
  6.91† 0.14 
(0.03-0.33) 
MH 74.8  
(18.0) 
74.0  
(18.8) 
70.0  
(20.4) 
  5.72† 0.12 
(0.02-0.27) 
PCS 34.5  
(8.1) 
33.1  
(8.6) 
30.6  
(8.2) 
18.11 0.38 
(0.19-0.62) 
MCS 52.6  
(11.4) 
52.2  
(12.0) 
49.2  
(12.6) 
  7.38* 0.15 
(0.03-0.32) 
All measures scored so a lower score=poorer health, except for KOOS-PS where lower score=better health.  
KOOS-PS N=1,102. Bold=most valid scale or scale RV not significantly different from 1.00. 
All F-statistics p<0.0001 except for *p<0.001, † p<0.01, ‡ p<0.05, § p>0.05.  
107 
 
Table 4.6: Summary of cross-sectional known-groups validity tests, pre-TKR 
 F-statistic  Relative Validity (95% CI) 
 Knee Pain Device Comorbid  Knee Pain Device Comorbid 
KOOS        
Symptoms 100.62 20.59   0.29§  0.43 
(0.34-0.56) 
0.11 
(0.04-0.22) 
0.01 
(0.00-0.02) 
Pain 232.33 73.04   5.04†  1.00 
- 
0.38 
(0.24-0.59) 
0.11 
(0.02-0.26) 
ADL 137.98 118.17 10.57  0.59 
(0.48-0.70) 
0.62 
(0.44-0.90) 
0.22 
(0.08-0.45) 
Sport 61.72 52.93   3.64‡  0.27 
(0.18-0.37) 
0.28 
(0.15-0.46) 
0.08 
(0.00-0.22) 
QOL 115.34 39.79   1.90§  0.50 
(0.38-0.65) 
0.21 
(0.11-0.34) 
0.04 
(0.00-0.12) 
KOOS-PS (-) 114.78 100.14 10.22  0.49 
(0.40-0.64) 
0.53 
(0.35-0.80) 
0.21 
(0.08-0.48) 
WOMAC        
Stiffness 121.47 23.70   4.33‡  0.52 
(0.40-0.67) 
0.12 
(0.05-0.24) 
0.09 
(0.01-0.24) 
Pain 211.57 77.68   5.16†  0.91 
(0.84-1.00) 
0.41 
(0.25-0.61) 
0.11 
(0.02-0.25) 
ADL 137.98 118.17 10.57  0.59 
(0.48-0.70) 
0.62 
(0.44-0.90) 
0.22 
(0.08-0.45) 
Short WOMAC Function       
Liebs 134.01 100.89   7.46*  0.58 
(0.46-0.68) 
0.53 
(0.35-0.76) 
0.16 
(0.04-0.35) 
Tubach 142.01 117.05   9.28*  0.61 
(0.49-0.73) 
0.62 
(0.43-0.88) 
0.19 
(0.07-0.41) 
Whitehouse 137.02 109.39 10.29  0.59 
(0.48-0.70) 
0.57 
(0.40-0.86) 
0.21 
(0.07-0.42) 
IRT-based KOOS ADL/Sport      
Theta score 142.12 127.45 11.54  0.61 
(0.50-0.72) 
0.67 
(0.49-0.97) 
0.24 
(0.10-0.48) 
CAT RTT≥0.95 139.11 120.46   8.99*  0.60 
(0.48-0.71) 
0.63 
(0.45-0.90) 
0.19 
(0.06-0.38) 
CAT RTT≥0.90 120.47 116.35   7.89*  0.52 
(0.41-0.64) 
0.61 
(0.42-0.86) 
0.16 
(0.05-0.36) 
SF-36        
PF 36.13 190.27 11.16  0.16 
(0.09-0.23) 
1.00 
- 
0.23 
(0.08-0.42) 
RP 50.71 153.08   9.38*  0.22 
(0.14-0.30) 
0.80 
(0.58-1.09) 
0.20 
(0.06-0.37) 
BP 176.81 92.05 11.56  0.76 
(0.59-0.93) 
0.48 
(0.32-0.72) 
0.24 
(0.09-0.45) 
GH 11.76 116.63 47.91  0.05 
(0.02-0.09) 
0.61 
(0.41-0.94) 
1.00 
- 
VT 46.63 62.00 12.98  0.20 
(0.13-0.29) 
0.33 
(0.18-0.52) 
0.27 
(0.12-0.48) 
SF 34.49 130.74 10.83  0.15 
(0.09-0.22) 
0.69 
(0.46-1.02) 
0.23 
(0.07-0.43) 
RE 17.81 69.57   6.91†  0.08 
(0.04-0.13) 
0.37 
(0.21-0.59) 
0.14 
(0.03-0.33) 
MH 18.05 36.94   5.72†  0.08 
(0.03-0.13) 
0.19 
(0.09-0.37) 
0.12 
(0.02-0.27) 
PCS 70.12 184.63 18.11  0.30 
(0.21-0.40) 
0.97 
(0.78-1.20) 
0.38 
(0.19-0.62) 
MCS 17.44 47.38   7.38*  0.08 
(0.04-0.13) 
0.25 
(0.12-0.44) 
0.15 
(0.03-0.32) 
All measures scored so a lower score=poorer health, except for KOOS-PS where lower score=better health. 
Bold=most valid scale or scale RV not significantly different from 1.00. 
All F-statistics p<0.0001 except for *p<0.001, † p<0.01, ‡ p<0.05, § p>0.05.  
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Table 4.7: Relative validity tests for change in physical activities SET item (n=818) 
 Mean Change Score (Standard Deviation) 
F statistic RV (95% CI)  
Lot more 
capable 
(n=451) 
More 
capable 
(n=207) 
Same 
(n=77) 
 
Less 
capable 
(n=83) 
KOOS       
Symptoms 30.6 
(21.9) 
22.4 
(19.4) 
14.5 
(22.3) 
8.9 
(22.7) 
33.28 0.45 
(0.28-.63) 
Pain 38.4 
(19.9) 
30.0 
(19.0) 
23.6 
(23.5) 
14.0 
(19.9) 
42.97 0.58 
(0.40-.79) 
ADL 32.6 
(17.0) 
26.3 
(17.8) 
20.5 
(18.3) 
12.4 
(19.3) 
37.40 0.51 
(0.35-.68) 
Sport 37.4 
(25.4) 
22.8 
(24.5) 
15.5 
(26.3) 
11.1 
(24.6) 
41.96 0.57 
(0.38-.78) 
QOL 46.1 
(22.6) 
31.1 
(21.6) 
23.3 
(22.9) 
12.0 
(22.2) 
73.90 1.00 
- 
KOOS-PS (-) -22.9 
(14.2) 
-16.2 
(14.1) 
-14.2 
(15.0) 
-9.2 
(15.6) 
27.51 0.37 
(0.24-.57) 
WOMAC       
Stiffness 32.5 
(26.0) 
24.3 
(25.5) 
18.7 
(27.4) 
9.9  
(29.3) 
21.42 0.29 
(0.16-.44) 
Pain 35.8 
(19.7) 
29.1 
(18.8) 
23.7 
(23.2) 
14.5 
(19.4) 
32.01 0.43 
(0.28-.61) 
ADL 32.6 
(17.0) 
26.3 
(17.8) 
20.5 
(18.3) 
12.4 
(19.3) 
37.40 0.51 
(0.35-.68) 
Short WOMAC Function      
Liebs 37.3 
(18.3) 
29.6 
(18.5) 
22.4 
(19.8) 
15.8 
(19.7) 
41.06 0.56 
(0.39-.76) 
Tubach 34.8 
(18.1) 
27.3 
(17.9) 
20.9 
(20.1) 
13.4 
(21.1) 
39.42 0.53 
(0.37-.74) 
Whitehouse 31.8 
(17.3) 
25.4 
(18.2) 
19.6 
(20.2) 
12.8 
(21.2) 
31.55 0.43 
(0.29-.62) 
IRT-based KOOS ADL/Sport     
Theta score 1.53 
(0.78) 
1.11 
(0.77) 
0.84 
(0.71) 
0.52 
(0.78) 
54.27 0.73 
(0.57-.98) 
CAT RTT≥0.95 1.55 
(0.79) 
1.17 
(0.78) 
0.86 
(0.75) 
0.53 
(0.77) 
51.24 0.69 
(0.51-.92) 
CAT RTT≥0.90 1.51 
(0.80) 
1.10 
(0.76) 
0.88 
(0.72) 
0.47 
(0.79) 
51.71 0.70 
(0.50-.93) 
SF-36       
PF 30.7 
(22.2) 
18.6 
(19.5) 
10.2 
(25.1) 
3.4  
(22.1) 
52.64 0.71 
(0.50-.99) 
RP 32.7 
(28.1) 
18.7 
(24.6) 
9.5  
(28.4) 
1.9  
(23.2) 
44.96 0.61 
(0.42-.88) 
BP 30.5 
(22.2) 
18.9 
(19.2) 
13.4 
(16.7) 
7.9  
(19.7) 
42.18 0.57 
(0.40-.85) 
GH 3.6  
(12.7) 
-0.5 
(15.3) 
-0.3 
(12.8) 
-4.3 
(16.4) 
10.17 0.14 
(0.05-.25) 
VT 12.6 
(17.7) 
6.3 
(15.2) 
5.1  
(17.8) 
-3.2 
(20.9) 
22.56 0.31 
(0.17-.46) 
SF 17.6 
(24.7) 
9.3 
(23.7) 
5.8  
(22.1) 
0.8  
(28.3) 
15.72 0.21 
(0.11-.35) 
RE 11.1 
(26.5) 
9.8 
(26.2) 
3.8  
(24.7) 
0.2 
(25.5) 
   5.22* 0.07 
(0.02-.15) 
MH 8.2  
(16.0) 
5.8 
(14.0) 
4.3 
(13.7) 
-0.3 
(17.3) 
  7.70 0.10 
(0.03-.22) 
PCS 12.6 
(8.7) 
6.8 
(7.4) 
4.1 
(8.2) 
1.4 
(7.9) 
65.79 0.89 
(.66-1.22) 
MCS 2.2 
(10.2) 
1.9 
(9.5) 
1.2 
(7.5) 
-1.0 
(10.7) 
   2.61† 0.04 
(0.00-.09) 
All measures scored so lower score=poorer health except KOOS-PS where lower score=better health. KOOS-PS N=787. 
Bold=most valid scale or scale RV not significantly different from 1.00. All F-statistics p<0.0001 except *p<0.01, †p>0.05.  
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Table 4.8: Relative validity tests for change in daily work role SET item (n=815) 
 Mean Change Score (Standard Deviation) 
F statistic RV (95% CI)  Lot more able (n=415) 
More able 
(n=216) 
Same 
(n=108) 
Less able 
(n=76) 
KOOS       
Symptoms 31.3  
(22.3) 
23.4 
(18.0) 
15.1 
(22.0) 
7.3 
(22.6) 
38.21 0.43 
(0.28-.62) 
Pain 39.5 
(20.3) 
30.7 
(18.2) 
21.4 
(20.0) 
14.9 
(20.4) 
49.83 0.56 
(0.39-.75) 
ADL 33.4 
(17.6) 
26.8 
(16.7) 
19.3 
(16.8) 
12.5 
(19.4) 
42.43 0.47 
(0.33-.64) 
Sport 38.0 
(25.9) 
24.7 
(22.5) 
16.0 
(27.4) 
10.3 
(23.8) 
43.69 0.49 
(0.33-.68) 
QOL 47.6 
(22.4) 
32.7 
(21.3) 
22.2 
(20.6) 
10.5 
(21.5) 
89.39 1.00 
- 
KOOS-PS (-) -23.4 
(14.7) 
-17.0 
(13.1) 
-13.0 
(14.0) 
-9.2 
(16.1) 
30.89 0.35 
(0.24-.53) 
WOMAC       
Stiffness 33.9  
(26.3) 
23.7 
(25.1) 
18.4 
(26.1) 
9.5 
(28.7) 
26.09 0.29 
(0.18-.44) 
Pain 36.6  
(20.2) 
29.9 
(18.0) 
21.3 
(20.4) 
16.5 
(20.2) 
34.28 0.38 
(0.25-.53) 
ADL 33.4  
(17.6) 
26.8 
(16.7) 
19.3 
(16.8) 
12.5 
(19.4) 
42.43 0.47 
(0.33-.64) 
Short WOMAC Function      
Liebs 38.0  
(18.9) 
30.9 
(17.0) 
21.2 
(18.7) 
15.9 
(19.6) 
46.25 0.52 
(0.35-.70) 
Tubach 35.6  
(18.7) 
28.1 
(16.6) 
19.9 
(19.1) 
13.0 
(20.5) 
45.76 0.51 
(0.35-.69) 
Whitehouse 32.6  
(17.9) 
26.1 
(17.0) 
18.3 
(18.4) 
12.4 
(21.2) 
38.30 0.43 
(0.28-.59) 
IRT-based KOOS ADL/Sport     
Theta score 1.57  
(0.80) 
1.13 
(0.71) 
0.81 
(0.71) 
0.53 
(0.77) 
60.75 0.68 
(0.50-.87) 
CAT RTT≥0.95 1.58  
(0.82) 
1.19 
(0.73) 
0.85 
(0.72) 
0.53 
(0.77) 
56.51 0.63 
(0.46-.82) 
CAT RTT≥0.90 1.54  
(0.82) 
1.14 
(0.71) 
0.81 
(0.71) 
0.48 
(0.76) 
57.69 0.65 
(0.47-.84) 
SF-36       
PF 31.2  
(21.8) 
19.5 
(20.5) 
13.8 
(23.8) 
0.3  
(22.4) 
55.27 0.62 
(0.44-.89) 
RP 33.2  
(28.9) 
20.3 
(25.1) 
12.5 
(24.1) 
-0.9 
(22.8) 
46.35 0.52 
(0.35-.74) 
BP 31.8  
(22.1) 
18.1 
(19.4) 
15.0 
(17.6) 
6.8  
(17.5) 
51.31 0.57 
(0.39-.87) 
GH 3.8  
(12.6) 
-0.1 
(15.2) 
0.6 
(13.7) 
-6.2 
(15.8) 
12.65 0.14 
(0.06-.26) 
VT 13.0  
(17.7) 
6.5  
(16.4) 
5.8  
(16.8) 
-5.4 
(18.0) 
27.72 0.31 
(0.20-.45) 
SF 18.5  
(25.5) 
8.9  
(23.3) 
6.3  
(21.0) 
-0.7 
(25.9) 
19.67 0.22 
(0.12-.36) 
RE 11.7  
(26.8) 
9.0  
(24.8) 
4.0 
(25.9) 
0.3 
(27.2) 
   5.66* 0.06 
(0.02-.14) 
MH 8.5  
(16.1) 
5.4 
(15.1) 
5.1 
(12.5) 
-1.8 
(15.3) 
10.40 0.12 
(0.05-.20) 
PCS 12.9  
(8.7) 
7.3 
(7.8) 
5.4 
(7.5) 
0.2 
(7.4) 
69.59 0.78 
(.56-1.10) 
MCS 2.4 
(10.4) 
1.5 
(9.3) 
1.0 
(8.3) 
-1.4 
(9.8) 
   3.45† 0.04 
(0.01-.08) 
All measures scored so lower score=poorer health except KOOS-PS where lower score=better health. KOOS-PS N=785. 
Bold=most valid scale or scale RV not significantly different from 1.00. All F-statistics p<0.0001 except *p<0.001, †p<0.05.  
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Table 4.9: Relative validity tests for change in emotional problems SET item (n=792) 
 Mean Change Score (Standard Deviation) 
F statistic RV (95% CI)  
Much less 
bothered 
(n=305) 
Less 
bothered 
(n=103) 
Same 
(n=327) 
 
More 
bothered 
(n=57) 
KOOS       
Symptoms 30.2 
(22.0) 
28.6 
(23.9) 
20.8 
(20.7) 
15.3 
(26.1) 
14.03 0.38 
(0.20-.65) 
Pain 39.2 
(20.1) 
34.5 
(21.4) 
27.9 
(19.9) 
20.8 
(23.1) 
23.11 0.62 
(0.38-.94) 
ADL 33.3 
(16.8) 
28.3 
(19.9) 
24.6 
(17.9) 
16.8 
(21.0) 
19.96 0.54 
(0.31-.80) 
Sport 35.4 
(26.2) 
31.0 
(26.8) 
24.4 
(26.0) 
14.7 
(26.1) 
15.33 0.41 
(0.23-.68) 
QOL 46.2 
(23.9) 
35.3 
(23.5) 
32.6 
(22.7) 
14.3 
(25.8) 
37.28 1.00 
- 
KOOS-PS (-) -22.6 
(14.2) 
-20.3 
(15.6) 
-16.4 
(14.6) 
-12.8 
(17.0) 
12.13 0.33 
(0.18-.54) 
WOMAC       
Stiffness 32.5 
(26.4) 
28.5 
(28.4) 
23.3 
(26.2) 
19.1 
(28.5) 
  8.17 0.22 
(0.09-.40) 
Pain 36.6 
(19.7) 
33.6 
(20.9) 
26.8 
(19.4) 
20.7 
(23.0) 
18.41 0.49 
(0.28-.78) 
ADL 33.3 
(16.8) 
28.3 
(19.9) 
24.6 
(17.9) 
16.8 
(21.0) 
19.96 0.54 
(0.31-.80) 
Short WOMAC Function      
Liebs 37.9 
(18.3) 
32.0 
(20.5) 
28.2 
(19.0) 
18.7 
(22.5) 
23.00 0.62 
(0.36-.91) 
Tubach 35.4 
(18.1) 
29.8 
(20.3) 
25.8 
(19.3) 
17.8 
(21.6) 
20.93 0.56 
(0.33-.85) 
Whitehouse 32.6 
(17.3) 
27.3 
(20.1) 
23.8 
(18.8) 
17.2 
(22.0) 
17.51 0.47 
(0.25-.71) 
IRT-based KOOS ADL/Sport     
Theta score 1.54 
(0.76) 
1.26 
(0.87) 
1.08 
(0.80) 
0.70 
(0.87) 
27.65 0.74 
(.48-1.09) 
CAT RTT≥0.95 1.58 
(0.77) 
1.28 
(0.88) 
1.10 
(0.80) 
0.71 
(0.91) 
28.70 0.77 
(.49-1.12) 
CAT RTT≥0.90 1.51 
(0.79) 
1.24 
(0.90) 
1.07 
(0.80) 
0.69 
(0.87) 
24.49 0.66 
(0.40-.95) 
SF-36       
PF 34.2 
(28.7) 
24.4 
(29.7) 
17.7 
(26.5) 
5.4  
(22.5) 
24.19 0.65 
(.38-1.01) 
RP 31.2 
(23.2) 
23.8 
(17.8) 
19.3 
(20.7) 
8.3  
(17.4) 
28.12 0.75 
(.40-1.17) 
BP 31.2 
(23.3) 
24.5 
(18.9) 
19.5 
(20.8) 
12.8 
(17.4) 
27.73 0.74 
(.45-1.18) 
GH 4.2  
(12.8) 
2.3  
(14.8) 
0.1  
(13.1) 
-6.9  
(19.6) 
12.27 0.33 
(0.11-.61) 
VT 14.5 
(17.5) 
10.5 
(17.6) 
5.3  
(16.7) 
-6.8  
(17.5) 
31.41 0.84 
(.52-1.34) 
SF 19.2 
(26.0) 
14.4 
(24.5) 
8.9  
(22.8) 
-3.9  
(23.9) 
18.87 0.51 
(0.27-.86) 
RE 13.8 
(27.4) 
10.4 
(27.9) 
7.1  
(24.4) 
-4.2  
(24.3) 
  8.94 0.24 
(0.09-.45) 
MH 8.6  
(16.1) 
10.6 
(17.2) 
4.9  
(13.5) 
-3.4  
(19.0) 
13.18 0.35 
(0.16-.72) 
PCS 12.6  
(9.2) 
8.7  
(8.0) 
7.4  
(8.5) 
2.5  
(8.3) 
31.36 0.84 
(.51-1.28) 
MCS 3.2  
(10.3) 
3.6  
(10.7) 
0.9  
(8.8) 
-4.0  
(10.7) 
10.89 0.29 
(0.12-.57) 
All measures scored so lower score=poorer health except KOOS-PS where lower score=better health. KOOS-PS N=763. 
Bold=most valid scale or scale RV not significantly different from 1.00. All F-statistics are p<0.0001.
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Table 4.10: Relative validity tests for change in general health SET item (n=814) 
 Mean Change Score (Standard Deviation) 
F statistic RV (95% CI)  Much better (n=290) 
Better 
(n=223) 
Same 
(n=252) 
Worse 
(n=49) 
KOOS       
Symptoms 32.5  
(20.8) 
25.8 
(22.1) 
17.4 
(21.1) 
13.4 
(25.7) 
26.93 0.46 
(0.28-.73) 
Pain 40.8  
(20.1) 
31.1 
(19.0) 
25.7 
(20.7) 
21.6 
(26.0) 
30.05 0.51 
(0.32-.79) 
ADL 34.4  
(17.1) 
26.8 
(15.7) 
22.7 
(19.3) 
17.3 
(22.8) 
26.13 0.45 
(0.25-.70) 
Sport 39.3  
(26.1) 
27.7 
(23.5) 
20.1 
(26.1) 
17.6 
(30.1) 
28.94 0.50 
(0.29-.79) 
QOL 48.6  
(23.7) 
34.8 
(19.6) 
28.6 
(23.6) 
16.9 
(30.7) 
48.47 0.83 
(.53-1.26) 
KOOS-PS (-) -24.4  
(14.1) 
-17.4 
(12.6) 
-14.5 
(15.8) 
-16.3 
(17.2) 
22.56 0.39 
(0.25-.73) 
WOMAC       
Stiffness 35.0  
(25.0) 
25.6 
(26.8) 
20.1 
(27.3) 
17.3 
(31.1) 
16.58 0.28 
(0.14-.49) 
Pain 37.5  
(19.8) 
29.6 
(18.8) 
25.8 
(20.5) 
20.2 
(25.8) 
20.86 0.36 
(0.19-.59) 
ADL 34.4  
(17.1) 
26.8 
(15.7) 
22.7 
(19.3) 
17.3 
(22.8) 
26.13 0.45 
(0.25-.70) 
Short WOMAC Function      
Liebs 39.0  
(18.6) 
30.9 
(16.2) 
25.7 
(20.5) 
22.0 
(24.3) 
27.20 0.47 
(0.28-.74) 
Tubach 36.9  
(18.2) 
28.2 
(16.0) 
23.5 
(20.9) 
19.0 
(23.4) 
28.66 0.49 
(0.29-.77) 
Whitehouse 33.6  
(17.4) 
25.9 
(16.3) 
22.0 
(20.4) 
18.0 
(22.8) 
22.68 0.39 
(0.21-.62) 
IRT-based KOOS ADL/Sport     
Theta score 1.63 
(0.79) 
1.17 
(0.66) 
0.99 
(0.84) 
0.75 
(0.98) 
38.88 0.67 
(.41-1.02) 
CAT RTT≥0.95 1.62 
(0.81) 
1.21 
(0.70) 
1.05 
(0.85) 
0.72 
(0.99) 
32.49 0.56 
(0.33-.87) 
CAT RTT≥0.90 1.57 
(0.82) 
1.18 
(0.71) 
1.01 
(0.84) 
0.67 
(0.95) 
31.02 0.53 
(0.30-.82) 
SF-36       
PF 33.0  
(23.6) 
21.7 
(19.7) 
16.1 
(22.7) 
4.5  
(25.1) 
38.62 0.66 
(0.51-.86) 
RP 35.5  
(29.8) 
23.8 
(25.6) 
14.6 
(25.6) 
2.0  
(25.8) 
37.95 0.65 
(0.51-.85) 
BP 34.9  
(22.7) 
21.4 
(18.2) 
16.0 
(20.1) 
7.2  
(16.4) 
52.68 0.90 
(.68-1.16) 
GH 4.7  
(13.1) 
2.1  
(13.4) 
-0.4 
(13.2) 
-12.8 
(16.7) 
25.79 0.44 
(0.24-.76) 
VT 15.6  
(19.1) 
7.7  
(14.0) 
4.2  
(16.5) 
-4.8 
(21.6) 
31.65 0.54 
(0.33-.84) 
SF 20.4  
(25.5) 
12.6 
(23.5) 
5.9  
(23.5) 
1.0  
(26.4) 
19.93 0.34 
(0.18-.56) 
RE 12.9  
(26.1) 
9.5  
(25.3) 
6.1  
(23.9) 
-3.3 
(36.4) 
  6.93* 0.12 
(0.03-.29) 
MH 9.3  
(17.5) 
7.0  
(13.6) 
3.5  
(13.1) 
-1.0 
(19.7) 
10.25 0.18 
(0.06-.37) 
PCS 13.9  
(9.2) 
8.6  
(7.5) 
6.1  
(8.1) 
0.9  
(8.2) 
58.42 1.00 
- 
MCS 3.0  
(10.5) 
2.1  
(9.1) 
0.5  
(8.6) 
-2.1 
(12.8) 
  5.71* 0.10 
(0.02-.23) 
All measures scored so lower score=poorer health except KOOS-PS where lower score=better health. N for KOOS-PS=784.  
Bold=most valid scale or scale RV not significantly different from 1.00. All F-statistics p<0.0001 except * p<0.001.  
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Table 4.11: Summary of longitudinal self-evaluated transition (SET) tests 
 F-statistic  Relative Validity (95% CI) 
 Phys. Act. Role Emotional Health  Phys. Act. Role Emotional Health 
KOOS          
Symptoms 33.28 38.21 14.03 26.93  0.45 
(0.28-.63) 
0.43 
(0.28-.62) 
0.38 
(0.20-.65) 
0.46 
(0.28-.73) 
Pain 42.97 49.83 23.11 30.05  0.58 
(0.40-.79) 
0.56 
(0.39-.75) 
0.62 
(0.38-.94) 
0.51 
(0.32-.79) 
ADL 37.40 42.43 19.96 26.13  0.51 
(0.35-.68) 
0.47 
(0.33-.64) 
0.54 
(0.31-.80) 
0.45 
(0.25-.70) 
Sport 41.96 43.69 15.33 28.94  0.57 
(0.38-.78) 
0.49 
(0.33-.68) 
0.41 
(0.23-.68) 
0.50 
(0.29-.79) 
QOL 73.90 89.39 37.28 48.47  1.00 
- 
1.00 
- 
1.00 
- 
0.83 
(.53-1.26) 
KOOS-PS (-) 27.51 30.89 12.13 22.56  0.37 
(0.24-.57) 
0.35 
(0.24-.53) 
0.33 
(0.18-.54) 
0.39 
(0.25-.73) 
WOMAC          
Stiffness 21.42 26.09 8.17 16.58  0.29 
(0.16-.44) 
0.29 
(0.18-.44) 
0.22 
(0.09-.40) 
0.28 
(0.14-.49) 
Pain 32.01 34.28 18.41 20.86  0.43 
(0.28-.61) 
0.38 
(0.25-.53) 
0.49 
(0.28-.78) 
0.36 
(0.19-.59) 
ADL 37.40 42.43 19.96 26.13  0.51 
(0.35-.68) 
0.47 
(0.33-.64) 
0.54 
(0.31-.80) 
0.45 
(0.25-.70) 
Short WOMAC Function         
Liebs 41.06 46.25 23.00 27.20  0.56 
(0.39-.76) 
0.52 
(0.35-.70) 
0.62 
(0.36-.91) 
0.47 
(0.28-.74) 
Tubach 39.42 45.76 20.93 28.66  0.53 
(0.37-.74) 
0.51 
(0.35-.69) 
0.56 
(0.33-.85) 
0.49 
(0.29-.77) 
Whitehouse 31.55 38.30 17.51 22.68  0.43 
(0.29-.62) 
0.43 
(0.28-.59) 
0.47 
(0.25-.71) 
0.39 
(0.21-.62) 
IRT-based KOOS ADL/Sport        
Theta score 54.27 60.75 27.65 38.88  0.73 
(0.57-.98) 
0.68 
(0.50-.87) 
0.74 
(.48-1.09) 
0.67 
(.41-1.02) 
CAT RTT≥0.95 51.24 56.51 28.70 32.49  0.69 
(0.51-.92) 
0.63 
(0.46-.82) 
0.77 
(.49-1.12) 
0.56 
(0.33-.87) 
CAT RTT≥0.90 51.71 57.69 24.49 31.02  0.70 
(0.50-.93) 
0.65 
(0.47-.84) 
0.66 
(0.40-.95) 
0.53 
(0.30-.82) 
SF-36          
PF 52.64 55.27 24.19 38.62  0.71 
(0.50-.99) 
0.62 
(0.44-.89) 
0.65 
(.38-1.01) 
0.66 
(0.51-.86) 
RP 44.96 46.35 28.12 37.95  0.61 
(0.42-.88) 
0.52 
(0.35-.74) 
0.75 
(.40-1.17) 
0.65 
(0.51-.85) 
BP 42.18 51.31 27.73 52.68  0.57 
(0.40-.85) 
0.57 
(0.39-.87) 
0.74 
(.45-1.18) 
0.90 
(.68-1.16) 
GH 10.17 12.65 12.27 25.79  0.14 
(0.05-.25) 
0.14 
(0.06-.26) 
0.33 
(0.11-.61) 
0.44 
(0.24-.76) 
VT 22.56 27.72 31.41 31.65  0.31 
(0.17-.46) 
0.31 
(0.20-.45) 
0.84 
(.52-1.34) 
0.54 
(0.33-.84) 
SF 15.72 19.67 18.87 19.93  0.21 
(0.11-.35) 
0.22 
(0.12-.36) 
0.51 
(0.27-.86) 
0.34 
(0.18-.56) 
RE 5.22† 5.66* 8.94 6.93*  0.07 
(0.02-.15) 
0.06 
(0.02-.14) 
0.24 
(0.09-.45) 
0.12 
(0.03-.29) 
MH 7.70 10.40 13.18 10.25  0.10 
(0.03-.22) 
0.12 
(0.05-.20) 
0.35 
(0.16-.72) 
0.18 
(0.06-.37) 
PCS 65.79 69.59 31.36 58.42  0.89 
(.66-1.22) 
0.78 
(.56-1.10) 
0.84 
(.51-1.28) 
1.00 
- 
MCS 2.61§ 3.45‡ 10.89   5.71*  0.04 
(0.00-.09) 
0.04 
(0.01-.08) 
0.29 
(0.12-.57) 
0.10 
(0.02-.23) 
All measures scored so a lower score=poorer health, except for KOOS-PS where lower score=better health. 
KOOS-PS N=789. Bold=most valid scale or scale RV not significantly different from 1.00. 
All F-statistics p<0.0001 except for * p<0.001, † p<0.01, ‡ p<0.05, § p>0.05. 
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Table 4.12: Responsiveness of knee-specific and SF-36 measures (n=820) 
 Pre-TKR 6 month Post-TKR Change Score   
 Mean SD Mean SD Mean SD ES SRM 
KOOS         
Symptoms 49.2 19.8 74.1 16.9 24.9 22.7 1.25 1.10 
Pain 47.6 18.1 80.1 17.2 32.5 21.5 1.80 1.51 
ADL 54.0 18.2 81.8 16.5 27.9 18.8 1.53 1.49 
Sport 19.0 19.4 48.1 27.2 29.0 27.1 1.49 1.07 
QOL 26.7 18.5 63.4 22.6 36.8 25.2 1.99 1.46 
KOOS-PS (-) 48.2 14.1 29.1 13.7 -19.1 15.2 1.36 1.25 
WOMAC         
Stiffness 44.0 22.5 71.0 20.4 26.9 27.4 1.20 0.98 
Pain 53.1 18.9 84.0 15.9 30.9 20.9 1.63 1.47 
ADL 54.0 18.2 81.8 16.5 27.9 18.8 1.53 1.49 
Short WOMAC Function        
Liebs 49.0 18.8 80.8 16.9 31.8 20.0 1.69 1.59 
Tubach 51.0 18.6 80.5 17.1 29.5 19.9 1.58 1.48 
Whitehouse 55.4 18.4 82.5 16.2 27.1 19.3 1.47 1.41 
IRT-based KOOS ADL/Sport       
Theta score -0.36 0.73 0.90 0.83 1.26 0.85 1.72 1.49 
CAT RTT≥0.95 -0.37 0.72 0.92 0.82 1.29 0.86 1.79 1.50 
CAT RTT≥0.90 -0.35 0.71 0.89 0.81 1.24 0.86 1.76 1.45 
SF-36         
PF 40.1 22.1 63.1 24.3 23.0 23.9 1.04 0.96 
RP 44.4 27.4 68.2 27.2 23.8 28.9 0.87 0.82 
BP 37.0 18.2 60.8 22.9 23.7 22.3 1.31 1.06 
GH 71.8 18.1 73.2 19.5 1.4 14.1 0.08 0.10 
VT 53.4 20.7 62.1 20.0 8.7 18.1 0.42 0.48 
SF 69.7 27.0 82.4 23.1 12.7 25.2 0.47 0.50 
RE 76.1 27.7 85.1 22.3 9.0 26.4 0.32 0.34 
MH 74.7 18.6 81.1 16.2 6.4 15.7 0.34 0.41 
PCS 33.6 8.5 42.8 9.8 9.2 9.2 1.08 1.00 
MCS 52.8 11.6 54.5 9.7 1.7 9.9 0.15 0.17 
ES=Effect size; SRM=Standardized response mean.  
All measures scored so a lower score=poorer health, except for KOOS-PS where lower score=better health. 
KOOS-PS N=789. 
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Figure 4.1: Content of self-evaluated transition items in 6-month follow-up survey 
 
Thinking about your everyday physical activities today (such as walking, climbing stairs, carrying 
groceries, or participating in sports); Compared to before your joint surgery, are you more or less 
capable now in your everyday physical activities because of your joint surgery? 
o a lot more capable now 
o somewhat more capable now 
o about the same 
o somewhat less capable now 
o a lot less capable now 
 
Thinking about your daily work at home or in the workplace; Compared to before your joint 
surgery are you more or less able to accomplish your work now because of your joint surgery? 
o a lot more able to accomplish now 
o somewhat more able to accomplish now 
o about the same 
o somewhat less able to accomplish now 
o a lot less able to accomplish now 
 
Compared to the time before your joint surgery, how often do you feel bothered by emotional 
problems, such as feeling anxious, depressed, or irritable now? 
o feel this way a lot more often now 
o feel this way somewhat more often now 
o feel about the same 
o feel this way somewhat less often now 
o feel this way much less often now 
 
Compared to the time before your joint surgery, how would you rate your health in general now? 
o much better now than before surgery 
o somewhat better now than before surgery 
o about the same 
o somewhat worse now than before surgery 
o much worse now than before surgery 
 
 
Source: FORCE-TJR Six-Month Follow-up Knee Survey. Survey Version Date January 10, 2012 
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CHAPTER V: DISCUSSION AND CONCLUSIONS 
 
Results from this research support use of the KOOS and WOMAC among total 
knee replacement patients in the US. (Summary information for all knee-specific 
measures and selected SF-36 measures is presented in Table 5.1, including data on 
reliability, tests of scaling assumptions, floor and ceiling effects, validity, and 
responsiveness). Rates of missing KOOS and WOMAC data were low. Most tests of 
psychometric properties including scaling assumptions were met, and internal 
consistency reliability estimates exceeded recommendations for group-level 
comparisons. These results were consistent across groups differing in age and gender, 
socioeconomic status and clinical status, with few exceptions. Floor (percent with the 
worst measured score) and ceiling (percent with the best measured score) effects 
generally were low and followed expected patterns before and after TKR. KOOS and 
WOMAC scales demonstrated construct validity; hypothesized patterns of correlations 
among scales were observed, and knee-specific scales discriminated well between 
groups differing in knee pain frequency and did not discriminate as well as generic 
measures between groups differing in the number of comorbid conditions, as 
hypothesized. KOOS and WOMAC scales were responsive to TKR surgery in terms of 
statistics such as the effect size and in relation to patient self-evaluated ratings of 
change after TKR.  
By examining numerous knee-specific and generic measures at the same time, 
this study also provided information that is useful in considering how to measure patient-
reported outcomes in TKR more efficiently. Conclusions from these comparative 
analyses and implications for future measurement development are addressed below. 
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How well can knee-specific function be estimated with fewer than 17 items?  
This study compared the 17-item Function in ADL scale used in both the KOOS 
and WOMAC with six different shorter function measures: 7 and 8-item short WOMAC 
function scales developed by Liebs, Tubach and Whitehouse; the 7-item KOOS-PS; a 
CAT score with a reliability≥0.95 or a maximum of 10 items; and a CAT score with a 
reliability≥0.90 or a maximum of 10 items. These comparisons indicated the following: 
1. Fixed-length short function measures generally had similar validity as the longer 
Function in ADL scale.  
The three short WOMAC function scales had extremely high (r=0.94-0.97) 
correlations with the KOOS/WOMAC Function in ADL scale. Correlations with the 
KOOS/WOMAC ADL scale were lower for the KOOS-PS (r=-0.89), but were still high. 
Thus, it was not surprising that relative validity statistics for all these measures generally 
were not notably different, within each cross-sectional and longitudinal known groups 
validity test. In addition, in support of their construct validity, the shorter and full-length 
function measures had similar correlations with scales measuring other constructs. 
2. CAT scores performed better than fixed-length short function scales in tests of known 
groups validity. 
Both CAT scores consistently had higher relative validity than fixed-length short 
function scales in all longitudinal validity tests. CAT scores with a reliability≥0.95 (a level 
recommended instead of a reliability≥0.90 when using a CAT with individual patients) 
were obtained in a mean of 7 to 8 items; similarly, the KOOS-PS and short WOMAC 
function scales each had 7 or 8 items. However, reliability of the KOOS-PS and short 
WOMAC function scales ranged from 0.86-0.90, well below the level of 0.95 
recommended for use in individual patient monitoring and decision-making. These 
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findings suggest that a short knee-specific function measure that targets items to each 
individual patient, as a CAT does, can be more useful than a similar length measure that 
administers the same items to all patients. Further research would need to be conducted 
with additional patient samples, and the item bank would need to be expanded (see 
point #5 below), prior to adoption of a KOOS-based function CAT. In addition, the issue 
of the equivalence and direct comparability of CAT scores and scores estimated from 
the same items administered to all respondents would need to be addressed. However, 
this is a promising area for future research. 
3. Existing fixed-length short function scales may not contain optimal item content. 
IRT models provided a test of how informative each KOOS Function in ADL and 
Sport item was in estimating function, and simulated CATs picked the most informative 
items for each patient. Items in the short WOMAC function scales (Liebs, Tubach, 
Whitehouse) only accounted for 40-56% of all CAT item administrations even for the 
CAT requiring the most items (CAT stopped when reliability was ≥0.95 or at 10 items), 
and the KOOS-PS items only accounted for 19-31% of CAT item administrations (Table 
5.2). Two highly informative items were never (A17, light domestic duties) or were rarely 
(A8, going shopping) included in the existing fixed-length short function scales. A fixed-
length short function scale that was created based on CAT item usage would have 
notably different item content than any existing fixed-length short function scale. 
4. KOOS-PS had notably weaker performance than other short function scales. 
The KOOS-PS has the lowest effect size of all function measures six months 
after TKR, along with the lowest relative validity in comparisons of groups rating their 
health as better, same or worse post-TKR. KOOS-PS items generally were not 
frequently selected in CAT simulations. In addition, there was a higher rate of missing 
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data for the KOOS-PS compared to all other function scales. KOOS-PS scores were 
missing for 5.2% of patients before and 6 months after TKR, because the KOOS-PS 
scoring algorithm requires that all seven KOOS-PS items be answered in order for a 
score to be calculated. Altogether, these results indicate that the KOOS-PS is not a 
preferred function measure for use in TKR. 
5. KOOS and WOMAC do not contain enough relevant items at high function levels. 
CAT simulations showed that while a function score could be estimated precisely 
and efficiently with many fewer than the 22 function items included in the KOOS (or the 
17 function items in the WOMAC) for those with severe OA, the item bank was less 
successful for patients with better levels of knee-specific function. One third of patients 
could not achieve a function score with a reliability of 0.95 six months post-TKR, even 
after administration of 10 items; these patients tended to score at higher levels. While 
the Sport/Recreation items were added to the KOOS in part to measure higher function 
levels, these items had lower item information functions and thus were not frequently 
selected in CAT simulations.   
Additional knee-specific items need to be written to measure higher levels of 
function. One way to do this is to write items that ask about activities that are more 
difficult than those in the Function in ADL scale and are more applicable to an older and 
sicker patient population than the Sport items. For example, this approach was used to 
develop the PROMIS Physical Function item bank; the PROMIS bank includes items 
about more difficult domestic and recreational activities than those in widely-used 
physical functioning scales contained in measures such as the SF-36 and WOMAC130. A 
second approach is to ask about similar activities as in the Function in ADL scale but 
use a different set of responses that extend the range of measurement, such as an 
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“easy-difficult” response continuum in which the best level of function is only achieved by 
patients who report ease in doing an activity, not just that the activity is not difficult. This 
approach is being evaluated by the developer of the SF-36 as a way to construct 
improved physical functioning measures131 and has also been evaluated by others156. 
How useful is the KOOS Sport/Recreation scale among TKR patients? 
While the KOOS Function in Sport/Recreation scale had good reliability and met 
all tests of scaling assumptions, more than one in four patients had the worst possible 
Sport score prior to TKR, and the mean pre-TKR Sport score was very low. As a result, 
the Sport scale only had moderate correlations with the SF-36 Physical Functioning 
scale prior to TKR and did not discriminate between known groups at baseline as well as 
other function measures. Six months after TKR, though, the Sport scale was as 
responsive as all other function scales. 
However, results also suggest that the Sport scale may have limited applicability 
to the entire TKR population. There was a notable increase from pre-TKR to post-TKR 
(from 1.4% to 2.7%) in the percentage of patients for whom a Sport scale could not be 
calculated because fewer than half of the Sport items were answered. Most Sport items 
were not as informative as ADL items and were infrequently chosen in CAT simulations, 
even after TKR. In addition, there was considerable variation in Sport scores post-TKR, 
with the scale standard deviation increasing from a value of 19.4 pre-TKR to a value of 
27.2 six months after TKR in the responsiveness analysis. While this may reflect 
differences in the trajectories of patient recovery, some of this variation may also reflect 
differences in patient preferences for sport activities. Some sport activities may not be 
meaningful to many TKR patients, who may not attempt them post-TKR. While CAT 
simulations show that more difficult items than those in the Function in ADL scale are 
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needed to monitor TKR patients after surgery, the Sport items do not completely fill that 
gap in the TKR patient population. 
Are the KOOS Pain and KOOS Function in ADL scales distinct? 
Previous studies have questioned the extent to which the WOMAC Pain and 
Function scales are conceptually distinct, because they are highly correlated61, 96, 98. 
These high correlations were attributed at least in part to content overlap, since items 
about the same activities (e.g., pain walking, difficulty walking) are included in both 
scales97. High correlations also were seen in this study between the KOOS Pain and 
KOOS Function in ADL scales and between the WOMAC Pain and WOMAC Function 
scales. However, the Pain and Function scales performed somewhat differently in tests 
of known groups validity. Thus, this study lends some support to the distinctiveness of 
the Pain and Function measures. However, this research also suggests that the KOOS 
and WOMAC Pain scales should primarily be interpreted as measures of pain while 
doing physical activities. 
Is the KOOS Pain scale preferable to the WOMAC Pain scale?  
In some respects, the KOOS and WOMAC Pain scales are similar. As would be 
expected for two scales with five items in common, the scales were highly correlated 
(r=0.94). Both scales had good internal consistency reliability, and scale scores could be 
calculated for almost all patients at both time points. However, the four additional pain 
items in the KOOS Pain scale do not have content overlap with the Function in ADL 
items. As a result, the KOOS Pain scale had better item discriminant validity than the 
WOMAC Pain scale in multitrait scaling tests. The KOOS Pain scale also had a lower 
proportion of patients with the best possible score 6 months post-TKR (14% for KOOS 
versus 22% for WOMAC). The KOOS Pain scale also had higher relative validity than 
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the WOMAC Pain scale in longitudinal known groups validity tests, and the KOOS Pain 
scale also had a larger effect size and standardized response mean. Although the 
KOOS Pain scale is longer than the WOMAC scale, the additional items notably 
enhanced scale performance. Thus, the KOOS Pain scale is recommended over the 
WOMAC Pain scale, in spite of the greater respondent burden of the KOOS Pain scale. 
Is the KOOS Symptoms scale preferable to the WOMAC Stiffness scale? 
It is less clear whether to recommend the KOOS Symptoms scale over the 
WOMAC Stiffness scale. The KOOS Symptoms scale is relatively heterogeneous and 
contains items about a variety of knee symptoms, while the WOMAC Stiffness scale only 
includes two items about stiffness. Both scales had similar internal consistency reliability, 
but for different reasons. Items in the KOOS Symptoms scale were not highly correlated 
with each other, but this scale has seven items which increased its internal consistency 
reliability since reliability is based on the average inter-item correlation and number of 
items in a scale. Items in the WOMAC Stiffness scale were highly correlated but the 
scale only contains two items. Six-months after TKR, the WOMAC Stiffness scale had a 
higher percentage of patients with the best possible score (16%) than the KOOS 
Symptoms scale (4%), indicating that a notable percentage of TKR patients experience 
symptoms post-TKR that are not captured by the WOMAC scale. In addition, the KOOS 
Symptoms scale better discriminated between groups with different self-rated 
longitudinal outcomes than the WOMAC Stiffness scale. These findings suggest that 
there may be advantages to using the KOOS Symptoms scale in studies of TKR. 
However, this scale’s relatively low item homogeneity, which is often seen in scales of 
symptoms that largely vary independently, indicate that it may benefit from separate 
scoring and interpretation of its stiffness and non-stiffness components in addition to its 
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overall score. In addition, the WOMAC Stiffness scale may be preferable in some 
studies where only a brief measure of the key OA symptom of stiffness is needed.  
Should the KOOS Quality of Life (QOL) scale be used in all TKR studies? 
While the KOOS QOL scale was not particularly strong in discriminating between 
groups in cross-sectional tests, it stood out in the longitudinal validity tests as the knee-
specific measure with the highest relative validity in discriminating among groups that 
self-evaluated their functioning or well-being as better, same or worse over time. It also 
had the largest effect size 6 months after TKR. The KOOS QOL scale also had good 
internal consistency reliability, little missing data, and met all tests of scaling 
assumptions. This scale has a broader conceptualization of the impact of knee problems 
than other KOOS and WOMAC measures, containing items about the cognitive, 
emotional, functional, and overall general QOL impact of a knee problem. Even if the 
entire KOOS is not used in favor of a shorter questionnaire such as the WOMAC, it is 
highly recommended that the 4-item KOOS QOL scale be included in all TKR studies.  
Should both joint-specific and generic health measures be used in TKR? 
Many TKR studies administer both a knee-specific questionnaire (e.g., WOMAC, 
KOOS) and a generic questionnaire (e.g., SF-36), to include measures that are more 
specific to the impact of knee problems as well as measures that allow for outcomes to 
be compared across different conditions140. However, this increases respondent burden 
and raises the issue as to whether both types of questionnaires are needed in studies of 
knee OA and TKR. As in previous studies27, 155, this study found that knee-specific 
measures of function and pain had larger effect sizes and standardized response means 
than generic measures six months after TKR. However, KOOS, WOMAC and SF-36 
function and pain scales had similar validity in discriminating among groups who rated 
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their health as better, same or worse six months after TKR, with the best SF-36 measure 
(PCS) and best knee-specific scale (KOOS QOL) having equivalent relative validity. 
It is notable that patients who rated their physical and role functioning outcomes 
as “worse” 6 months after TKR improved on average (by 0.4-0.8 SD) on all KOOS 
scales. In contrast, mean scores for the “worse” group generally declined or remained 
stable on the generic SF-36 measures, with the exception of the SF-36 Bodily Pain 
scale. The difference between generic and knee-specific results for the “worse” group 
may reflect the impact of comorbid (non-knee) conditions on health (leading to lower 
generic change scores) even if there was an actual knee-specific improvement, or it may 
reflect other factors. This discrepancy is a subject for future research.  From a 
measurement perspective, however, these results suggest that knee-specific measures 
are not sufficient by themselves to fully understand patient outcomes after TKR and 
should be supplemented with generic measures such as the SF-36 or shorter SF-12® 
Health Survey157. PROMIS provides another set of generic measures that might be 
considered for use in TKR, although experience with PROMIS in osteoarthritis patients is 
limited158. In any event, administering fewer knee-specific function items appears to be a 
more effective way to lower respondent burden than eliminating generic measures from 
TKR studies altogether.  In addition, these results suggest that better measurement of 
comorbidities and their impact is needed in evaluating TKR outcomes. 
Study Limitations  
This study had a number of limitations. First, TKR patients were from high 
volume orthopedic centers in the US only; the types of analyses reported in this study 
should be replicated for TKR patients from other countries, particularly countries in which 
English is not the primary language.  Second, the IRT analyses in Chapter III used the 
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graded response model, which is one type of IRT model used for classical categorical 
rating items such as those in the KOOS and WOMAC. Analyses might be replicated 
using other IRT models such as the generalized partial credit model, although it is 
unlikely that conclusions from the IRT modeling and CAT simulations would change 
based on use of a different IRT model65. Third, criteria used to establish the known 
groups in Chapter IV were based on patient self-report; additional analyses using 
clinician reports to define OA severity groups should be conducted. Fourth, only 6-month 
post-TKR data was available, and responsiveness of all knee-specific and generic 
measures should be re-examined one year or more after surgery. Finally, the patient 
population was limited to those with severe OA who were eligible for TKR. Replication of 
tests of scaling assumptions, reliability, known groups validity and responsiveness in 
patients with milder knee OA and other knee disorders is encouraged. Results of this 
study may not apply to these other patient populations.  
Conclusion 
In summary, this study found that the KOOS and WOMAC scales are reliable, 
valid and responsive among TKR patients in the US. Reliable knee-specific function 
scales that are shorter than the existing KOOS and WOMAC function scale can be 
developed, either as a CAT or a fixed-length short form, but new items that measure 
higher levels of function are required. TKR outcomes should routinely be evaluated with 
a knee-specific quality of life scale such as the KOOS QOL, as well as knee-specific 
measures of pain and function. A generic health measure such as the SF-36 also is 
needed to fully understand patient outcomes after TKR and to compare these outcomes 
with outcomes in other therapeutic areas.  
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Table 5.1: Summary of psychometric tests across measures  
   
% Disc. 
Validity† 
% Floor‡ % Ceiling‡  SF-36 
Correlation§ 
Scale k α* 
Pre-
TKR 
Post-
TKR 
Pre-
TKR 
Post-
TKR 
 
 PF BP 
KOOS           
Symptoms 7 0.74 75 0.7 0.0 0.3 3.6  0.38 0.46 
Pain 9 0.88 89 1.3 0.0 0.5 13.7  0.49 0.66 
Function in ADL 17 0.95 99 0.7 0.0 0.3 9.4  0.57 0.64 
Function in Sport 5 0.89 100 28.8 4.1 0.9 3.9  0.44 0.42 
Quality of Life 4 0.81 100 14.5 0.6 0.1 8.2  0.50 0.53 
KOOS-PS (-) 7 0.86 - 1.3 0.0 0.2 4.1  -0.51 -0.57 
WOMAC           
Stiffness 2 0.78 100 6.2 0.7 2.2 15.6  0.37 0.50 
Pain 5 0.84 70 1.3 0.0 0.9 21.7  0.50 0.63 
Function 17 0.95 91 0.7 0.0 0.3 9.4  0.57 0.64 
Short WOMAC Function           
Liebs 7 0.89 86 1.0 0.0 0.5 15.6  0.55 0.62 
Tubach 8 0.90 94 0.8 0.0 0.6 14.1  0.56 0.64 
Whitehouse 7 0.89 93 0.7 0.0 0.5 15.6  0.53 0.62 
IRT Function           
IRT Theta 22 0.98 - 0.6 0.0 0.1 2.1  0.58 0.64 
CAT RTT≥0.95 3-10 0.95 - 0.7 0.0 0.1 2.2  0.56 0.63 
CAT RTT≥0.90 3-10 0.92 - 0.7 0.0 0.1 2.2  0.56 0.61 
SF-36           
Physical Functioning (PF) 10 0.87 - 1.7 0.7 0.4 2.1  - 0.53 
Bodily Pain (BP) 2 0.77 - 4.7 0.9 0.5 8.0  0.53 - 
PCS 35 0.92 - 0.1 0.0 0.0 0.1  0.82 0.69 
MCS 35 0.92 - 0.0 0.1 0.1 0.0  0.25 0.38 
All measures scored so a lower score=poorer health, except for KOOS-PS where lower score=better health. 
Abbreviations: k=number of items; CAT RTT≥0.95=CAT stopped at SE≤0.23 or maximum of 10 items; CAT 
RTT≥0.90=CAT stopped at SE≤0.32 or maximum of 10 items; PCS=Physical Component Summary; MCS=Mental 
Component Summary.  
* Reliability is measured with Cronbach’s coefficient alpha for all scales, except for IRT theta and CAT scores where 
reliability is the mean reliability across all patient scores.  
† Percent of multitrait scaling tests in which item-hypothesized scale correlation is significantly (p<0.05) higher than item-
other scale correlation. 
‡ % Floor=% with worst possible score; % Ceiling=% with best possible score. Sample for all scales is n=1,143 pre-TKR 
and n=820 6 months post-TKR, except for n=1,102 pre-TKR and n=789 6 months post-TKR for KOOS-PS. 
§ Correlation of scale with SF-36 PF and BP scales, pre-TKR. Sample is n=1,143 except for n=1,102 for KOOS-PS. 
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Table 5.1: Summary of psychometric tests across measures (continued) 
Scale k 
RV Cross-Sectional# 
 
RV Longitudinal# 
ES SRM 
Knee Pain Device Physical Role 
KOOS         
Symptoms 7 0.43 
(0.34-0.56) 
0.11 
(0.04-0.22) 
 0.45 
(0.28-.63) 
0.43 
(0.28-.62) 
1.25 1.10 
Pain 9 1.00 
- 
0.38 
(0.24-0.59) 
 0.58 
(0.40-.79) 
0.56 
(0.39-.75) 
1.80 1.51 
Function in ADL 17 0.59 
(0.48-0.70) 
0.62 
(0.44-0.90) 
 0.51 
(0.35-.68) 
0.47 
(0.33-.64) 
1.53 1.49 
Function in Sport 5 0.27 
(0.18-0.37) 
0.28 
(0.15-0.46) 
 0.57 
(0.38-.78) 
0.49 
(0.33-.68) 
1.49 1.07 
Quality of Life 4 0.50 
(0.38-0.65) 
0.21 
(0.11-0.34) 
 1.00 
- 
1.00 
- 
1.99 1.46 
KOOS-PS (-) 7 0.49 
(0.40-0.64) 
0.53 
(0.35-0.80) 
 0.37 
(0.24-.57) 
0.35 
(0.24-.53) 
1.36 1.25 
WOMAC         
Stiffness 2 0.52 
(0.40-0.67) 
0.12 
(0.05-0.24) 
 0.29 
(0.16-.44) 
0.29 
(0.18-.44) 
1.20 0.98 
Pain 5 0.91 
(0.84-1.00) 
0.41 
(0.25-0.61) 
 0.43 
(0.28-.61) 
0.38 
(0.25-.53) 
1.63 1.47 
Function 17 0.59 
(0.48-0.70) 
0.62 
(0.44-0.90) 
 0.51 
(0.35-.68) 
0.47 
(0.33-.64) 
1.53 1.49 
Short WOMAC Function        
Liebs 7 0.58 
(0.46-0.68) 
0.53 
(0.35-0.76) 
 0.56 
(0.39-.76) 
0.52 
(0.35-.70) 
1.69 1.59 
Tubach 8 0.61 
(0.49-0.73) 
0.62 
(0.43-0.88) 
 0.53 
(0.37-.74) 
0.51 
(0.35-.69) 
1.58 1.48 
Whitehouse 7 0.59 
(0.48-0.70) 
0.57 
(0.40-0.86) 
 0.43 
(0.29-.62) 
0.43 
(0.28-.59) 
1.47 1.41 
IRT Function         
IRT Theta 22 0.61 
(0.50-0.72) 
0.67 
(0.49-0.97) 
 0.73 
(0.57-.98) 
0.68 
(0.50-.87) 
1.72 1.49 
CAT RTT≥0.95 3-10 0.60 
(0.48-0.71) 
0.63 
(0.45-0.90) 
 0.69 
(0.51-.92) 
0.63 
(0.46-.82) 
1.79 1.50 
CAT RTT≥0.90 3-10 0.52 
(0.41-0.64) 
0.61 
(0.42-0.86) 
 0.70 
(0.50-.93) 
0.65 
(0.47-.84) 
1.76 1.45 
SF-36         
Physical Functioning (PF) 10 0.16 
(0.09-0.23) 
1.00 
- 
 0.71 
(0.50-.99) 
0.62 
(0.44-.89) 
1.04 0.96 
Bodily Pain (BP) 2 0.76 
(0.59-0.93) 
0.48 
(0.32-0.72) 
 0.57 
(0.40-.85) 
0.57 
(0.39-.87) 
1.31 1.06 
PCS 35 0.30 
(0.21-0.40) 
0.97 
(0.78-1.20) 
 0.89 
(.66-1.22) 
0.78 
(.56-1.10) 
1.08 1.00 
MCS 35 0.08 
(0.04-0.13) 
0.25 
(0.12-0.44) 
 0.04 
(0.00-.09) 
0.04 
(0.01-.08) 
0.15 0.17 
All measures scored so a lower score=poorer health, except for KOOS-PS where lower score=better health. 
Abbreviations: k=number of items; RV=relative validity; ES=effect size; SRM=standardized response mean;  
CAT RTT≥0.95=CAT stopped at SE≤0.23 or maximum of 10 items; CAT RTT≥0.90=CAT stopped at SE≤0.32 or  
maximum of 10 items; PCS=Physical Component Summary; MCS=Mental Component Summary.  
# Relative validity in relation to scale with highest F-statistic in known groups validity test (frequency of knee pain, use of 
assistive walking device, patient better/same/worse rating of 6 month change in physical activities and daily work role). 
Bold=most valid scale or scale RV not significantly different from 1.00. See Chapter IV for sample sizes.  
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Table 5.2: Percentages of item administrations (most to least) in simulated function CATs 
relative to content of short function scales 
  CAT Utilization (%)* Items in Short Function Scales† 
Label Scale/Item Content 
Pre- 
TKR 
Post- 
TKR Liebs Tubach 
White-
house 
KOOS
-PS 
Activities of Daily Living       
A8 Going shopping 14.39 11.91  ●   
A10 Rising from bed 14.28 9.14   ● ● 
A17 Light domestic duties 14.25 7.80     
A4 Standing 13.65 8.29 ●    
A6 Walking on flat surface 13.15 5.08 ● ● ●  
A15 Getting on/off toilet 11.82 4.01  ●   
A7 Getting in/out of car 9.47 10.02 ● ● ●  
A3 Rising from sitting 4.53 9.00 ● ● ● ● 
A2 Ascending stairs 1.69 6.76 ● ● ●  
A16 Heavy domestic duties 0.52 6.27     
A13 Getting in/out of bath 0.50 0.19     
A1 Descending stairs 0.34 5.67 ● ●   
A14 Sitting 0.28 0.03   ●  
A11 Taking off socks/stockings 0.21 0.04     
A12 Lying in bed 0.18 0.05     
A9 Putting on socks/stockings 0.11 0.14  ● ● ● 
A5 Bending to floor 0.10 2.51 ●   ● 
       
Sport/Recreation       
Sp4 Twisting/pivoting 0.18 4.51    ● 
Sp1 Squatting 0.14 3.26    ● 
Sp3 Jumping 0.10 2.58     
Sp5 Kneeling 0.07 2.05    ● 
Sp2 Running 0.02 0.68     
        
Percent of total CAT item administrations‡     
Pre-TKR   42.9 55.5 43.5 19.4 
Post-TKR   47.3 52.6 40.2 30.6 
* Percent of time an item was selected in a simulated CAT with a stopping rule of SE≤0.23 (reliability≥0.95) or maximum 
number of 10 items. Each column sums to a total of 100% of person-item administrations. 
† The ● indicates that the item is included in the fixed-length short function scale. 
‡ Percent of all person-item administrations accounted for by items included in the short function scale. 
.  
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